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Abstract
Imprinted genes are a subset of loci, positioned on autosomes and the X‐chromosome,
which are expressed monoallelically in a parent‐of‐origin specific manner. The influence of
such genes on the regulation of embryonic growth and postnatal energy homeostasis is
well established. The parental conflict hypothesis predicts that, in utero, paternally‐
expressed genes will promote maternal resource acquisition and thus growth, whereas
maternally‐expressed genes will oppose this action, restricting resource investment in a
single brood in the interests of the lifetime reproductive success of the mother. Grb10 is an
imprinted gene which encodes the cytoplasmic adaptor protein Growth factor receptor
bound protein 10. In the majority of tissues, Grb10 is expressed from the maternally‐
derived chromosome. Consistent with conflict theory, transgenic mice inheriting a
disrupted Grb10 allele through the maternal line (Grb10Δ2‐4m/+) exhibit embryonic
overgrowth, although the mechanisms and signalling pathways responsible for this effect
are unclear. Grb10Δ2‐4m/+ mice also demonstrate enhanced insulin signalling and improved
whole body glucose clearance, consistent with the established role of imprinted genes in
the regulation of postnatal metabolism. An integrated LacZ gene‐trap in the Grb10Δ2‐4
allele failed to fully recapitulate endogenous Grb10 expression, notably within the central
nervous system. To address this issue, a second transgenic mouse line, Grb10KO, was
created. This allele produced strong LacZ reporter expression in the central nervous
system, but only when transmitted through the paternal line (Grb10KO+/p), establishing
Grb10 as the only known imprinted gene with a reciprocal imprinting profile between the
central nervous system and peripheral tissues. Grb10KO+/p mice exhibit a social dominance
phenotype, suggesting distinct roles for maternally‐  and paternally‐expressed Grb10,
consistent with their respective sites of expression. The current study characterised the
Grb10KO allele at the genetic level, and in doing so, revealed a phenotypic difference
between Grb10KOm/p and Grb10Δ2‐4m/p mice for which a possible explanation was
provided. Importantly, with this knowledge, the current study elucidated the genetic and
molecular basis for inconsistencies in reporter expression between the two transgenic
lines, identifying a novel tissue‐specific enhancer element at the locus. In addition to the
central nervous system, this enhancer appeared to be active in the mammary epithelium,
identifying a novel site of Grb10 expression, which was pregnancy‐dependent and
specifically from the maternally‐inherited chromosome. Characterisation of the functional
significance of expression in this tissue revealed that maternally‐expressed Grb10 mediates
a supply/demand system between lactating mother and suckling pup, acting as a supply
promoter and demand suppressor. This role is inconsistent with conflict theory, but
suggests the maintenance of the Grb10 imprint in the mammary epithelium might be
associated with improved coadaptiveness between mother and offspring. Intriguingly, in
utero, Grb10 is both a demand and supply suppressor. When considered together, these
findings suggest a wider role for maternally‐expressed Grb10 in the homeostatic control of
growth and achievement of optimal fitness.
1
Chapter One 
Introduction
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Chapter One 
1.1 Genomic Imprinting
1.1.1 Introduction
The concept and basic behaviour of ‘the gene’ was defined in 1865 by the Augustinian
priest Gregor Mendel, whose experimental work on the inherited traits of pea plants
remains a historic milestone in our understanding of biology. The importance of his work
was not widely recognised until the twentieth century, when eminent names such as
William Bateson and R.A. Fisher applied Mendel’s theories to explain other examples of
phenotypic variation.
Although the terminology we use today to describe genes and heredity did not exist at the
time of Mendel’s discovery, he postulated that ‘particulate factors’ (genes) may pass
unchanged from parent to progeny and that these factors may exist in alternative forms
(alleles). Diploid organisms with two sets of chromosomes would inherit one copy from
each parent, implying equal parental contribution to progeny characteristics. Whilst this
holds true in the majority of cases, some genes appear to be ‘exempt’ from Mendel’s laws
of inheritance, such that the parental contribution to a given trait is not equal.
One of the most striking demonstrations of the non‐equivalence of parental genomes
comes from the study of mice with uniparental disomies (UPD), in which zygotes possess
two paternal or two maternal copies of a specific chromosome. This can be achieved
through Robertsonian translocations, a type of balanced translocation in which the long
arms of two chromosomes join. Whilst a carrier of such a translocation possesses the
normal complement of genetic information, progeny can inherit an extra dose. Studies in
the 1970s demonstrated that, whilst zygotes with maternal or paternal disomy (mUPD or
pUPD, respectively) for chromosomes 1, 4, 5, 9, 13, 14 and 15 appeared to develop
normally (Cattanach, 1986), mice disomic for chromosome 11, for example, exhibited
opposite growth phenotypes depending on the parental origin of the disomy. When both
chromosome 11 copies were of maternal origin, neonates exhibited growth retardation,
whilst neonatal overgrowth was apparent in mice inheriting two copies of chromosome 11
through the paternal line (Cattanach and Moseley, 1973; Cattanach and Kirk, 1985).
Functional non‐equivalence was further illustrated using pronuclear transplantation
experiments, which convincingly demonstrated a requirement for both parental genomes
for successful embryonic development (McGrath and Solter, 1983). The technique was
employed to generate parthenogenetic zygotes (possessing two maternal genome copies;
also called gynogenetic; Pg) and androgenetic zygotes (possessing two paternal genome
copies; Ag), which failed to develop beyond implantation, despite possessing the full
complement of genes (McGrath and Solter, 1984; Surani et al, 1984). Further, the resulting
embryos exhibited somewhat opposing characteristics; parthenogenotes predominantly
consisted of embryonic material, whilst androgenotes displayed a much greater
development of extra‐embryonic tissue (Barton et al, 1984). The phrase ‘imprinting of the
genome’ in reference to this observation was first coined by Surani et al (1984), who
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suggested that the presence of both a male and female pronucleus is essential for a zygote
to develop to term.
The observation that mice with UPD for certain chromosomes essentially developed
normally suggested that, rather than the entire gene complement of the genome,
individual genes or chromosomal regions might be responsible for these parent‐of‐origin
specific effects. The Insulin‐like growth factor 2 (Igf2) gene was the first such imprinted
gene to be identified (DeChiara et al, 1991). Whilst the growth effects of Igf2 had been
studied for some years previously, its imprinted status was not realised until mice with a
targeted disruption of the gene were engineered. Inheritance of this mutation engendered
a dwarfing phenotype, but only when the disrupted allele was transmitted through the
paternal line. RNase protection assays and in situ hybridisation confirmed that the
paternally‐derived copy was transcriptionally active in embryo and placenta, whereas
transcripts arising from the maternally‐inherited copy could not be detected, except in the
choroid plexus.
To date, 131 imprinted genes have been identified in mouse (MouseBook, UK Medical
Research Council, www.mousebook.org), although estimates of how many exist are wide‐
ranging; up to 600 have been predicted (Luedi et al, 2005). Genomic imprinting is also
evident in flowering plants (angiosperms) and coccid insects, as well as sciarid flies; 12
imprinted genes have been found in flowering plants, all of which are imprinted in the
endosperm (Feil and Berger, 2007). Indeed, the phenomenon of parent‐of‐origin specific
effects was first revealed in maize (Kermicle, 1970), although the term ‘genomic imprinting’
was not applied to this effect until later. Originally, ‘genomic imprinting’ referred to the
process of whole chromosome inactivation in sciarid flies (Crouse, 1971), which is
responsible for sex determination (reviewed in Goday and Esteban, 2001). Both the
functions and mechanisms of imprinting exhibit some commonalities between mammals
and plants (discussed later), suggestive of convergent evolution (Feil and Berger, 2007), but
the system in insects appears to have evolved for entirely different reasons, and is not
discussed further in this review.
Early attempts to identify murine imprinted genes focussed on mapping candidates within
chromosomal regions which displayed opposite phenotypes when inherited as uniparental
disomies or following uniparental transmission of a deletion. This approach led to the
identification of Insulin‐like growth factor 2 receptor (Igf2r) as an imprinted gene, which
was found to be the gene responsible for the maternal‐effect mutation in mouse called
Tme (Barlow et al, 1991). Later, more high‐throughput screens were performed using
subtractive hybridisation or microarray experiments. Schulz et al (2006), for example,
describe a microarray‐based screen for imprinted genes using mice with uniparental
duplication (UpDp) of chromosomes 7 and 11. Because imprinted genes are monoallelically
expressed, UpDp might be expected to double their expression levels or ablate them
altogether, depending on the directions of the imprint and the duplication. Transcript levels
of biallelically‐expressed genes would not be expected to differ. Microarray analysis was
used to compare the transcriptomes of maternal UpDp (mUpDp) and paternal UpDp
(pUpDp) tissues, to identify imprinted candidates. The technique provided an inbuilt filter
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to eliminate false positives; many candidates could be excluded because they were
positioned outside of the chromosomal duplication. This study led to the identification of
seven novel imprinted genes, whose imprinted status was validated by single nucleotide
polymorphism (SNP) analysis. One disadvantage of this microarray‐based approach is that
the outcome is limited by the transcripts represented on the DNA‐chip.
Subtractive hybridisation circumvents this problem, and has been used to identify Peg3,
Peg1/Mest and Neuronatin (Kuroiwa et al, 1996; Kaneko‐Ishino et al, 1995; Kagitani et al,
1997). In the case of Peg1/Mest, cDNA from Pg embryos was biotinylated. This was pooled
with cDNA from normal embryos, which had been ligated to oligonucleotide linkers. Upon
denaturation and reassociation, cDNA from the two sources cross‐hybridised, and these
products were subsequently purified out using beads conjugated to streptavidin. The
absence of paternally‐expressed genes in the Pg embryos prevented the corresponding
cDNA from the normal embryos hybridising to biotinylated‐cDNA. Any products not pulled
out using streptavidin could thus be identified by the polymerase chain reaction (PCR),
using primers recognising the oligonucleotide linkers. Although this technique has proved
successful in identifying novel imprinted genes, its scope is limited as Pg embryos die early,
preventing the assessment of imprinting at later developmental stages or in specific tissues
(Oakey and Beechey, 2002).
One property common to most imprinted genes is differential DNA methylation. This is
discussed in more detail in Section 1.1.3, but, briefly, imprinted genes can exhibit different
patterns of methylation dependent on their parent‐of‐origin, thereby enabling the
maternally‐  and paternally‐derived alleles to be distinguished. This property can be
exploited in the search for novel imprinted genes, using a technique called methylation
representational difference analysis (Me‐RDA). Again, the approach compares UpD or
UpDp embryos with normal controls. Genomic DNA is digested by a methylation‐sensitive
restriction enzyme, such as HpaII, and digestion products are ligated to oligonucleotides to
drive PCR amplification. Any DNA species in common between the two samples are
removed by successive rounds of subtractive hybridisation, leaving sequences enriched for
differential DNA methylation. Nesp, Gnasxl and Nespas have all been identified using this
technique (Peters et al, 1999; Kelsey et al, 1999; Wroe et al, 2000). Although the approach
again relies on Pg/Ag embryos, it can be used to identify imprinted genes which are
differentially methylated but might not be expressed at early embryonic stages.
1.1.2 Evolutionary theories of genomic imprinting
The advantages of diploidy are manifested at two levels. For the individual, possessing two
copies of a gene is beneficial if one copy is damaged, as the other can often compensate.
For the population, diploidy promotes the diffusion of genetic variance, increasing the
ability to respond to new environmental stresses, such as disease. Genes subject to
genomic imprinting are functionally haploid. This means that two copies are inherited, but
only one is transcriptionally active, thereby effectively eliminating the benefits to the
individual of diploidy. Thus, imprinting must confer an advantage which outweighs the cost
5
Chapter One 
of functional haploidy. Theories to explain the evolution of imprinting are plentiful, and the
matter is hotly‐contested.
The most widely‐accepted theory is the parental conflict hypothesis, otherwise referred to
as the parental tug‐of‐war, or simply conflict theory (Haig and Westoby, 1989; Moore and
Haig, 1991). The model describes how paternally‐expressed genes in an embryo or placenta
(or indeed, in an endosperm) will promote maternal resource acquisition, whilst
maternally‐expressed genes will antagonise such an activity. A pregnant female mouse, for
example, would be expected to limit resource transfer to developing embryos in the
interests of her lifetime reproductive success, whereas males, who may not father
subsequent offspring from the same female, and whose energy investment in raising a
brood is relatively small, might promote nutrient transfer to provide his offspring with the
best chance of survival. At the time of its conception, this model was supported by the
gross phenotype of Ag embryos, which exhibit enlarged trophoblasts, a structure involved
in nutrient transfer from mother to offspring. The growth retardation associated with
mUPD for chromosome 11, and the overgrowth associated with pUPD for the same
chromosome, also provided support for this model.
Advances in mouse genetics have enabled the functions of many imprinted genes to be
elucidated, no longer relying on the study of large‐scale modifications such as
chromosomal translocations. For many imprinted genes, such studies have revealed
functions consistent with the parental conflict hypothesis. Indeed, the discovery of the
growth retardation phenotype of mice inheriting a dysfunctional Igf2 allele through the
paternal line (DeChiara et al, 1991) could be explained by the model. Further, a prediction
of the model is that some imprinted genes might be in an ‘arms race’ with others,
suggesting that maternally‐  and paternally‐expressed genes might act antagonistically in
the same molecular or genetic pathways. This also sits comfortably with some imprinted
gene examples. Igf2r is maternally‐expressed and opposes the actions of paternally‐
expressed Igf2 in the same signalling pathway (Barlow et al, 1991). The non‐coding
maternally‐expressed H19 gene also regulates Igf2 imprinting, such that a relaxation of H19
expression causes Igf2 to be transcribed from both parental alleles, an example of
antagonism at the genetic level (Steenman et al, 1994).
A similar effect is observed for imprinted genes in the endosperm of flowering plants. An
increased dosage of maternal genomes reduces endosperm size and restricts seed
development, with the opposite effect resulting from multiple paternal genomes (Scott et
al, 1998). MEDEA (MEA) is a maternally‐expressed gene active in the endosperm (Kiyosue
et al, 1999). Maternal inheritance of a loss‐of‐function MEA mutant results in endosperm
overgrowth, suggesting the normal function is to restrict endosperm development
(Kinoshita et al, 1999). Such observations are consistent with the conflict theory. The
development of flowering plant seeds, like mammalian embryos, requires a much greater
maternal than paternal investment, establishing the imbalance which is likely to favour the
evolution of imprinting.
It is interesting to note that the authors of the original parental conflict hypothesis made
some predictions about where and when murine imprinted genes might be expressed to
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correlate with this proposed role of regulating maternal resource allocation; essentially any
loci involved in the acquisition of maternal nutrients, including loci influencing placental
growth, suckling, neonatal behaviour, appetite and hypothalamic function, nutrient
metabolism and postnatal growth rate (Moore and Haig, 1991). At the time of publication,
only the Igf2 gene had been identified as being imprinted, yet subsequent studies have
revealed imprinted genes involved in all of these processes. Indeed, the imprinted gene
encoding the Growth factor receptor bound protein 10, Grb10, influences at least three of
these processes in the mouse; placental growth, nutrient metabolism and postnatal growth
(Charalambous et al, 2003; Smith et al, 2007; Charalambous et al, submitted).
An alternative proposal is derived from the observation that parthenogenetic mammals do
not exist, and efforts to produce such lines in the laboratory have generated
teratocarcinomas (Kaufman et al, 1983). Such a phenomenon does occur in other
vertebrates, including some reptiles, fish and even birds (Lampert, 2008). As genomic
imprinting is limited among vertebrates to mammals, it has been proposed that such a
system developed to prevent parthenogenesis, requiring a contribution from both parental
genomes. Imprinting would therefore be under maternal control. However, silencing an
allele which terminates parthenogenetic embryos would also prevent asexual
reproduction, thereby decreasing its frequency compared with an active allele which
permitted this mode of reproduction. Thus, an allele with such properties would be
selected against (Hurst, 1997). However, an argument in favour of preventing
parthenogenesis has been presented by Varmuza and Mann (1994). Through their
dramatically named ‘ovarian time bomb’ hypothesis, the authors argue that ovarian
trophoblastic disease has sufficient cost to warrant the elimination of parthenogenotes.
Trophoblastic disease could arise from an unfertilised egg developing in the ovaries, with
potentially fatal consequences for the mother. Inactivation of maternal growth‐promoting
genes would guard against such a catastrophe, and the system would spread rapidly due to
the increased fitness correlated with suppression of a deadly disease (Varmuza and Mann,
1994; Weisstein et al, 2002).
One strong counter‐argument to the ovarian time bomb hypothesis is that the frequency of
mammalian ovarian teratomas is very low, and the selection pressure for the evolution of
imprinting to guard against this disease is not sufficiently strong (Solter, 1994). Weisstein et
al (2002) demonstrate that even a low frequency of teratomas provides sufficient selection
pressure to maintain genomic imprinting, but point out that the pressure must be higher
initially for imprinting to evolve. A second objection to the model is that the silencing of a
single maternal allele would be sufficient to prohibit parthenogenesis, and so the existence
of multiple imprinted genes is inconsistent (Haig, 1994). Thirdly, the ovarian time bomb
hypothesis fails to explain the silencing of paternally‐inherited alleles. Finally, the
reproductive strategies of angiosperms eliminate the possibility of ovarian cancer, and thus
the hypothesis cannot explain imprinting in this system (Haig, 1994; Moore, 1994).
A host of models has been proposed to explain the evolution of imprinting, each with their
merits and pitfalls (for a review, see Hurst, 1997), yet the most widely‐accepted remains
the parental conflict theory. However, despite its consistency with the elucidated functions
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of many imprinted genes, the hypothesis is inadequate to explain other observations. An
important limitation is that it cannot account for the persistence of imprinting in adult
tissues (Hurst et al, 2000). It also offers no explanation for the predominance of maternally‐
expressed imprinted genes in the placenta, which would be expected to occur with equal
frequency to paternally‐expressed genes. These two arguments are addressed by the
maternal‐offspring coadaptation theory (Wolf and Hager, 2006). This model describes how
genes which benefit both mother and offspring are under greater pressure to become
imprinted. This could occur through pleiotropy, in which a single gene affects different
traits in mother and offspring, or linkage disequilibrium, in which two genes on the same
chromosome might become tightly linked because one influences a maternal trait, and the
other, an offspring trait. In such situations, natural selection would favour genomic
imprinting because it promotes the genetic integration of coadapted mother and offspring
traits. Moreover, genes fulfilling this role are most likely to be maternally‐expressed,
explaining the predominance of maternally‐expressed imprinted genes in the placenta.
Further, the model would account for the persistence of imprinting in adult tissues if they
influenced maternal behaviour or physiology to enhance fitness. However, this model
cannot explain the apparent convergent evolution of imprinting in mammals and plants.
The maternal‐offspring coadaptation model is discussed further in Chapter Six.
Another provocative argument against the conflict theory is that imprinting persists in
monogamous species. This was demonstrated by Vrana et al (1998) comparing the
monogamous Peromyscus polionotus and the polyandrous P. maniculatus. P. polionotus is a
rare example of a monogamous rodent species, which inhabits much of North America
(Crossland and Lewandowski, 2006). Monogamy has been confirmed by genetic studies
(Foltz, 1981), as well as being inferred from the absence of sexual dimorphism, which
typically correlates with monogamy in wild populations (Vrana et al, 1998). The imprinted
statuses of H19, Igf2 and Igf2r observed in P. maniculatus, which are similar to those
observed in the more common laboratory mouse speciesMus musculus, also persisted in P.
polionotus. On the surface, this observation cannot be explained by the conflict theory,
which relies on multiple paternities. The authors argue that the theory might have
predicted a relaxation of imprinting in the monogamous species. However, as highlighted
by Moore and Mills (1999), the loss of imprinting (LOI) of a potent growth promoter, such
as Igf2, would double gene dosage and by inference, increase resource demands. Such LOI
would therefore be strongly counter‐selected, and would be sufficient to maintain genomic
imprinting even in the absence of multiple paternities. Additionally, even a low rate of
partner exchange may be sufficient to exceed the negative effects of exposure to
deleterious recessive alleles, maintaining imprinting (Hurst, 1998; Haig, 1999).
In conclusion, the conflict theory persists as the most widely‐accepted model for the
evolution of imprinting in mammals, accounting for the majority of imprinted gene
expression patterns and functions. Further, this remains the only model accounting for the
apparent convergent evolution of imprinting in mammals and plants. However, it is
plausible that whilst parental conflict may have been the initial selective pressure for
imprinting mechanisms to evolve, the system may have been subsequently adopted by
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other loci in the mammalian genome for different reasons. Perhaps there is not a ‘one size
fits all’ model.
1.1.3 Mechanisms and features of imprinted genes
As well as stimulating much debate on the fundamental reasons for its evolution, genomic
imprinting raises another key question: how can such a system be regulated? If two alleles
of a gene, one from each parent, are identical in sequence, how can they be distinguished
to permit parent‐of‐origin specific expression?
Almost all imprinted genes identified in mammals and plants thus far are under the
influence of differential DNA methylation. DNA can be methylated on CpG dinucleotides,
such that the sequence of the DNA is unaffected. This is referred to as an epigenetic
modification. Sequences rich in CpG dinucleotides are called CpG islands, and imprinted
genes are typically rich in such regions; around 88 % of mouse imprinted genes include or
overlap with a CpG island, compared with the genomic average of 47 % (Reik and Walter,
2001). CpG islands can be differentially methylated, such that one parental allele is
relatively rich in methyl groups (hypermethylated) whilst the other is relatively poor
(hypomethylated). This provides a mechanism for distinguishing parental alleles.
Differentially methylated regions (DMRs) vary in their properties. Whilst some are tissue
specific (somatic DMRs) others are established in parental germ cells and persist at all
developmental stages and tissue types (germline DMRs). Additionally, whilst promoter
methylation at biallelically‐expressed loci has traditionally been considered repressive for
transcription, methylation at DMRs can be associated with the promotion or suppression of
gene activity, depending on the locus in question.
If DNA methylation is to mark parental alleles, and so permit their discrimination, the mark
must be reset every generation, such that the imprint in the gametes reflects the gender of
the parent. To this end, there is a well‐defined life cycle for imprints, involving erasure of
the existing imprint early in germ cell development, establishment of a new imprint in the
germ cells, and maintenance of the imprint as chromosomes segregate and cells multiply
and differentiate (Figure 1.1). At around embryonic day 12.5 (e12.5), the germ cells of both
sexes undergo a global demethylation event (Tada et al, 1998), although it is not certain if
this is an active or passive process. The fusion of embryonic germ (EG) cells isolated at this
stage with somatic cells causes demethylation of the somatic genome, suggesting the
process is active and dominant (Tada et al, 1997). At later foetal stages, and persisting after
birth, the germ cells undergo de novo methylation. For oocytes, which are held in meiotic
arrest, de novomethylation occurs during their growth (Obata et al, 1998), whilst the nuclei
of sperm are methylated prior to meiosis (Ueda et al, 2000). However, a mechanism must
exist to permit specific targeting of DMRs in the male or female germ cells. This is made
more challenging because the de novomethylation event is not specific to imprinted genes,
but a global effect. Thus, the CpG islands of imprinted genes must exhibit other features
which mark them out. One possible mechanism is the different timing of DNA replication
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during S phase which is characteristic of imprinted genes (Kitsberg et al, 1993). Indeed, this
feature arises early in germ cell development, and at least in oocytes, precedes de novo
methylation (Simon et al, 1999). Such timing differences might alter the accessibility of
DMRs to de novo methylation enzymes, marking them out from other genes. The key de
novo methylation enzymes are DNA methyltransferase (Dnmt)3A and Dnmt3B, which
methylate CpG dinucleotides on previously unmethylated DNA. Although very similar in
tertiary structure, both proteins are essential for embryonic development, as deficiency for
either protein is embryonic lethal, suggesting some non‐redundant roles for each (Okano et
al, 1999). Whilst Dnmt3A and Dnmt3B can catalyse de novo methylation, they are unable,
alone, to establish sex‐specific imprints in the germ line. Dnmt3L was identified as a
potential candidate for this role based on sequence similarity to Dnmt3A and Dnmt3B
(Aapola et al, 2000), but intriguingly, lacked some of the active sites necessary to catalyse
CpG methylation itself (Bourc’his et al, 2001). Mice inheriting a disrupted Dnmt3L allele,
although viable, were infertile (Bourc’his et al, 2001). Analysis of germ cells confirmed that
Dnmt3L was expressed at the stages when imprints are established, utilising a LacZ gene
trap knocked‐in to the locus. Moreover, maternally‐methylated imprinted genes, including
Snrpn and Peg1, were heavily methylated in control oocytes, but hypomethylated in
Dnmt3L‐disrupted oocytes. Global DNA methylation was not notably affected by ablation of
Dnmt3L, suggesting this formed part of the mechanism for establishing maternal
methylation imprints during oogenesis, although the lack of a DNA methyltransferase
domain implied that the protein did not perform de novomethylation itself (Bourc’his et al,
2001). Interestingly, in Dnmt3L‐/‐ oocytes, some DMRs are methylated ‘correctly’, but this is
a stochastic process (Arnaud et al, 2006). This suggests that other factors may also be
involved in mediating this process, which can, alone, be sufficient to correctly methylate
some DMRs.
The maintenance of differential methylation is mediated by a different enzyme, Dnmt1.
Mice deficient for Dnmt1 die in mid‐gestation, exhibiting delayed development, with a 3‐
fold reduction in DNA methylation (Li et al, 1992). Dnmt1 interacts with several cell cycle
regulators, including proliferating cell nuclear antigen (PCNA) and p21WAF, a cyclin‐
dependent kinase (CDK) inhibitor (Chuang et al, 1997), suggesting it is tightly coupled to cell
replication. Maintenance of methylation is achieved through the preference of Dnmt1 for
hemi‐methylated, rather than unmethylated, DNA (Zucker et al, 1985). However, there is a
second wave of global demethylation which follows fertilisation, and subsequent de novo
methylation post‐implantation. Imprints must resist these, yet it is not known how this is
achieved. The fertilisation‐induced demethylation occurs in the pronuclei, before nuclear
fusion. In the paternal pronucleus, the process is predominantly active (Oswald et al, 2000).
The female pronucleus, however, fails to maintain methylation during DNA replication,
thereby demethylating its genome in a passive manner (Rougier et al, 1998). This is
associated with the exclusion of Dnmt1 from the nucleus (Carlson et al, 1992), so this
enzyme cannot form part of the mechanism responsible for protecting imprints.
Polycomb group (PcG) proteins are also involved in the epigenetic regulation of imprinted
genes. The imprinted paternal X chromosome is reactivated in embryos deficient for the
PcG protein Eed (Wang et al, 2001). This was extended to examine autosomal imprinted
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loci, for which LOI was apparent for four paternally‐repressed genes: Cdkn1c, Ascl2, Grb10
and Meg3 (Mager et al, 2003). Other imprinted loci exhibited normal parent‐of‐origin
specific expression, indicating that Eed regulates imprinting of a subset of genes. LOI
correlated with aberrant DMR methylation in e7.5 Eed‐/‐ embryos.
Eed is a component of Polycomb repressor complex 2 (PRC2), which mediates histone
methylation. This is another example of an epigenetic modification, which can regulate the
expression of genes. Histone modifications are discussed in more detail in Chapter Five, but
in summary, are important for the regulation of imprinting at some loci, both in mammals
and plants. For example, the imprinted expression of Grb10 is partly regulated by histone
methylation, which is lost in Eed‐/‐ embryonic stem (ES) cells, resulting in relaxation of the
imprint (Sanz et al, 2008). This suggests that Eed, through its role in PRC2, regulates histone
methylation, and that this, in turn, may perturb DNA methylation at some DMRs. This
illustrates the intimate relationship between various regulatory mechanisms to tightly
control imprinted gene expression.
Non‐coding antisense transcripts are also involved in regulating genomic imprinting, and in
some cases, these have also been shown to tightly couple with histone modifications.
Intriguingly, most of these transcripts identified to date are themselves subject to
imprinting (Reik and Walter, 2001). The most extensively studied example is the Air
transcript which is driven by a promoter located in intron 2 of the Igf2r gene (Lyle et al,
2000). Air is expressed exclusively from the paternally‐inherited chromosome. In the
embryo proper, Air suppresses Igf2r expression in cis. The mechanism for achieving this is
not clear, but given the overlap between the two, it is conceivable that the Air transcript
hybridises with the Igf2r transcript, resulting in dsRNA‐induced degradation. However, this
is disputed. Evidence against this mechanism comes from the observation that Air also
suppresses the transcription of two other imprinted paternally‐expressed genes, Slc22a2
and Slc22a3, which are situated over 230 kb away from the Air promoter (Sleutels et al,
2002; 2003). Further, suppression of these two genes is tissue‐ and stage‐specific, occurring
only in the early‐ and mid‐gestation placenta (Nagano et al, 2008). Imprinting of Slc22a3 is
relaxed between e11.5 and e15.5, although Air continues to be transcribed. Intriguingly, Air
transcripts were found to overlap with the Slc22a3 gene locus in the e11.5 placenta, as
demonstrated by RNA‐DNA fluorescence in situ hybridisation (FISH). A cover index was
used to quantify the extent of the paternal Slc22a3 locus ‘clouded’ by Air in situ signal. At
e11.5, an analysis of z‐stacked images suggested a high cover index, which was significantly
reduced at e15.5, concomitant with a relaxation of the Slc22a3 imprint. These results
implied that Air transcripts coat the genomic locus to suppress transcription, in a
mechanism reminiscent of that observed for X chromosome inactivation (reviewed in Chow
and Heard, 2009). Whether this is also the mechanism for the regulation of Igf2r expression
requires further attention.
As a further demonstration of the coupling of regulatory mechanisms, the Slc22a3
promoter is subject to differential histone modifications at e11.5 versus e15.5. As discussed
in Chapter Five, specific modifications are associated with transcriptionally active and
inactive DNA. At e11.5, histone modifications at the paternal Slc22a3 locus were
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predominantly repressive, which were replaced by active marks at e15.5 (Nagano et al,
2008). This correlation between the enrichment of such marks and the changes in Air cover
index suggested the two may be functionally linked. One possibility was that Air may
recruit histone‐modifying complexes, such as the G9a histone methyltransferase, which is
involved in modifying histones at the Kcnq1 imprinted domain in the placenta (Wagschal et
al, 2008). RNA immunoprecipitation (RNA IP) demonstrated that Air and G9a were
physically coupled, and chromatin immunoprecipitation (ChIP) confirmed G9a enrichment
only at the paternally‐inherited allele (Nagano et al, 2008). In mice with a truncated Air
transcript, Air‐T (Sleutels et al, 2002), inherited through the paternal line, FISH signal for Air
was weak at the Slc22a3 promoter. Moreover, ChIP suggested a considerable reduction in
G9a at the site, suggesting that full‐length Air is necessary for the correct targeting of G9a
to the paternal promoter.
The complexities of understanding imprinted gene regulation are further obscured by the
clustering of such genes. Clusters can include a range of maternally‐, paternally‐  and
biallelically‐expressed genes, which share regulatory elements, such as DMRs. Germline
DMRs which influence the expression of multiple genes in a cluster are called imprinting
control regions (ICRs). Thus, despite the earlier statement that ~88 % of imprinted genes
possess CpG islands, almost all others are probably influenced by DMRs shared with other
genes. The H19/Igf2 locus exemplifies several of the regulatory features of imprinted
clusters, and is discussed further in Chapter Five.
The control of imprinted gene expression is complex, with multiple mechanisms interacting
to achieve fine‐tuned levels of transcription. As many imprinted genes encode potent
regulators of growth, metabolism and behaviour (discussed in the next section), changes to
their expression can have dramatic, and often catastrophic, consequences. Human
disorders such as Beckwith‐Weidemann syndrome, Angelman syndrome and Prader‐Willi
syndrome can all arise as a consequence of aberrant imprinting.
1.1.4 Imprinted genes in mammals – functions and disease
As mentioned earlier, the parental conflict hypothesis predicted that imprinted loci should
be a subset of genes involved with the regulation of maternal resource allocation, and the
authors proposed several physiological processes likely to be under the influence of
genomic imprinting (Moore and Haig, 1991). It follows that the mutation of such genes, or
their LOI, would perturb these processes, resulting in aberrant development and
potentially disease. Here, we review the various physiological processes influenced by
imprinted genes and relate them, where possible, to human disease states.
Perhaps most predictably, several imprinted genes influence the growth of the mammalian
placenta, which is a transient organ largely responsible for regulating foetal development.
Although the functions of many imprinted genes have been elucidated through gene
knockout experiments, many are expressed in both the placenta and foetus, and it can
therefore be difficult to determine the influence of gene ablation in the placenta alone on
13
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foetal development. This problem can be conveniently circumvented in the case of Igf2,
because the majority of transcripts expressed in the placenta arise from a tissue‐specific
promoter. Ablation of these so‐called Igf2P0 transcripts resulted in placental growth
retardation similar to that observed for complete Igf2 null embryos (DeChiara et al, 1991;
Constância et al, 2002; Reik et al, 2003).
Igf2 encodes the ligand insulin‐like growth factor 2, which forms part of the important
growth regulatory IGF signalling system. Whilst ablation of either Igf2 or the structurally‐
related Igf1 engendered a 40 % growth reduction at birth relative to wild type controls
(DeChiara et al, 1990; Liu et al, 1993), dual ablation resulted in a more dramatic growth
restriction. Intriguingly, these double knockout mice were essentially indistinguishable
from animals lacking the Insulin‐like growth factor 1 receptor (Igf1r) gene, suggesting the
growth effects of these two ligands are predominantly mediated through IGF1R (Liu et al,
1993). This signalling system is in part regulated by the actions of the insulin‐like growth
factor 2 receptor (IGF2R), also called the mannose‐6‐phosphate receptor (M‐6‐Pr), the
genetic ablation of which results in embryonic overgrowth, when maternally transmitted
(Lau et al, 1994). Igf2r‐/‐ mice can be rescued from perinatal lethality on an Igf2‐/‐
background, supporting earlier evidence that the lethality is associated with elevated IGF2
levels which are incompatible with life (Ludwig et al, 1996). As mentioned previously, this
identified Igf2r as a negative regulator of Igf2 activity. Igf2r is itself imprinted and
expressed from maternally‐inherited chromosome 17 in mouse (Barlow et al, 1991),
providing a classic example of the antagonistic actions of maternally‐  and paternally‐
expressed genes in the regulation of foetal growth, consistent with conflict theory. Further,
M‐6‐Pr orthologs in chicken, Xenopus and platypus, species which do not exhibit imprinting,
lack the IGF2 binding domain, suggesting that this function correlates with the evolution of
genomic imprinting (Killian et al, 2000).
IGF2 in the placenta signals through an as‐yet unidentified receptor, and whilst IGF2
appears to control placental size, and by inference foetal growth, the mechanism by which
this is achieved remains unclear. The actions of IGF2 in the placenta are further discussed in
Chapter Four.
Although a large part of the growth effects of Igf2 appear to be attributable to Igf2P0 in the
placenta, changes in the levels of IGF2 expression in humans correlate with an imprinted
gene disorder called Beckwith‐Weidemann syndrome (BWS). BWS is characterised by
intrauterine overgrowth of both embryonic and extra‐embryonic tissues, which persists
postnatally, as well macroglossia (hypertrophy of the tongue), anterior abdominal wall
defects and a predisposition to childhood cancers (Maher and Reik, 2000). The molecular
basis of the syndrome is complex, being associated with a cluster of at least fifteen genes
on human chromosome 11p15.5, referred to as the BWS locus. At least nine of these are
imprinted, and include IGF2 and H19. The embryonic and postnatal overgrowth are often
correlated with elevated IGF2 expression. Indeed, a large proportion of patients which do
not possess cytological abnormalities, such as duplication of 11p15.5, demonstrate
increased IGF2 expression (Weksberg et al, 1993). This is typically the result of aberrant
14
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methylation at the IGF2/H19 ICR, resulting in silencing of H19 and biallelic expression (or
LOI) of IGF2.
The maternally‐expressed p57KIP2 gene also forms part of the BWS locus. Point mutations
in this gene are associated with 5‐10 % of sporadic and 40 % of familial BWS cases (Smith et
al, 2006). Whilst these patients do not exhibit altered levels of IGF2/H19 expression, the
disease presentation is similar to that for cases in which the primary genetic defect is
disruption of IGF2/H19. This suggests that the protein product of the p57KIP2 gene may
negatively regulate the IGF2 growth pathway. This hypothesis is supported by mouse
genetics, in which Igf2 over‐expression suppresses the ortholog of p57KIP2, Cdkn1c
(Grandjean et al, 2000). Additionally, mice exhibiting both loss of function of Cdkn1c and
LOI of Igf2 more closely recapitulate the aetiology of the human syndrome than mice with
either mutation alone (Smith et al, 2006). Thus, perhaps Igf2/IGF2 and Cdkn1c/p57KIP2 act
antagonistically in the same growth pathway, again consistent with conflict theory.
A further epigenetic cause of BWS is loss of methylation on the maternal allele at the ICR
situated near the KVLQT1 gene, referred to as KvDMR1. Patients with an inversion
breakpoint at this DMR exhibited biallelic IGF2 expression, whilst retaining imprinted H19
expression and normal methylation patterns at the IGF2/H19 locus (Brown et al, 1996). This
suggests that IGF2 expression can be regulated in a manner independent of H19, although
the mechanism for this is not certain. Loss of methylation on the maternal KvDMR1
correlates with expression of an antisense transcript, KCNQ1OT, from the maternal gene
copy, which might act to de‐repress IGF2 imprinting (Maher and Reik, 2000).
Like paternally‐expressed Igf2, maternally‐expressed Grb10 is expressed in both the
placenta and embryo proper, but the relative influence of these sites of expression on
foetal growth have not been determined. Mice inheriting a disrupted Grb10 allele through
the maternal line are 30 % larger than wild type littermates at birth, and possess
disproportionately enlarged livers, whilst the brain is spared (Charalambous et al, 2003).
This correlates with sites of action of Grb10 expressed from the maternally‐inherited allele
in the foetus, suggesting part of the overgrowth is attributable to Grb10 expression in the
embryo itself. However, the associated placentae are also overgrown, with
disproportionately enlarged labyrinths (Charalambous et al, submitted), the cell layer
involved in mediating maternal nutrient transfer. Thus, the direct and indirect influences of
Grb10 ablation on foetal development cannot be uncoupled, without further genetic or
transplantation experiments.
An increased dosage of GRB10 has been implicated with Silver‐Russell syndrome (SRS), a
disease characterised by intrauterine and postnatal growth restriction, as well as other
features (for a review, see Preece, 2002). About 10 % of SRS cases correlate with maternal
UPD of chromosome 7, and whilst three imprinted genes reside on this chromosome, most
cases are associated with mUPD of 7p11.2‐p12 at which GRB10 is situated (Preece, 2002).
Two other genes within this region influence foetal growth, IGFBP1 and EGFR, but both are
biallelically‐expressed, leaving GRB10 as the most likely SRS candidate gene. Indeed, Grb10
over‐expression in mice results in intrauterine growth restriction (Shiura et al, 2005), as
does a maternal duplication of mouse proximal chromosome 11, which includes Grb10
15
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(Cattanach et al, 1996). However, no methylation abnormalities at the GRB10 locus have
been identified in SRS patients, suggesting that, if GRB10 expression is the molecular basis
for SRS, it may be mediated by another regulatory mechanism. Recently, an imprinted
antisense RNA was identified at the mouse Grb10 locus (Babak et al, 2008), although its
properties and functions are yet to be investigated.
Foetal growth and adult metabolism are closely linked, often involving the same genetic
pathways or players. Impaired foetal development has long been correlated with adult
disease states, and nutrition availability in utero can influence the epigenetic regulation of
genes involved with metabolism (for a review, see Waterland and Jirtle, 2004), in the
process of ‘foetal programming’. Many of the imprinted genes implicated in growth
therefore influence postnatal energy homeostasis. Murine Grb10, for example, also
influences adult metabolism. Grb10 ablation on the maternal chromosome enhances blood
glucose clearance, in part by enhancing insulin signalling and also because Grb10 ablation
results in increased lean tissue, a sink for glucose (Smith et al, 2007).
The human Zinc finger protein that regulates apoptosis and cell‐cycle arrest (ZAC) and
Hydatidiform‐mole associated and imprinted transcript (HYMAI) genes are also thought to
influence both foetal growth and adult metabolism. Both genes are imprinted and
expressed from paternally‐inherited chromosome 6q24, situated at a region associated
with transient neonatal diabetes mellitus (TNDM). This paternal‐transmission disorder is
characterised by intrauterine growth retardation, dehydration and hyperglycaemia, with
associated hypoinsulinaemia (Hamilton‐Shield, 2007). Following the neonatal period, most
TNDM patients demonstrate normal glucose homeostasis until adolescence or early
adulthood, when type 2 diabetes reappears (Temple et al, 2000). ZAC is pro‐apoptotic and
was independently discovered as a tumour suppressor gene (originally called Pleomorphic
adenoma gene‐like 1, PLAGL1; Kas et al, 1998). One of its transcriptional targets is the
Pituitary adenylate‐cyclase activating polypeptide (PACAP) type 1 receptor (PAC1‐R) gene;
PACAP regulates insulin secretion in response to elevated serum glucose and promotes
pancreatic  β‐cell proliferation (Ciani et al, 1999; Rodríguez‐Henche et al, 2002).
Perturbation of  β‐cell proliferation or secretory function is thought to be the basis for
TNDM; this was supported by the post‐mortem histological assessment of a patient with
TNDM, whose pancreas was lacking insulin‐positive cells (Blum et al, 1993). Mice over‐
expressing the human TNDM locus also demonstrate a reduction in fully‐differentiated β‐
cells, suggesting this is the likely pathological basis for the disorder (Ma et al, 2004).
The Gnas locus on mouse chromosome 2 is predominantly associated with the control of
metabolic processes, rather than growth. The locus consists of a maternally‐expressed
gene, Nesp, three paternally‐expressed genes, Nespas, Gnasxl and Exon 1A, as well as the
Gnas gene itself, which is generally biallelically‐expressed but imprinted (paternally‐
silenced) in some tissues, including the proximal renal tubules, anterior pituitary gland,
thyroid gland and ovary (Yu et al, 1998; Hayward et al, 2001; Germain‐Lee et al, 2002;
Mantovani et al, 2002). Gnas and Gnasxl encode G‐protein  α subunits (Gαs and XLαs,
respectively) which activate adenylyl cyclases in response to ligand‐binding at G‐protein
16
Chapter One 
coupled receptors (GPCRs), promoting the synthesis of cyclic adenosine monophosphate
(cAMP).
Gnas exon 2 is common to all transcripts arising at the Gnas locus identified to date, except
for Nespas which produces a non‐coding RNA (Plagge et al, 2008). Mice inheriting a
dysfunctional exon 2 through the maternal line are hypometabolic, whereas paternal
transmission results in mice which are lean and hypermetabolic, reflecting the imprinted
status of the locus (Yu et al, 1998). Specific deletion of Gnasxl produces mice which are lean
and exhibit reduced circulating insulin, glucagon and glucose levels, comparable with the
hypometabolic state engendered by paternal deletion of Gnas exon 2 (Plagge et al, 2004).
Conversely, paternal deletion of Gnas exon 1, which affects only Gnas transcripts,
engenders obesity and insulin resistance, comparable to maternal Gnas exon 2 ablation
(Chen et al, 2005). Together, these results imply that Gnas and Gnasxl have opposite
effects on glucose and lipid metabolism (Plagge et al, 2004; Plagge et al, 2008). This is likely
to be a consequence of their differential expression profiles in the central nervous system
(CNS) which correlate with distinct functions in the regulation of homeostasis; for example,
XLαs is expressed in the orofacial motornuclei, which are required for the physical action of
suckling, and is thus likely to be a contributory factor to the lean phenotype following
Gnasxl ablation (Plagge et al, 2004).
GNAS mutations in humans are associated with Albright’s hereditary osteodystrophy
(AHO). Clinical features of this disorder include subcutaneous ectopic ossifications, obesity,
cognitive defects and brachydactyly. However, AHO can also be associated with hormone
resistance, but this is parent‐of‐origin specific (Davies and Hughes, 1993). Transmission of a
mutation in the GNAS locus through the maternal line results in resistance to a range of
hormones, including parathyroid hormone (PTH), thyroid‐stimulating hormone (TSH) and
growth hormone‐releasing hormone (GHRH) in adulthood. An identical mutation which is
paternal in origin produces no such hormone resistance, reflecting the importance of the
imprinted (maternally‐expressed) Gnas transcripts detected in some cell types (Weinstein
et al, 2001). Such resistance is likely to arise as a direct consequence of impaired signal
transduction in target cells, consistent with the role of maternally‐expressed GNAS
products as Gα subunits.
Other imprinted genes have been implicated in neuroendocrine disorders. Prader‐Willi
syndrome (PWS), for example, is characterised by hypotonia and failure to suckle at birth,
which is overcompensated for by a voracious appetite in early childhood. Other features
are more variable, and include behavioural abnormalities, such as obsessive‐compulsive
traits and tantrums (Cassidy and Driscoll, 2009). The physiological basis of the disease is
perturbed hypothalamic/pituitary axis function, which causes low serum levels of
testosterone and gonadotrophins, the latter most probably due to a resistance to
gonadotropin releasing hormone (GnRH; Davies et al, 2008). Growth hormone (GH) levels
are also low, resulting in reduced Igf1 expression (Miller et al, 2007). Paradoxically, PWS
patients also exhibit elevated obestatin levels, a hormone which suppresses appetite
(Butler et al, 2007). The extreme hyperphagia observed in childhood is likely to be a
consequence of developing resistance to high obestatin levels.
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The genetic basis for PWS is the absence, or reduction, of expression from a locus on
paternally‐inherited chromosome 15q11‐q13. This is most commonly caused by a genetic
deletion at the locus, but can also occur as a consequence of mUPD for the region, or a
mutation at the ICR. Several imprinted genes reside at this locus, and the variable
phenotypes of the disorder are likely to be dependent on the number of genes affected by
a particular mutation. For example, mice deficient for the paternally‐expressed gene
Necdin recapitulate some of the neuroanatomical features of PWS, including a reduction in
oxytonergic and GnRH neurones (Muscatelli et al, 2000). This PWS model also results in
early lethality, which is common to PWS patients, and exhibits several of the behavioural
characteristics of the disorder, including improved spatial learning and memory. Deletions
of the murine Magel2 gene reproduce the excessive weight gain and increased adiposity
observed in PWS patients post‐weaning (Bischof et al, 2007). Perhaps the most
comprehensive model of PWS is the PWS‐IC deletion mouse, which ablates the ICR and
results in suppression of paternally‐expressed genes at the locus, with concomitant
activation (and thus biallelic expression) of normally maternally‐expressed genes
(Chamberlain et al, 2004). This is strong evidence that PWS is an imprinting disorder which
is caused by the LOI of several clustered genes. Recently, the importance of a non‐coding
small nucleolar RNA (snoRNA) species has been revealed in the aetiology of PWS. mbii‐52
(or hbii‐52 in humans), which is expressed from the paternal chromosome at the PWS
locus, regulates the post‐transcriptional editing of the Serotonin 2C receptor (5htr2c) pre‐
mRNA (Doe et al, 2009). Loss of editing is associated with the alteration of a number of
5HTR2C‐mediated behaviours, which recapitulate some of the specific features of PWS
patients.
The involvement of imprinted genes in the regulation of adult metabolism is not necessarily
consistent with the predictions of the parental conflict hypothesis, which cannot account
for the persistence of imprinting post‐weaning, as previously discussed. Indeed, it is
apparent from mouse genetics studies that imprinted genes expressed from both the
maternally‐ and paternally‐inherited chromosomes can influence energy homeostasis in a
similar manner. For example, at the gross level, both the ablation of maternally‐expressed
Grb10 and paternally‐expressed Gnasxl reduce adult adiposity (Smith et al, 2007; Plagge et
al, 2004). Whilst the molecular events responsible for this effect are very different, the
phenotypic outcome is similar, although the models also exhibit other, disparate,
phenotypes. It could be argued that the involvement of imprinted genes in adult
metabolism is simply a result of their importance in foetal growth, two physiological
processes which share many of the same signalling pathways and molecular players. As
such, imprinting in adult tissues would be the result of a ‘bystander effect’. However, the
importance of imprinted genes, such as those at the Gnas locus, in regulating adult
metabolism but having a negligible effect on embryonic development, argues against this
suggestion. Additionally, it has become apparent in recent years that several imprinted
genes are expressed in the adult brain and affect behaviour; for many, a function in foetal
development has not been defined. Behaviour thus represents an additional physiological
process under the influence of imprinting, which we briefly address here.
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As highlighted already, some imprinted genes expressed in the brain influence
neuroendocrine function and can thus be grouped with many other peripherally‐expressed
genes as regulators of metabolism. The brain expression of other imprinted genes is
inconsistent with such a role. For example, Ube3a is maternally‐expressed in neurons of
the hippocampus and cerebellum, whilst being biallelically‐expressed in glia (Yamasaki et
al, 2003). Maternal ablation of this gene in mice results in motor dysfunction, seizures and
learning deficits, recapitulating several of the features of Angelman syndrome (AS), a
human disorder caused by silencing of the UBE3A gene (Jiang et al, 1998).
Grb10 is an intriguing example of an imprinted gene with reference to behaviour. Whilst
maternally‐expressed Grb10 influences foetal development and postnatal metabolism
(Charalambous et al, 2003; Shiura et al, 2005; Smith et al, 2007), it is the paternally‐derived
allele which is expressed in the brain (Garfield, 2007; Garfield et al, submitted). This
reciprocal imprinting profile is apparently unique to Grb10. Transmission of a dysfunctional
Grb10 allele through the paternal line produced mice which were socially dominant over
wild type controls, but otherwise indistinguishable when assayed for other behavioural
characteristics. This was demonstrated by use of the ‘tube‐test’ and the observation of
increased allogrooming (barbering of other animals) in cages containing mutant mice.
These results suggest that paternally‐expressed Grb10mediates a specific behavioural trait,
which does not influence foetal development or postnatal metabolism (Smith et al, 2004;
Garfield, 2007; Garfield et al, submitted).
Why imprinted genes should be associated with modulating social behaviour is unclear.
Indeed, Grb10 does not appear to be alone; Nesp55, a maternally‐expressed transcript
arising from the Gnas cluster, promotes risk‐tolerance (Plagge et al, 2005). This is of
additional interest because Nesp55 and Grb10 expression exhibit considerable overlap in
the brain, and the opposite phenotypes of knock‐out mouse models suggest they may act
antagonistically in the same neurological pathway (Garfield et al, submitted). It is intriguing
that they are also expressed from opposing alleles, reminiscent of the antagonistic basis of
conflict theory. As already discussed, the influences of some imprinted genes on maternal
behaviour can be explained in the context of coadaptation between mother and offspring,
exemplified by Peg3. However, the evolutionary basis for the control of social dominance,
or indeed, for the reciprocal Grb10 imprint, remains elusive, yet represents an evocative
area for future studies.
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1.2 Growth factor receptor bound protein 10
1.2.1 The Grb7 family
Growth factor receptor bound protein 10 (Grb10) is a member of the Grb7 superfamily of
adapter proteins, which also includes Grb7 and Grb14. These proteins do not possess
catalytic activity, but are characterised by several molecular interaction domains,
permitting association with a range of intracellular signalling molecules. This includes a N‐
terminal proline‐rich (P) domain, a pleckstrin homology (PH) domain, a C‐terminal Src‐
homology 2 (SH2) domain and a unique region positioned between the PH and SH2
domains termed the BPS domain (for between PH and SH2; Figure 1.2; Lim et al, 2004).
Additionally, a Ras‐associating (RA) domain has been predicted based on sequence
comparisons (Wojcik et al, 1999), but the significance of this to Grb7/10/14 function
remains unclear. Certainly, biochemical studies have shown Grb14 has the capability of
interacting with Ras, but this has not been extrapolated to an in vivo context (Depetris et al,
2009). The amino acid sequence of the SH2 domain is highly conserved between the three
members, with Grb14 exhibiting 67 % and 74 % identity with Grb7 and Grb10, respectively,
in this region (Daly et al, 1996). In general, the N‐terminal P domain is poorly conserved
between family members, with the exception of a single proline‐rich motif P(S/A)IPNPFPEL
(Daly et al, 1996). Members of the superfamily are also structurally related to the Mig‐10
protein isolated from Caenorhabditis elegans, which possesses both P and PH domains;
thus, this region has been termed the GM region, for Grb10 and Mig (Manser et al, 1997).
The function of Mig‐10 is comparable to that of Grb7, both of which transduce signals
responsible for cell migration (Manser et al, 1997; Han et al, 1999).
Several murine Grb10 transcripts have been described, which are tissue‐  and parent‐of‐
origin specific (Figure 1.2; Arnaud et al, 2003; Hikichi et al, 2003; Sanz et al, 2008). As
discussed previously, the majority of transcripts arise from the maternally‐inherited
chromosome. The two predominant maternally‐expressed transcripts are Grb10α and
Grb10δ, which initiate at exon 1A and differ by their inclusion and exclusion of exon 5,
respectively. Interestingly, exon 5 encodes the RA domain, suggesting that this is not
required for some of the functions of Grb10. Most in situ and Northern hybridisation
experiments do not permit differentiation between these isoforms, and whether there are
tissue‐specific differences in their expression profiles thus remains unclear. An embryo‐
specific transcript has also been detected, which initiates at exon 1A and splices onto exon
1C, before continuing downstream (Sanz et al, 2008). It is not clear if this transcript
includes or excludes exon 5. Transcripts originating from the paternally‐inherited
chromosome initiate at exons 1B1, 1B2 and 1C, and all splice onto exon 2. Paternal
transcripts have been described which lack exons 5 and 6, but it is not clear if all
combinations are possible (i.e. transcripts initiating at each of 1B1, 1B2 and 1C which
incorporate or exclude exons 5 and 6; Arnaud et al, 2003). The translation initiation site for
all variants is located in exon 3, and only the 3’ extreme of exon 18 forms the 3’
untranslated region (UTR).
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Three human GRB10 protein isoforms have been described to date: GRB10β, GRB10γ and
GRB10ζ. GRB10ζ is the most similar to Grb10α, but lacks a 88 amino acid sequence close to
the N‐terminus of the protein, and a 46 amino acid sequence which forms part of the PH
domain. The remaining functional domains show extensive sequence homology; the SH2
domain, for example, is 99 % identical at the amino acid level between Grb10α and GRB10ζ 
(Lim et al, 2004). GRB10β does not possess a PH domain due to the exclusion of exon 7
from the transcript. Transcripts encoding GRB10γ do not contain exon 1, resulting in the
use of an alternative initiation codon and the loss of 55 amino acids at the N‐terminus of
the protein.
In addition to the proline‐rich motif common to all Grb7 superfamily members, murine
Grb10 also possesses two other such motifs, only one of which is conserved in human
GRB10 isoforms, exhibiting 64 % amino acid sequence identity (Lim et al, 2004). Typically,
sequences rich in proline interact with Src‐homology 3 (SH3) and tryptophan‐rich (WW)
domains of other proteins. Rat Grb10 has been shown to interact with the non‐tyrosine
kinase c‐Abl, which possesses a SH3 domain, and the interaction was outcompeted by a
proline‐rich peptide mimetic (Frantz et al, 1997), suggesting a likely interaction mediated
by these two domains. Two novel binding partners of Grb10 were identified in a yeast two‐
hybrid screen using the Grb10 N‐terminus as bait (Giovannone et al, 2003). These were
termed Grb10 interacting GYF protein (GIGYF)1 and GIGYF2; GYF (glycine‐tyrosine‐
phenylalanine) domains were first identified in the CD2 binding protein (CD2BP) and were
shown to bind proline‐rich peptide sequences in the CD2 tail (Nishizawa et al, 1998). At
least two of the three proline‐rich motifs in Grb10 are necessary to permit interaction with
GIGYF1 and GIGYF2, and thus it would be interesting to establish if this interaction
extrapolates to humans.
The novel GIGYF proteins are thought to mediate IGF1 signalling. Stimulation of fibroblasts
with IGF1 promotes the association of both Grb10 and GIGYF1 with the IGF1R (Giovannone
et al, 2003). This implicates the two proteins in cooperative modulation of IGF1 signalling.
Mutations in the human GIGYF2 gene have been associated with some cases of familial
Parkinson disease (PD). A screen of unrelated Central European PD patients and their
families revealed a total of seven different missense mutations in the gene resulting in
single amino acid substitutions (Lautier et al, 2008). Together, these were associated with
4.8 % of the PD patients screened but were not detected in controls, suggesting aberrant
GIGYF2 activity may be associated with PD pathology, and that mutations in the gene might
be a risk‐factor for the disease. However, no such mutations were found amongst North
American or Belgian populations of PD patients (Guo et al, 2009; Meeus et al, 2009).
The PH domain was first described in the cytoskeletal protein pleckstrin, and now
represents the eleventh most common domain in the human proteome (Haslam et al,
1993; Lemmon, 2007). It is commonly associated with the binding of phosphoinositides.
These signalling molecules are generated at the cell membrane in response to receptor
activation, and recruit PH domain‐containing proteins to the membrane. It is unclear if
phosphoinositide binding is performed by Grb10, as the human GRB10β  isoform lacks a
functional PH domain and is still capable of translocating to the cell membrane (Dong et al,
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1997a). Alternatively, the PH domain may promote the interaction of Grb10 with the
insulin receptor (IR) and IGF1R, which is mediated by the SH2 and BPS domains, by
providing a more favourable structural conformation (Dong et al, 1997b).
SH2 domains are associated with the binding of phosphotyrosine (pY) residues,
representing another mechanism by which Grb10 may interact with cellular signalling
partners. pY residues are commonly associated with activated proteins, and thus are
widespread, but specificity of binding is achieved by the recognition of 3‐6 amino acid
residues C‐terminal to the pY (Songyang et al, 1993). Intriguingly, the SH2 domain of GRB10
is dimeric in solution (Stein et al, 2003), unlike the more typical monomeric behaviour of
this domain in other proteins. An α‐helix situated in the C‐terminal half of the domain is
responsible for the dimerisation, and the amino acid sequence in this region is highly
conserved with GRB7 and GRB14, suggesting these may also dimerise in solution (Lim et al,
2004). Resolving the GRB10 crystal structure has revealed that dimeric GRB10 is likely to
favour the binding of dimeric, turn‐containing pY sequences, which are found on both the
IR and IGF1R (Stein et al, 2003).
The BPS domain is critical for the interaction of Grb10 with the IGF1R. The domain is
relatively small, constituting 50 amino acids, and is unique to Grb7/10/14. A yeast two‐
hybrid screen of a mouse embryonic library also identified the ubiquitin protein ligase
Nedd4 as a possible partner of Grb10, an association mediated by the BPS domain.
Although Grb10 is not ubiquitinated by Nedd4 (Morrione et al, 1999), together the proteins
have been shown to negatively regulate IGF1 signalling (Vechione et al, 2003). Ligand‐
activated receptor recruits the Grb10 and Nedd4 complex, which results in multi‐
ubiquitination of the receptor, triggering internalisation and degradation (Monami et al,
2008). The association of Grb10 and the IGF1R seems to be a role specific to this Grb7
superfamily member, although the IGF1R was sensitive to the inhibition of tyrosine kinase
activity by Grb14 in an in vitro system, albeit much less so than the IR (Béréziat et al, 2002).
1.2.2 Cellular signalling partners
Biochemical studies have identified a considerable number of cellular signalling cascades
potentially mediated by the Grb7 superfamily, but their relevance to an in vivo context is
variable. Indeed, Grb10 was first identified in a bacterial expression library screen in which
the C‐terminus of the epidermal growth factor receptor (EGFR) was used (Ooi et al, 1995),
but this interaction has not been demonstrated in vivo. Grb10 demonstrates a preference
for binding to the IR over other receptor tyrosine kinases (RTKs; Frantz et al, 1997; Laviola
et al, 1997), and has since been shown to play a key role in the negative modulation of
insulin signalling in vivo (discussed in Chapter Three; Shiura et al, 2005; Smith et al, 2007).
However, the results of in vitro studies are conflicting. Over‐expression of the human
GRB10β  isoform in Chinese hamster ovary cells also over‐expressing Insulin receptor (Insr;
CHO/IR) inhibited the tyrosine phosphorylation of insulin receptor substrate‐1 (IRS‐1), a
downstream effector of insulin signalling (Liu and Roth, 1995). PI 3‐kinase activity was also
perturbed. The mode of action of Grb10 in this system appears to be as a physical block to
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IR/IRS‐1 interaction, rather than suppressing the catalytic activity of the receptor. This was
demonstrated in a yeast tri‐hybrid experiment, which showed human GRB10ζ  inhibited
IR/IRS‐1 association in a SH2‐dependent manner (Wick et al, 2003). These in vitro studies
support the apparent role of Grb10 in vivo as a negative regulator of insulin signalling, but
other experiments have indicated that Grb10 may have a positive effect on the same signal
transduction pathway. Over‐expression of Grb10 in differentiated 3T3‐L1 adipocyte cells
promoted the cellular response to insulin, and correspondingly, dominant‐negative Grb10
SH2 peptide mimetics abolished such effects (Deng et al, 2003). This is in conflict with the
majority of other studies, and may reflect a different role for Grb10 in a context‐dependent
manner. Grb14 also appears to interact with the IR and, like Grb10, negatively regulates
insulin signalling in vivo (Cooney et al, 2004). Compound Grb10/Grb14 mutant mice exhibit
similar phenotypes to single knockout models, suggesting considerable functional
redundancy (Smith et al, 2007; Holt et al, 2009).
Grb7 has been shown to associate with the IR in vivo, using co‐immunoprecipitation (Kasus‐
Jacobi et al, 2000), but the association appears to be much weaker than that for Grb10 and
Grb14, suggesting Grb7 may perform distinct cellular functions (Holt and Siddle, 2005).
Consistent with this, GRB7 is over‐expressed in a range of cancers, including breast, gastric
and oesophageal cancer cell lines, suggesting it has a positive mitogenic role. GRB7 is
consistently co‐amplified in cancers with the tyrosine kinase receptor HER2, which is
located on the same chromosomal region as GRB7, 17q11‐q21 (Stein et al, 1994; Tanaka et
al, 1997). Unlike the roles of Grb10 and Grb14, which are widely considered to be inhibitory
in growth factor signalling, knock‐down of GRB7 in a breast cancer cell line reduced
tyrosine phosphorylation of the receptor and of the mitogenic AKT signalling family,
suggesting GRB7 is an activator of growth factor signalling (Bai and Luoh, 2008). Whilst this
property was determined in a cancer cell line, GRB7/HER2 interaction also occurs in a
normal cellular context, and appears to promote epithelial development in kidney, lung
and gut (Leavey et al, 1998). Additionally, Grb7 has been shown to stimulate cell growth
both in vitro and in vivo by binding to caveolin‐1 (Lee et al, 2000). Whether the over‐
expression of GRB7 is a common contributory factor to cancer progression requires further
investigation, but one study does provide support for this hypothesis (Bai and Luoh, 2008).
GRB7 was over‐expressed in a breast cancer cell line stably transfected to express HER2
(MCF::HER2 cells). Four million of these cells were transplanted subcutaneously into nude
mice. Cells transfected with a green fluorescent protein (GFP) control produced small
tumours, but those over‐expressing GRB7 produced significantly larger tumours,
demonstrating that GRB7 can facilitate HER2‐mediated signalling leading to tumour
growth, at least in this context.
Human GRB10ζ also interacts with the mitogen‐activated protein (MAP) kinase MEK1, as
demonstrated by co‐immunoprecipitation and in vitro binding experiments (Nantel et al,
1998). The MAP kinase signalling cascade is key in coupling cellular responses to the
binding of growth factors at cell surface receptors. It consists of a series of kinases
activated in sequence, thus permitting amplification of the signal. In summary, receptor
activation recruits docking proteins, such as Grb2 (unrelated to the Grb7 superfamily) and
the guanine nucleotide exchange factor (GEF) Son of sevenless (SOS) which stimulates
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activation of Ras by promoting the switching of the Ras‐associated GDP molecule for GTP.
Ras‐GTP dissociates from the complex and activates the first serine/threonine kinase, RAF.
In turn, MEK, MAPK and MNK are phosphorylated, which results in the activation of
transcription factors such as the cAMP response element binding protein (CREB; Shaywitz
and Greenberg, 1999). Both Grb10 and MEK1 have been shown to associate with Raf1 in
vitro, although, as mentioned previously, Grb10 has not been detected bound to Ras
despite possessing a RA domain. The Grb10/MEK1/Raf1 association is phospho‐
serine/threonine‐dependent, but does not require tyrosine phosphorylation (Nantel et al,
1998). Raf1 is anti‐apoptotic, and indeed the Raf1/Grb10 association is increased in
ultraviolet (UV)‐irradiated apoptosing cells (Nantel et al, 1999). Interestingly, this
interaction was also detected in the mitochondria of these cells, suggesting Grb10 may act
as a link between activation of receptors at the cell surface and the apoptotic machinery of
the mitochondrial outer membrane. These data suggest that GRB10ζ is a promoter of MAP
kinase signalling.
Grb10/GRB10 has been implicated in associations with a range of other signalling
molecules, both RTKs and non‐RTKs. For example, the Eph receptor family member ELK
(Eph‐related receptor tyrosine kinase), used as bait in a yeast two‐hybrid experiment,
yielded the Grb10 SH2 domain (Stein et al, 1996). In a cellular context, ligand‐stimulated
activation of ELK caused the recruitment of Grb10 following autophosphorylation of the
receptor; indeed, the association was dependent on the phosphorylation of ELK at a critical
tyrosine residue. Eph family receptors are implicated in various physiological processes,
including cell migration, axon guidance and vascular development (Kullander and Klein,
2002). The Grb10 SH2 domain was also yielded when the Ret tyrosine kinase receptor was
used as bait in a yeast two‐hybrid assay (Pandey et al, 1995), an interaction confirmed in
vitro and also apparent for Grb7/Ret (Pandey et al, 1996). This receptor plays a key role in
the development of endocrine organs and the enteric nervous system.
Already mentioned briefly to illustrate the properties of the SH2 domain, the association of
Grb10 with c‐Abl (Frantz et al, 1997) is notable because of its relevance to oncogenesis.
Bcr‐Abl is an oncoprotein generated by the fusion of part of the Bcr serine/threonine kinase
to the tyrosine kinase Abl, encoded by c‐Abl. This occurs because of the juxtaposition of the
breakpoint cluster region on human chromosome 22, at which Bcr is located, to the c‐Abl
gene on chromosome 9 (Chan et al, 1987). Bcr‐Abl proteins vary in their properties,
depending on how much of Bcr is fused to Abl, and typically activate the PI 3‐kinase, MAP
kinase and STAT signalling cascades. Bcr‐Abl isoforms have been implicated in chronic
myelogenous leukaemia (CML) and acute lymphoblastic leukaemia (ALL) (reviewed in
Advani and Pendergast, 2002).
Grb10 has been implicated in antigen receptor signalling in lymphocytes, by its association
with Tec, an interaction again established by yeast two‐hybrid experiments (Mano et al,
1998). Tec is a non‐receptor tyrosine kinase. Although over‐expression of Grb10 does not
inhibit the kinase activity of the enzyme, downstream effector activation is inhibited. This
was demonstrated by a down‐regulation of expression of a luciferase reporter gene driven
by the c‐fos promoter, a classic target of antigen receptor activation.
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An interaction between GRB10 and the growth hormone receptor (GHR) has also been
demonstrated in vitro, mediated by the SH2 domain (Moutoussamy et al, 1998). Ligand‐
induced receptor activation promotes the recruitment and autophosphorylation of Janus
kinase 2 (JAK2), which subsequently phosphorylates the GHR cytoplasmic domain. SH2‐
domain containing proteins, such as Signal transducer and activator of transcription (STAT)
family members, are recruited to the receptor and activated. GRB10 physically interacts
with JAK2 (Moutossamy et al, 1998), and although over‐expression of GRB10 had no effect
on the phosphorylation of JAK2, GHR or STAT5, it inhibited the transcription of reporter
genes containing GH response elements. These data implicate GRB10 in the negative
regulation of GH signalling.
In conclusion, Grb10/GRB10 has been shown to potentially associate with a considerable
number of cellular signalling molecules, both receptors and non‐receptors, and by
extrapolation has been implicated in several physiological processes. Whilst some
interactions have only been demonstrated by biochemical means (e.g. EGFR), and thus
their relevance to physiological conditions questionable, others have been shown in vitro
(e.g. GHR) and even in vivo (e.g. IR). This is also true for the other members of the Grb7
superfamily, and thus these molecules are highly likely candidates for regulating cross‐talk
between various signalling cascades (Riedel, 2004).
1.2.3 Grb10 as an imprinted gene
Although Grb10 was cloned in 1995 (Ooi et al, 1995), the imprinted nature of the Grb10
gene was not revealed until 1998 (Miyoshi et al, 1998), using a subtractive hybridisation
approach to identify novel maternally‐expressed genes. Its potential as a candidate for SRS
was recognised immediately, and supported two years later by the identification of
sequence mutations in the GRB10 genes of two SRS patients (Yoshihashi et al, 2000). The
same study confirmed that human GRB10 was also imprinted, a result previously predicted
by the observation of early DNA replication at the locus, a hallmark of imprinted genes
(Monk et al, 2000). In the same year, Blagitko et al (2000) demonstrated that GRB10
expression in the human foetal brain was specifically from the paternally‐inherited copy,
whilst peripheral tissues typically demonstrated biallelic expression, with maternal‐specific
expression in skeletal muscle. The finding of paternally‐derived transcripts in the brain was
reported as being reciprocal to that found in mouse, but Arnaud et al (2003) revealed the
conservation of paternal‐specific expression in the mouse brain. This study, followed up by
Sanz et al (2008), characterised tissue‐ and allele‐specific transcripts in considerable detail
(Figure 1.2).
The regulation of murine Grb10 imprinting was elucidated by Arnaud et al (2003), Hikichi et
al (2003) and Sanz et al (2008). The promoter region of the gene possesses three CpG
islands (Figure 1.2). CpG island 1 (CGI1) is hypomethylated on both alleles in all tissues and
stages investigated, including oocytes and sperm, and thus is not a DMR, despite
overlapping with the transcription initiation exon for maternally‐derived transcripts (exon
1A). Instead, the silencing of the paternal allele in most tissues is achieved by a germline
26
Chapter One 
DMR (CGI2) situated 3’ to exon 1A, which is hypermethylated on the maternal
chromosome. This is, therefore, an example of hypermethylation being permissive for
transcription. Brain‐specific transcripts initiate from exons 1B1, 1B2 and 1C, and are under
the control of a tissue‐specific (somatic) DMR, forming part of CGI3. In peripheral tissues,
CGI3 is biallelically hypermethylated, but is hypomethylated on the paternal allele
specifically in brain. Although not illustrated in Figure 1.2, differential promoter usage is
associated with specific histone tail modifications. Methylation of lysine 27 on histone H3
(H3K27me3) is considered a repressive mark, as it is typically associated with
transcriptionally inactive chromatin. This mark was enriched on the unmethylated paternal
allele at the germline DMR (CGI2), but this was dissociated in brain (Sanz et al, 2008), and is
therefore likely to form part of the mechanism for controlling the promoter switch. What is
responsible for the initiation of such tissue‐specific epigenetic marks remains unsolved.
The first knockout of murine Grb10 was reported by Charalambous et al (2003), in which
transcripts were trapped by the integration of a LacZ reporter cassette, such that reporter
expression was under the control of the endogenous Grb10 promoter. The allele was
termed Grb10Δ2‐4. This permitted further characterisation of the imprinted nature of the
gene, and confirmed that the majority of embryonic and adult expression was derived from
the maternally‐inherited chromosome. In agreement with Arnaud et al (2003), the adult
hypothalamus expressed the LacZ reporter only when the trapped allele was transmitted
through the paternal line (Smith et al, 2007). Intriguingly, no reporter expression was
detected in the foetal brain, regardless of parental origin, except in the fourth ventricle and
choroid plexus, in which Grb10 was maternally‐expressed (Charalambous et al, 2003).
Immunostaining suggested a more widespread presence of Grb10 protein in the developing
brain. To address this shortcoming, Garfield et al (submitted) utilised a second transgenic
mouse line, containing a LacZ reporter cassette integrated more 3’ at the Grb10 locus,
termed Grb10KO. Inheritance of this trapped allele through the maternal line (Grb10KOm/+)
recapitulated the sites of expression reported by Grb10Δ2‐4m/+. However, extensive
expression of Grb10 in the developing CNS was observed following paternal transmission of
the gene trap (Grb10KO+/p). As discussed previously, the two knockout models also
permitted characterisation of the parent‐of‐origin specific in vivo roles for Grb10: maternal
expression was fundamental for the regulation of foetal growth and adult metabolism,
whilst expression from the paternal allele tempered social behaviour.
1.2.4 Concluding remarks and aims
Despite the wealth of information regarding signalling partners of Grb10, and the
characterisation of its roles in foetal growth, postnatal metabolism and adult behaviour,
many intriguing questions remain, related both to its in vivo function and the control of its
imprint. For example, whilst its influence on postnatal metabolism is achieved through the
modulation of insulin signalling, it is still not clear through which genetic pathways Grb10
controls foetal development. Genetic evidence argues strongly against the IGF1 and IGF2
signalling pathways (Charalambous et al, 2003; Garfield, 2007). The observation that the
paternally‐expressed imprinted gene Dlk1 maps to many of the sites of Grb10 expression,
27
Chapter One
and that Dlk1‐deficient mice exhibit opposite growth effects to Grb10‐deficient animals, is
provocative, and may represent the predominant pathway through which Grb10 influences
growth. An investigation of this potential relationship is currently under way.
Additionally, it is not currently possible to discriminate between the direct influence of
Grb10 on foetal growth, and its indirect influence through effects on the placenta. Is
disproportionate placental overgrowth a response to foetal overgrowth, or does an
improvement in placental efficiency drive foetal development?
Before the present study was conducted, another pressing issue which required attention
was the apparent inability of the Grb10Δ2‐4 allele, when transmitted through the paternal
line (Grb10Δ2‐4+/p), to report expression in the developing CNS, in the light of strong
reporter expression in this tissue from the paternal Grb10KO allele. Indeed, limited
characterisation of the Grb10KO allele had been performed, and thus it was difficult to
speculate on the molecular basis for these differences.
With these points in mind, the current study began with three key aims:
1) to characterise the structure of the Grb10KO allele, and perform a molecular
demonstration of its efficacy in trapping Grb10 transcripts;
2) to use this knowledge to address the molecular basis for differences in the reporter
expression profiles of the two transgenic models;
3) to expand on existing work demonstrating the influence of Grb10 on placental
development and foetal growth, by characterising the expression profile of Grb10
in the placenta and the morphological consequences of Grb10 ablation.
Unexpectedly, the genetic characterisation of the Grb10KO allele, and the elucidation of
the molecular basis for differences in reporter expression, led to the identification of a
previously unidentified site of Grb10 expression in the adult; namely, the mammary
epithelium. We characterised the imprinting status and function of Grb10 in this tissue, and
defined a novel role for maternally‐expressed Grb10 in regulating nutrient transfer from
mother to suckling offspring. This extended our previous understanding of the role of
Grb10 as a growth regulator. When viewed in light of the role of Grb10 in the placenta,
which controls nutrient transfer in utero, we were able to comment on a more general role
for Grb10 in the control of reproductive strategy.
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Materials and Methods
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2.1 Transgenic mouse lines
2.1.1 Animal husbandry
All mouse strains were maintained in accordance with United Kingdom Home Office
regulations, on a 13‐hour light/11‐hour dark cycle, including 30 minutes each of artificial
dawn and dusk lighting. Ambient temperature was maintained at 21°C ± 2°C, with a relative
humidity of 55 ± 10 %. Animals were permitted unrestricted access to food (CRM formula,
Special Diets Services, Essex, UK) and water, and were housed at a density of one to six
animals per cage. Cages were individually ventilated.
2.1.2 Transgenic mouse strains
All transgenic strains were maintained on a C57BL/6:CBA mixed background. The Grb10KO
strain was generated from aggregation chimeras made by Dr Kim Moorwood and Dr Joanne
Stewart‐Cox, from the XC302 embryonic stem (ES) cell gene trap line (Baygenomics, CA,
USA; Garfield et al, submitted). The Grb10Δ2‐4 strain was created by Dr William Bennett,
using the KST268 ES cell gene trap line (Baygenomics) in an ES cell co‐culture method, as
previously described (Charalambous et al, 2003).
2.1.3 Genotyping of transgenic animals
Genotyping of transgenic stock animals was performed using DNA samples in the
polymerase chain reaction (PCR). Ear clips (from adult) or tail clips (from embryo) were
boiled for 10 minutes in 600 µl 0.1 M sodium hydroxide (Fisher Scientific, UK), and
neutralised with 50 µl 1 M Tris‐HCl pH 8.0 (Tris and HCl both from Fisher Scientific). 1 µl
(adult ear clip) or 2 µl (embryonic tail clip) of each boiled sample was used as the template
in the PCR reaction. DNA from adult ear clips was amplified in a total volume of 20 µl using
GoTaq Master Mix (Promega, UK) diluted 1:2, with primers at a final concentration of 0.25
µM each (purchased from Invitrogen, UK; Table 2.1). Embryonic tail DNA was amplified in a
total volume of 25 µl using Kod Hot‐Start DNA Polymerase (Novagen, Germany), according
to the manufacturer’s instructions. Amplification for all samples was performed on a G‐
Storm Mark 1 thermal cycler (Gene Technologies Ltd., UK), using the following conditions:
initial denaturation for 5 minutes at 95°C, followed by 34 cycles of 60 seconds at 95°C, 60
seconds at 60°C, 60 seconds at 72°C, and a final extension of 72°C for 5 minutes. Following
amplification, samples were loaded and run on a 1 % (w/v) agarose (Invitrogen) gel
containing 0.5 µg/ml ethidium bromide (Sigma Aldrich, Dorset, UK) in 1x TAE buffer (2 M
Tris (Fisher Scientific), 50 mM EDTA (Sigma Aldrich), 5.7 % (v/v) acetic acid (Fisher
Scientific)). A 1 kb DNA ladder (Promega) was used for size estimation. DNA was visualised
under ultraviolet radiation (AlphaImager 3400).
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DNA from e7.5 embryos was obtained by boiling whole embryos in 100 µl 0.1 M sodium
hydroxide for 10 minutes. Genotyping was performed by PCR as described for adult ear
clips.
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Table 2.1 – Sequences of primers used in PCR amplification
Nucleotide sequences are presented for primers used for the purposes of genotyping,
mapping of the LacZ gene trap cassette, and RT‐PCR/qPCR. 1from Charalambous et al, 2003;
2from Charalambous et al, submitted; 3from Zhu et al, 2006. fwd – forward; rev – reverse.
Application Template Primer name Primer sequence
(5’ to 3’)
Genotyping –
presence of β‐
geo cassette
Grb10KO/Grb10Δ2‐4
genomic DNA
β‐geo fwd 1
β‐geo rev 1
ttcaacatcagccgctacag
ctcgtcctgcagttcattca
Genotyping –
allele
discrimination
LacZ cassette
mapping
Grb10KO genomic
DNA
Wild type (Grb10KO)
genomic DNA
Grb10Δ2‐4 genomic
DNA
Wild type (Grb10Δ2‐4)
genomic DNA
Grb10KO or wild type
genomic DNA
Set B fwd
β‐R1 rev
Set B fwd
Set B rev
β‐geo fwd 1
β‐geo rev 1
MP11‐F
MP11‐R
Set A fwd
Set A rev
Set B fwd
Set B rev
Set C fwd
Set C rev
β‐F1 fwd
β‐R1 rev
β‐R2 rev
ccaagtggagagtaccatgcc
cgacgggatcctctagagtccagatctgc
as above
tcacctgacaggcacctcccc
as above
as above
agcccgatgtgctgtctttct
agggacagacggttcagaga
aggcaagaggtgaaaaatcc
aagaatttgctctcacttgg
as above
as above
tggtatgctgacatcaacgcc
gctccttgtcaactttccagc
ctcatgctggagttcttcgccc
as above
acgacagtatcggcctcaggaagatcgc
RT‐PCR and
qPCR
Grb10 exons 3‐4
cDNA
Grb10 exons 11‐16
cDNA
Igf2 cDNA
IgfP0 cDNA
Slc38a4 cDNA
Prolactin cDNA
Growth hormone
cDNA
Hprt cDNA
β‐actin cDNA
Grb10‐Δ fwd 2
Grb10‐Δ rev 2
Grb10‐505 fwd 2
Grb10‐505 rev 2
Igf2 fwd 2
Igf2 rev 2
Igf2P0 fwd 2
Igf2P0 rev 2
Slc38a4 fwd 2
Slc38a4 rev 2
Prolactin fwd 3
Prolactin rev 3
GH fwd 3
GH rev 3
Hprt fwd 2
Hprt rev 2
β‐actin fwd
β‐actin rev
tgcaccacttcttgaggatg
accagtgagctccggaaatg
ctgacctggaagaaagcagc
gcgaggagtctcacaggatc
gacgtgtctacctctcaggcc
gggtgtcaattgggttgtttac
gcatccccggtcctctttat
gctctggctggacgagaagt
gcttcttctgccactatgctga
tccagtcacaaggaagaccaaa
aggcctatcctgaagccaaaggaa
tttggcacctcaggaccttgagaa
tgggcagatcctcaagcaaaccta
gaaggcacagctgctttccacaaa
caggccagactttgtggat
ttgcgctcatcttagccttt
gacccagatcatgtttgagacc
gttggcatagaggtctttacgg
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2.2 Molecular techniques
All solutions were made according to Sambrook and Russell (2001) with purified and
deionised water, prepared with the MilliQ water filtration system (Millipore Corporation,
MA, USA), unless otherwise stated.
2.2.1 Genomic DNA isolation from tissue samples
Although DNA for genotyping purposes was isolated from tissue biopsies as described in
Section 2.1.3, cleaner DNA preparations were required for other PCR amplification
experiments. 500 mg tissue samples were incubated overnight at 55°C in 560 µl digestion
buffer (50 mM Tris pH 8.0, 100 mM EDTA, 100 mM NaCl (Fisher Scientific), 1 % sodium
dodecyl sulphate (SDS; Fisher Scientific), 350 µg Proteinase K (Sigma Aldrich)). RNA was
degraded by the addition of 0.4 µg RNase A (Sigma Aldrich) at 37°C for 1 hour. DNA was
precipitated with the addition of NaCl to a final concentration of 1.3 M, followed by an
equal volume of chloroform:isoamyl alcohol (24:1; both reagents from Fisher Scientific),
and centrifuged at 12,000 x g for 10 minutes in a Sorvall Biofuge Pico microcentrifuge. One
volume of propan‐2‐ol (Sigma Aldrich) was added to the aqueous phase and the DNA
pelleted by centrifuging as before. The pellet was washed in 70 % ethanol (Fisher Scientific)
at 4°C for at least 1 hour and dissolved in an appropriate volume of Tris‐EDTA buffer (10
mM Tris pH 8.0, 1 mM EDTA). DNA preparations were stored at ‐20°C.
2.2.2 RNA isolation from tissue samples
Organs, whole embryos or tissue biopsies were isolated and snap‐frozen in liquid Nitrogen
(refer to Section 2.4.1 for details on tissue isolation). RNA was purified from frozen samples
using TRI reagent (Sigma Aldrich), essentially following the manufacturer’s instructions.
Briefly, 50‐100 mg tissue was homogenised thoroughly in 1 ml ice‐cold TRI reagent using a
T8.01 homogeniser (GMBH and Co., Germany). After centrifugation at 12,000 x g for 10
minutes in a microcentrifuge, the supernatant was transferred to a fresh 1.5 ml
microcentrifuge tube (Eppendorf). After adjusting to room temperature for 5 minutes, 0.2
ml chloroform was added and samples were mixed by shaking vigorously for 15 seconds.
After standing at room temperature for 15 minutes, samples were centrifuged at 12,000 x g
for 15 minutes at 4°C. 0.5 ml propan‐2‐ol was mixed with the aqueous phase and allowed
to stand at room temperature for 5‐10 minutes. Following centrifugation as before, RNA
pellets were washed in 1 ml ice‐cold 75 % ethanol and air‐dried. RNA was resuspended in
50‐200 µl DEPC‐treated deionised water (DEPC from Sigma Aldrich) by repeated pipetting of
samples warmed to 55°C. Samples for cDNA synthesis were further treated with DNase I,
using DNA‐free (Ambion, TX, USA) as described in the product literature. RNA samples were
used immediately or stored at ‐80°C.
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2.2.3 cDNA synthesis
For semi‐quantitative reverse transcription PCR (RT‐PCR) and amplification of probes for
Northern blotting, 1 µg DNase I‐treated RNA was heated to 65°C for 5 minutes in a G‐Storm
Mark 1 thermal cycler in a total volume of 13 µl, with 1 mM dNTP mix (Invitrogen) and 5
µM oligo‐dT20 (Invitrogen). For quantitative RT‐PCR (qPCR), 2 µg DNase I‐treated RNA was
used in the same reaction. The thermal cycler was paused and samples incubated on ice for
1 minute. The SuperScript III reverse transcriptase system (Invitrogen) was used to
synthesise cDNA, following the manufacturer’s recommended protocol. A control reaction
was also set up, from which the reverse transcriptase enzyme was omitted, permitting
accurate interpretation of subsequent PCR amplification.
2.2.4 Semi‐quantitative reverse transcription PCR (RT‐PCR) on adult brain cDNA
cDNA was synthesised from brain homogenates from wild type, Grb10Δ2‐4m/+ and Grb10Δ2‐
4+/p adult males, as described in Section 2.2.3. 1 µl cDNA from each sample was amplified
for 26 cycles using PCR conditions described previously (Section 2.1.3); primers amplified
Grb10 exons 11‐16 and  β‐actin (see Table 2.1 for primer sequences). Amplicons were
visualised by gel electrophoresis, as described before (Section 2.1.3).
2.2.5 Quantitative real‐time PCR (qPCR) analysis
Quantitative real‐time PCR with SYBR green was performed with SensiMix (Quantace, UK),
according to the manufacturer’s instructions. For qPCR on e17.5 placentae, primers were
used to amplify Grb10 exons 3‐4, Grb10 exons 11‐16, total Igf2, Igf2P0, Slc38a4 and the
house‐keeping gene Hprt (refer to Table 2.1 for primer sequences). The relative standard
curve method was employed for quantification (Pfaffl, 2001). Gene expression was
normalised to that of Hprt, the expression of which did not significantly differ between the
datasets (data not shown; Charalambous et al, submitted).
The same technique was employed to analyse gene expression in adult pituitary glands,
using primers for Prolactin, Growth hormone and  β‐actin (Table 2.1). Target gene
expression was normalised to β‐actin transcript levels.
For both analyses, the mean of each dataset was compared using the Kruskal‐Wallis test,
with Dunn’s multiple comparison test to compare each group to the relevant control
dataset.
qPCR analysis was performed by Dr Marika Charalambous (Department of Physiology,
Development and Neuroscience, University of Cambridge).
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2.2.6 PCR amplification and cloning of probes for Southern and Northern blotting
Probes for Southern blotting and the DNase I hypersensitivity assay were amplified by PCR
from 295 ng genomic DNA, isolated from a wild type adult mouse liver sample as described
in Section 2.2.1. Table 2.2 details the primers utilised for the amplification of each probe.
Products were amplified using GoTaq Master Mix and PCR conditions described previously
(Section 2.1.3).
Probes for Northern blotting were amplified, using the same conditions, from cDNA
synthesised from whole wild type e14.5 embryo RNA. Primer sequences are detailed in
Table 2.2.
PCR amplicons were purified from 1 % agarose gels using the Wizard SV Gel and PCR
Purification Kit (Promega), following the protocol described in the product literature. The
pGEM‐T Easy vector system (Promega) was used to clone the Taq‐amplified products,
exploiting the single base pair ‘A’‐tail overhangs generated in the PCR. Ligation reactions
contained insert:vector in a 1:1 to 5:1 ratio, 2 x Rapid Ligation Buffer (Promega) and 3 U T4
DNA ligase (Promega), in a 10 µl total volume. Reactions were incubated at 4°C overnight.
Competent Escherichia coli DH5α cells were prepared by Dr Masataka Nikaido (University of
Bath). A fresh single colony of cells growing on Luria agar (Sigma Aldrich) was picked into 50
ml sterilised SOB medium (2 % (w/v) bactotryptone (BD Biosciences, NJ, USA), 0.5 % (w/v)
yeast extract (Oxoid Ltd., Hampshire, UK), 10 mM NaCl, 2.5 mM KCl (Sigma Aldrich), 20 mM
Mg2+ (Sigma Aldrich)) in a 500 ml conical flask, and shaken at ~250 rpm at 18‐25°C. When
OD600 was between 0.4 and 0.6, cultures were placed on ice for 10 minutes, and cells
pelleted by centrifugation at 3000 rpm in a Beckman Coulter Allegra 25R benchtop
centrifuge for 10 minutes, at 4°C. Cells were resuspended in 1/3 volume of ice‐cold TB
medium (10 mM PIPES (Sigma Aldrich), 15 mM CaCl2.2H2O (Sigma Aldrich), 250 mM KCl, 55
mM MnCl2.4H2O (Sigma Aldrich), pH 6.7) and incubated on ice for 10 minutes. Cells were
pelleted as before and resuspended in 4 ml ice‐cold TB medium. DMSO (Sigma Aldrich) was
added to a final concentration of 7 %, mixed and cells placed on ice for 10 minutes. Cells
were snap‐frozen in liquid Nitrogen and stored at  ‐80°C. Competency was quantified with
known amounts of pBlueScript KS+ vector (Stratagene, CA, USA) and was typically ~108
colony forming units (cfu)/µg vector.
Plasmid DNA was purified from the salts of the ligation reaction mix by microdialysis, using
0.025 µm membrane filters (Millipore) floating on deionised water for 30 minutes.
Competent cells were incubated with all of the plasmid DNA from the ligation reaction on
ice in a pre‐chilled 14 ml Falcon tube for 30 minutes. Cells were heat‐shocked for 90
seconds at 42°C and chilled on ice for 2 minutes, permitting plasmid uptake. 1 ml pre‐
warmed Luria Broth (LB) medium (made as directed from LB powder, Sigma Aldrich) was
added to the cells, which were allowed to express β‐lactamase, the enzyme responsible for
the degradation of carbenicillin, in the absence of antibiotics, by incubating at 37°C for 1
hour, shaking at 200 rpm (Innova 4230 incubator, New Brunswick Scientific, NJ, USA). 200 µl
of cells were plated onto a Luria agar plate, containing 150 µl 100 mg/ml carbenicillin
(Bioline, UK), 240 µl 20 mg/ml isopropyl‐β‐D‐thiogalactopyranoside (IPTG; Sigma Aldrich)
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Table 2.2 – Southern and Northern hybridisation probes
Primers used for the amplification of probes for Southern and Northern hybridisation,
including the DNase I hypersensitivity assay, are presented. 1from Charalambous et al,
2003; 2from Menheniott et al, 2008. fwd – forward; rev – reverse.
Probe Amplification template Primer sequence (5’ to 3’)
Probe A Adult liver genomic DNA fwd: caactgggattaggtagggg
rev: caactgagcacagaaaaggg
Probe B
Probe C
Gapdh
Ddc
Whole e14.5 embryo
total RNA
Adult liver genomic DNA
Whole e14.5 embryo
total RNA
Whole e14.5 embryo
total RNA
fwd: ctgacctggaagaaagcagc 1
rev: gcgaggagtctcacaggatc 1
fwd: gggtgtttgtccttgatgct
rev: ctgacccccagaatgtgttt
fwd: cccatcaccatcttccaggagc
rev: ccagtgagcttcccttcagc
fwd: ctgggttaattggtggaataaagc 2
rev: tctgaaggtaagaccaaagactgc 2
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and 300 µl 40 mg/ml 5‐bromo‐4‐chloro‐3‐indolyl‐β‐D‐galactopyranoside (X‐gal; Fermentas,
Canada) per 300 ml. Overnight incubation at 37°C was sufficient to visualise colony growth
and permit blue/white selection.
White colonies, indicating disruption of the LacZ gene on the pGEM‐T Easy vector with the
PCR amplicon, were picked into 4 ml LB plus 2 µl 100 mg/ml carbenicillin, and propagated
overnight at 37°C in a shaking incubator (200 rpm). Cells from 2 ml of each culture were
pelleted at 3000 x g for 10 minutes, and the plasmid DNA was purified using the Wizard
Plus SV miniprep kit (Promega).
Clones were initially screened by appropriate restriction digestion strategies, and then
sequenced (MWG Biotech, Germany) using the T7 Promoter primer. A single clone for each
probe was propagated in 150 ml LB plus carbenicillin overnight, shaking at 200 rpm, and a
large‐scale plasmid purification performed using the GenElute HP plasmid maxiprep kit
(Sigma Aldrich), according to the manufacturer’s guidelines. Final preparations were
quantified using a spectrophotometer (Eppendorf BioPhotometer) and stored at 4°C.
Probe fragments were excised from the vector using appropriate restriction digestion.
Enzymes and associated digestion buffers were supplied by Promega, and reactions were
performed in line with the recommended protocol.
2.2.7 PCR amplification for gene‐trap cassette mapping
PCR was performed as described in Section 2.1.3 on 295 ng genomic DNA, isolated from an
adult liver biopsy or total e14.5 embryo. Primer sequences are provided in Table 2.1.
Amplicons were separated by gel electrophoresis, purified, cloned into pGEM‐T Easy and
sequenced, as described above. Subsequent genotyping was performed using a subset of
the mapping primers (Table 2.1) in PCR.
2.2.8 Southern and Northern blotting
To map the position of the β‐geo cassette in the Grb10KO allele, genomic DNA was purified
from liver samples of adult wild type and Grb10KO+/p animals, and from a rare Grb10KOm/p
embryo isolated at e14.5, as described in Section 2.2.1. 12 µg genomic DNA was digested
overnight at 37°C with 60 U PstI or BamHI (Promega) in a total volume of 50 µl. Samples
were diluted in 6x DNA loading buffer (Promega) and run on a 1 % agarose gel in 1x TAE
buffer containing 0.5 µg/ml ethidium bromide, at 25 V for 18 hours.
1 % agarose gels for the separation of RNA for Northern blotting were made in a 6 %
formaldehyde (Sigma Aldrich) and 1 x MOPS buffer (20 mM MOPS (Sigma Aldrich), 10 mM
sodium acetate (Sigma Aldrich), 1 mM EDTA, pH 7.0), using DEPC‐treated distilled water.
RNA was purified from homogenised tissue samples as described in Section 2.2.2 and 20‐50
µg was diluted in 2x loading buffer (Fermentas). RNA was denatured by heating at 70°C for
10 minutes and loaded onto agarose gels. Electrophoresis was performed in a 1 x MOPS
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running buffer for 5‐6 hours. All electrophoresis components were cleaned prior to use with
3 % hydrogen peroxide (Sigma Aldrich) and rinsed with DEPC‐treated distilled water, to
reduce RNase activity.
After electrophoresis, DNA gels were denatured by washing in 1 M NaCl, 0.5 M NaOH for 30
minutes at room temperature, followed by two washes in 1.5 M NaCl, 50 mM Tris, 1 mM
EDTA for 15 minutes to neutralise. Nucleic acid (RNA or DNA) was transferred to
nitrocellulose membrane (Gene Technologies Ltd.) by capillary blotting for at least 16
hours, using 20x SSC (3 M NaCl, 0.3 M sodium citrate (Sigma Aldrich)) as a buffer. For
Northern blotting, transfer equipment was cleaned prior to use as described for
electrophoresis. Nucleic acid was cross‐linked onto membranes using ultraviolet radiation
in a CL‐1000 UVP cross‐linker at 24000 µJ/cm2.
Membranes were pre‐hybridised in 15 ml Church buffer (50 % (v/v) phosphate buffer (0.95
M Na2HPO4 (Fisher Scientific), 0.8 % phosphoric acid (BDH, UK), pH 8.0), 1 mM EDTA, 7 %
(w/v) SDS, 1 % (w/v) bovine serum albumin (BSA; Sigma Aldrich)) plus 150 µl sonicated
salmon sperm DNA (Sigma Aldrich). Pre‐hybridisation was performed in rotating
hybridisation bottles overnight at 63.8°C in a Hybaid hybridisation oven. 25 ng of the
relevant DNA probe was denatured by boiling for 2 minutes in a total volume of 13 µl. A 5x
pre‐mixed labelling solution (High Prime, Roche, IN, USA) was added to the sample on ice. 3
µl α32P‐dCTP (Perkin Elmer, MA, USA), with an activity of at least 5 µCi/µl, was added to the
reaction mix and subsequently incubated at 37°C for 20 minutes.
The reaction mix volume was made up to 100 µl with TE, and labelled probe fragments
were purified from unincorporated nucleotides by centrifugation through a Sephadex‐G50
column (1200 x g for 2 minutes; Sephadex G‐50 from Sigma Aldrich). A further 100 µl TE
was added to the column and centrifuged again to elute probe fragments. The Klenow
enzyme was denatured by the addition of NaOH to a final concentration of 330 mM,
incubated for 5 minutes at room temperature, and the mix then neutralised with Tris HCl
pH 7.5 to a final concentration of 457 mM. The labelled probe fragments were hybridised
with nucleic acid on the relevant membranes overnight at 65°C in the existing Church buffer
and salmon sperm DNA solution.
Membranes were washed twice in wash solution 1 (4 % (v/v) phosphate buffer, 5 % (w/v)
SDS, 0.5 % (w/v) BSA, 1 mM EDTA) for 15 minutes each, and twice in wash solution 2 (4 %
(v/v) phosphate buffer, 1 % (w/v) SDS, 1 mM EDTA) for at least 1 hour each, to remove
unbound or loosely associated probe fragments. Membranes were wrapped in clingfilm and
exposed to imaging film (GE Healthcare) for up to two weeks at  ‐80°C. Development was
performed using an Optimax film processor (GmbH and Co.).
2.2.9 DNase I hypersensitivity assay
Whole brain and liver tissues were dissected from adult wild type male mice and rinsed
briefly in 0.1 % phosphate buffered saline (PBS; Oxoid Ltd.). Tissues were individually
homogenised in 10 ml ice‐cold buffer I (0.3 M sucrose (Sigma Aldrich), 60 mM KCl, 15 mM
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NaCl, 5 mM MgCl2 (Sigma Aldrich), 0.1 M EGTA (Sigma Aldrich), 15 mM Tris‐HCl pH 7.5, 0.5
mM DTT (Sigma Aldrich), 0.1 mM PMSF (Sigma Aldrich), fresh aprotinin (Sigma Aldrich) to
3.6 ng/ml) using a homogeniser. The resulting homogenates were filtered through four
layers of muslin cloth pre‐moistened with 2 ml buffer I. Cells were pelleted at 6000 x g for
20 minutes in a refrigerated centrifuge (Beckman Coulter Allegra 25R) and re‐suspended in
2 ml ice‐cold buffer I, pooling the nuclei isolated from each tissue type. Cells were lysed
with the addition of an equal volume of ice‐cold buffer II (as buffer I, plus 0.4 % (v/v) Igepal
CA‐630 (Sigma Aldrich)) and incubated on ice for 5 minutes. Lysed cell suspensions were
layered onto 8 ml sucrose cushions (1.2 M sucrose, 60 mM KCl, 15 mM NaCl, 5 mM MgCl2,
0.1 M EGTA, 15 mM Tris HCl pH 7.5, 0.5 mM DTT, 0.1 mM PMSF, fresh aprotinin to 3.6
ng/ml) in 14 ml glass centrifuge tubes and centrifuged at 10000 x g for 20 minutes at 4°C.
Pelleted nuclei were resuspended in 2 ml ice‐cold DNase I digestion buffer (as buffer I,
without aprotinin or PMSF). 200 µl of each suspension was digested with 0, 120 or 200 U
DNase I (Roche) for 20 minutes in a water bath at 25°C. Reactions were terminated with the
addition of an equal volume of 20 mM EDTA pH 8.0, 1 % (w/v) SDS. DNase I and DNA‐
associated proteins were digested at 50°C overnight with proteinase K at a final
concentration of 200 µg/ml, previously diluted to 20 mg/ml in TE buffer (10 mM Tris HCl pH
7.5, 1 mM EDTA) and incubated at 37°C for 15 minutes to activate. DNA was extracted
twice with phenol:chloroform:isoamyl alcohol (25:24:1); DNA exposed to 0 U DNase I was
too viscous to be extracted initially, and was thus sheared first by passing through a 30
gauge syringe needle 3 times. A final extraction with chloroform:isoamyl alcohol was then
performed for all samples. DNA was precipitated with the addition of 1/20 volume of 5 M
NaCl and one volume of propan‐2‐ol. After a 5 minute incubation at room temperature,
DNA was pelleted by centrifugation at 12000 x g for 20 minutes, rinsed in 70 % ethanol, air‐
dried and resuspended in 50 µl TE buffer.
Purified DNA was quantified and digested at 37°C overnight with an excess of BamHI,
according to the manufacturer’s guidelines (Promega). Digested DNA was precipitated with
an equal volume of propan‐2‐ol, rinsed in 70 % ethanol, air‐dried and dissolved in 50 µl TE
buffer. DNA suspensions were quantified as before and 10 µg of each sample mixed with 6x
gel loading buffer (Promega) and loaded on a 1 % agarose gel. Samples were
electrophoresed overnight at 15 V and transferred to nitrocellulose membrane by capillary
blotting, as described for Southern blotting (Section 2.2.8). The blot was challenged with a
radiolabelled probe (probe C; Table 2.2) by Southern hybridisation.
2.2.10 Western blotting
Whole e14.5 placentae were homogenised in 1 ml Igepal CA‐630 lysis buffer (50 mM Tris
HCl pH 8.0, 150 mM NaCl, 1 % (v/v) Igepal CA‐630, plus one Roche protease inhibitor
cocktail tablet per 10 ml buffer). Samples were incubated on ice for 30 minutes to permit
cell lysis and passed through a 21 gauge needle 5 times. Suspensions were centrifuged at
12000 x g for 10 minutes at 4°C to pellet cell debris and supernatants further centrifuged at
100000 x g for 15 minutes (Beckman TL‐100 ultracentrifuge) at 4°C. Total protein
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concentration was determined using the BCA protein assay kit (Pierce, IL, USA), and
samples stored at ‐20°C.
20 µg of each sample was mixed with 2x reducing sample buffer (250 mM Tris HCl pH 6.8, 2
% (w/v) SDS, 10 % (v/v) glycerol (Sigma Aldrich), 10 % (v/v)  β‐mercaptoethanol (Sigma
Aldrich), 0.02% (w/v) bromophenol blue (Sigma Aldrich)) and heated to 95°C for 5 minutes.
Samples were loaded onto a polyacrylamide gel (resolving gel: 8 % polyacrylamide (National
Diagnostics, GA, USA), 0.37 M Tris HCl pH 8.8, 0.1 % SDS, 0.05 % AMPS (Sigma Aldrich), 0.05
% TEMED (ICN Biomedicals Inc., OH, USA); stacking gel: 5 % polyacrylamide, 0.12 M Tris HCl
pH 6.8, 0.05 % AMPS, 0.1 % TEMED) alongside pre‐stained protein standards (Bio‐Rad
Laboratories, UK), and run at 100 V for 90 minutes in running buffer (0.1 % SDS, 25 mM Tris,
208 mM glycine (Fluka, Sigma Aldrich)). Protein was transferred onto PVDF membrane (Bio‐
Rad Laboratories) by wet transfer (25 mM Tris, 192 mM glycine, 20 % (v/v) methanol (Fisher
Scientific)). All subsequent incubations were performed on an orbital shaker. The
membrane was blocked in 5 % powdered skimmed milk (Tesco, UK), 0.1 % Tween‐20 (Sigma
Aldrich) in 0.1 % PBS for 2 hours at room temperature. Primary antibodies were diluted in 1
% milk in PBS‐T (0.1 % Tween‐20, 0.1 % PBS; see Table 2.3 for antibody concentrations
used) and applied to the appropriate membranes. Overnight incubation was permitted at
4°C. Membranes were washed three times in 0.1 % PBS‐T for 15 minutes per wash, and
incubated in peroxidase‐conjugated goat anti‐rabbit secondary antibody (Vector
Laboratories, CA, USA) diluted 1/10000 in 1 % milk in PBS‐T for 1 hour at room
temperature. Three further washes were performed as before and protein detection was
achieved using the ECL‐Plus system (GE Healthcare), as directed by the manufacturer.
Autoradiography film (GE Healthcare) was developed using an X‐ray processor.
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Table 2.3 – Primary antibodies utilised for Western blotting and immunohistochemistry
Species indicates the animal in which the antibody was raised. IHC – immuno‐
histochemistry.
Antigen Species Application Concentration Manufacturer
Stat5 Rabbit IHC
Western
1/200
1/200
Santa Cruz
Biotechnology
Grb7 Rabbit IHC
Western
1/200
1/500
Santa Cruz
Biotechnology
α‐tubulin Rabbit Western 1/30000 Sigma Aldrich
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2.3 In vitro techniques
2.3.1 Luciferase assay constructs
pRSV‐puroSTAT5B1*6 (Onishi et al, 1998) was kindly donated by Dr Fabrice Gouilleux
(University of Picardie‐Jules Verne, France) with the permission of Dr Toshio Kitamura
(University of Tokyo, Japan). pRL‐SV40, encoding Renilla luciferase, was a gift from Emily
Jane‐Myatt and Dr David Tosh (University of Bath). Donated plasmids were transformed
into competent E. coli DH5α cells, as described in Section 2.2.6.
The 799 bp genomic region, incorporating cis‐regulatory module 1 (CRM1), previously
amplified to generate the probe for DNase I hypersensitivity analysis, was excised from
pGEM‐T Easy using the SacII and SpeI restriction enzymes, and sub‐cloned into these sites in
the pBlueScript KS+ vector. The genomic region was subsequently cloned into the pGL3‐
Promoter vector (Promega) using KpnI and SacI to generate pGL3‐Pro‐CRM1, and the
integrity of the sequence confirmed by nucleotide sequencing (MWG Biotech, Germany).
Large scale plasmid purifications were performed for all constructs, including pGL3‐
Promoter alone, as previously described (Section 2.2.6).
2.3.2 Cell maintenance
A frozen aliquot of NIH/3T3 mouse fibroblast cells was kindly donated by Kathy O’Neill and
Dr David Tosh (University of Bath). Cells were rapidly thawed and maintained in Dulbecco’s
modified Eagle’s medium (DMEM; Gibco, Invitrogen) plus 10 % (v/v) newborn calf serum
(Gibco, Invitrogen), 1 % (v/v) penicillin/streptomycin (Gibco, Invitrogen) and 1 % (v/v) L‐
glutamine (Gibco, Invitrogen), herein referred to as complete media. Cells were incubated
at 37°C in 5 % CO2 and were maintained in 75 cm
2 flasks (Greiner Bio‐One, Belgium).
Complete media was changed as required. At around 70 % confluency, cultures were
passaged by washing briefly in 0.1 % PBS and detached from the flask with a 5 minute
incubation at 37°C with 1 ml 0.05 % trypsin/EDTA (Gibco, Invitrogen) per 25 cm2.
Trypsin/EDTA was neutralised with an equal volume of complete media and transferred to
a 15 ml centrifuge tube (Falcon). Cells were pelleted at 180 x g for 4 minutes (MSE Mistral
1000 centrifuge) and resuspended in 1 ml complete media, before distributing into fresh
flasks. Typically, cultures were split 1/20 every 4‐5 days.
2.3.3 Cell transfection
Near‐confluent flasks of NIH/3T3 cells were trypsinised as described before, and cells
counted by use of a haemocytometer slide. 100000 cells were seeded into each well of four
6‐well plates, each well containing 3 ml complete media. The complete media was
refreshed the following day. 48 hours after seeding, cells were ~60 % confluent, and
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complete media was replaced with DMEM plus 1 % newborn calf serum and 1 % L‐
glutamine. Cells were incubated at 37°C, 5 % CO2 in this antibiotic‐free media for 4.5 hours.
DNA mixes to be transfected were prepared in separate sterile microcentrifuge tubes, as
shown in Table 2.4. Each sample was incubated with 250 µl Optimem medium (Gibco,
Invitrogen) for 5 minutes at room temperature. Simultaneously, 10 µl Lipofectamine 2000
(Invitrogen) was incubated with 250 µl Optimem medium at room temperature for 5
minutes, for every replicate. The DNA and Lipofectamine 2000 mixes were pooled and
incubated for at least 30 minutes at room temperature. Transfection mixes were added to
the appropriate well containing NIH/3T3 cells in antibiotic‐free media, mixed gently and
incubated for 4.5 hours at 37°C, 5 % CO2. Media was replaced with complete media,
including antibiotics, and cells were left to grow and express recombinant proteins for 48
hours before performing the luciferase assay.
2.3.4 Luciferase assay
The Dual‐Luciferase Reporter Assay System (Promega) was used to quantify luciferase
activity, and was performed according to the manufacturer’s instructions. The passive cell
lysis method, rather than active lysis by scraping, was used to liberate cellular proteins. A
Microlumat Plus luminometer (EG&G Berthold, Germany) was used to assess the activity of
both firefly and Renilla luciferase. For each sample, firefly luciferase activity was normalised
to that for Renilla luciferase, thus controlling for cell viability and transfection efficiency.
Data was compared by one‐way analysis of variance (ANOVA) with Tukey’s post‐hoc test,
using Prism software.
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Table 2.4 – Plasmid DNA transfection mixes
pGL3‐Pro – pGL3‐Promoter vector (Promega); pGL3‐Pro‐CRM1 – pGL3‐Promoter vector with
cis‐regulatory module 1 cloned into the multiple cloning site. Constructs are depicted
graphically in Figure 5.9.
Mix # Plasmid Quantity Number of replicates
1 pGL3‐Pro 2 µg 6
pRL‐SV40 0.1 µg
2
3
4
5
6
pGL3‐Pro‐CRM1
pRL‐SV40
As mix #1, plus
pRSV‐puroSTAT5B1*6
As mix #2, plus
pRSV‐puroSTAT5B1*6
As mix #1, plus
pRSV‐puroSTAT5B1*6
As mix #2, plus
pRSV‐puroSTAT5B1*6
2 µg
0.1 µg
0.5 µg
0.5µg
1 µg
1 µg
6
3
3
3
3
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2.4 Histological techniques
2.4.1 Tissue isolation
Tissues were isolated from adult mice following death by cervical dislocation. Embryos, or
extra‐embryonic material, was obtained following cervical dislocation of the pregnant
female, isolation of the uterine horns and subsequent immersion in ice‐cold 0.1 % PBS for 5
minutes. Tissue biopsies, or whole organs, were removed, rinsed briefly in 0.1 % PBS and
processed as required. Adult mammary glands were spread across APTS‐subbed slides to
preserve the shape of the gland, protecting the epithelial component as much as possible.
2.4.2 Carmine staining of mammary glands
Wholemount glands were isolated from gravid and lactating females, all 10 weeks of age
and previously virgins at mating. For lactating females, litter size was normalised to 7 pups
on the day of birth. Glands, adhered to slides as described above, were incubated in
Carnoy’s fixative (60 % ethanol, 30 % chloroform, 10 % acetic acid) for 3 hours at room
temperature, transferred to 70 % ethanol for 15 minutes and hydrated slowly by gradual
replacement of the ethanol with tap water, using a gently running tap for ~3 minutes.
Carmine alum stain (0.2 % (w/v) carmine dye (BDH), 0.5 % (w/v) aluminium potassium
sulphate (Sigma Aldrich)) was prepared by boiling for 20 minutes, allowing to cool and
filtering through Whatmann #1 filter paper. Glands were stained in carmine alum for 18
hours at room temperature, and sequentially dehydrated, by incubating for 10 minutes in
each of 50 %, 70 %, 90 % and 100 % ethanol. Glands were stored in xylene (Fisher Scientific)
and mounted in DePex mounting medium (BDH).
2.4.3 Optical Projection Tomography
Wild type mammary glands isolated at gestational day 12.5 (G12.5), which had previously
been stained with carmine alum as described above, were cleared of DePex by incubating
at room temperature in xylene for several days. Glands were detached from slides and
cleared in four overnight incubations in 100 % methanol, followed by one overnight
incubation in benzyl alcohol (Sigma Aldrich). The free‐floating glands were embedded in
low melting point agarose, which was subsequently trimmed to an octagonal prism, and
scanned using a Bioptonics 3100. 400 2‐dimensional scans were reconstructed into a 3‐
dimensional image using Amira software.
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2.4.4 Staining for β‐galactosidase activity in mammary wholemounts
Glands were isolated and spread across slides as described in Section 2.4.1, and fixed for 2
hours in 2 % (w/v) paraformaldehyde (PFA; Sigma Aldrich), 0.25 % (v/v) glutaraldehyde
(Sigma Aldrich), 0.01 % (v/v) Igepal CA‐630 in 0.1 % PBS, at room temperature. Glands were
washed briefly in 0.1 % PBS and further fixed in 2 mM MgCl2, 0.01 % (w/v) sodium
deoxycholate (Sigma Aldrich), 0.02 % (v/v) Igepal CA‐630 in 0.1 % PBS for 2 hours at room
temperature, rocking gently. Following fixation, glands were incubated in 1 mg/ml X‐gal
(Sigma Aldrich) in stain base (30 mM K4Fe(CN)6 (Sigma Aldrich), 30 mM K3Fe(CN)6.3H2O
(Sigma Aldrich), 2 mMMgCl2, 0.01 % (w/v) sodium deoxycholate, 0.02 % (v/v) Igepal CA‐630
in 0.1 % PBS) for 18 hours at 28°C. X‐gal had been previously diluted to 40 mg/ml in N,N‐
dimethylformamide (DMF; Sigma Aldrich).
After staining, glands were cleared in acetone (Fisher Scientific) for 6.5 hours, dehydrated in
an ascending ethanol series as described for carmine alum staining, and stored in xylene.
Glands were mounted in DePex for photographing.
2.4.5 Staining for β‐galactosidase activity in e8.0 mouse embryos
Eight days after the observation of a cervical plug, pregnant females were sacrificed and
uterine horns removed. Embryos were isolated with the aid of a dissecting microscope and
washed in 0.1 % PBS. Fixation was performed for 30 minutes at 4°C in 1 % (w/v)
formaldehyde (Sigma Aldrich), 0.2 % (v/v) glutaraldehyde, 2 mM MgCl2, 5 mM EGTA, 0.02 %
(v/v) Igepal CA‐630 in 0.1 % PBS. Embryos were washed at room temperature in three
changes of 0.02 % (v/v) Igepal CA‐630 in 0.1 % PBS for 30 minutes each. Staining was
performed in the dark, using X‐gal diluted in stain base, as described in Section 2.4.4.
Embryos were post‐fixed in 4 % (w/v) PFA in 0.1 % PBS overnight at 4°C.
To permit sectioning, embryos were resin embedded, using Technovit 7100 (Heraeus,
Germany). First, they were dehydrated for 30 minutes each in 70 %, 96 % and 100 %
ethanol at room temperature. Next, a pre‐infiltration step was performed, incubating
embryos in a 1:1 ratio of ethanol:infiltration solution A (Heraeus) for 2 hours. Infiltration
was performed overnight by incubating embryos in 100 % infiltration solution A. Embryos
were embedded in solution B (Heraeus) and polymerisation permitted overnight. Blocks
were mounted, ready for sectioning, using Technovit 3040, according to the manufacturer’s
instructions. Sectioning was performed by Iryna Withington.
Sections were heated to 65°C for 1 hour, then counter‐stained in nuclear fast red solution
(Vector Laboratories) for 15 minutes. Following a wash with tap water, slides were left to
dry at 30°C and mounted in DePex.
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2.4.6 Sectioning and staining of the mature mouse placenta
Cryosectioning and assaying for β‐galactosidase activity
Placental genotype was determined by PCR amplification of embryonic tail clips, as
described in Section 2.1.3. Placentae were fixed for 30 minutes at room temperature in 4 %
(w/v) PFA, 0.2 % (v/v) glutaraldehyde in 0.1 % PBS. Tissue was cryo‐protected by incubating
in 30 % sucrose at 4°C, until the tissue had sunk to the bottom of the tube. After eliminating
excess sucrose solution, placentae were embedded in OCT (VWR International, UK) on dry
ice and stored at  ‐80°C until sectioning. Sections were cut at a thickness of 8 µm using a
Leica CM1850 cryostat, onto polysine slides (Menzel‐Gläser, Germany).
X‐gal was diluted in stain base, as described previously, and pipetted onto sections in a
dark, humidified chamber. Incubation proceeded for 18 hours at 37°C, except where
otherwise stated in the text. To permit counter‐staining, slides were washed gently in 0.1 %
PBS to remove excess X‐gal, and cleared in two 2 minute incubations with Histoclear
(National Diagnostics). Sections were hydrated in a descending ethanol series, incubating
for 2 minutes each in 100 %, 100 %, 95 %, 90 %, 70 %, 50 % ethanol and finally MilliQ water.
Sections were stained in filtered nuclear fast red for 90 seconds and dehydrated in 70 %
ethanol (15 seconds), 95 % ethanol (15 seconds) and two 100 % ethanol incubations (1
minute each). Sections were prepared for mounting with DePex by two 2 minute
incubations in Histoclear.
Assaying for β‐galactosidase activity, post‐fixing and paraffin sectioning
Placentae were isolated at e14.5, fixed for 30 minutes at 4°C in 4 % (w/v) PFA in 0.1 % PBS,
washed briefly in 0.1 % PBS and excess liquid removed on tin foil. Tissues were frozen
quickly on dry‐ice and sagittally bisected with a razor blade, before being stained in X‐gal
solution, diluted in stain base as previously, at 28°C. Samples were washed in 0.1 % PBS,
fixed overnight in 4 % (w/v) PFA in 0.1 % PBS at 4°C and prepared for sectioning using a
Leica tissue processor. Briefly, samples were dehydrated in an ascending ethanol series (2
hours in each of 50 %, 70 %, 90 %, 100 %, 100% ethanol), then cleared twice in Histoclear (2
hours each) and infiltrated with hot wax (three 2 hour incubations). Sections were taken at
a thickness of 8 µm (Leica RM2155).
Sections were hydrated, counter‐stained with nuclear fast red, dehydrated and mounted,
as described above.
Staining for morphological assessment
Whole e14.5 placentae were isolated, fixed overnight in 4 % (w/v) PFA in 0.1 % PBS at 4°C,
washed in 0.1 % PBS and stored in 70 % ethanol at 4°C. Samples were dehydrated and
sectioned as described above.
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To permit staining with haematoxylin and eosin, tissue sections were first cleared of excess
wax by two 2 minute washes in Histoclear and hydrated through a descending ethanol
series (100 %, 100 %, 95 %, 90 %, 70 %, 50 %), with 1 minute in each solution. Hydration
was completed with an incubation in MilliQ water for 1 minute. Nuclear staining was
achieved by incubation in filtered Ehrlich’s haematoxylin (Raymond Lamb, Fisher Scientific)
for 5 minutes. Excess stain was removed under a running tap for ~5 minutes. Sections were
placed in 1 % concentrated HCl in 70 % ethanol for 30 seconds, followed by 60 seconds in 1
% NH3 (Fisher Scientific) in 70 % ethanol. Sections were washed briefly (30 seconds) in 70 %
ethanol to remove traces of NH3, and then stained in filtered eosin (Fisher Scientific) for 5
minutes. Brief washes (~3 seconds) were performed in 70 %, 95 %, 100 % and 100 %
ethanol, and sections prepared for mounting with two 2 minute incubations in Histoclear.
Slides were mounted with DePex.
2.4.7 Immunohistochemistry
Paraffin‐sectioned tissue was cleared in Histoclear as before and hydrated through a
descending ethanol series, with a 1 minute incubation in each of 100 %, 95 %, 70 % and 50
% ethanol. Antigen retrieval was achieved by boiling sections in 10 mM citric acid (Sigma
Aldrich) three times for 5 minutes each. Endogenous peroxidase activity was quenched by
incubating in 0.3 % (v/v) hydrogen peroxide for 30 minutes at room temperature. Sections
were rinsed in 0.1 % PBS and blocked for 1 hour in 0.3 % (w/v) BSA, 0.01 % Tween‐20 in 0.1
% PBS. Stat5 or Grb7 antibody was diluted in blocking buffer (Table 2.3), applied to slides
and left to incubate overnight at 4°C. Negative (no primary antibody) controls were also
performed simultaneously.
Sections were washed three times in 0.1 % Tween‐20 in 0.1 % PBS for 15 minutes each,
removing excess primary antibody. The Vectastain ABC kit (Vector Laboratories) was used
for amplification of signal, according to the manufacturer’s instructions. Briefly, a
biotinylated goat anti‐rabbit secondary antibody was reconstituted as instructed in blocking
buffer, and applied to sections for 1 hour at room temperature. Sections were washed as
before and incubated in Vectastain ABC reagent for 45 minutes, as directed. Five washes of
5 minutes each were performed with 0.1 % PBS, and visualisation of protein localisation
was achieved by incubating with DAB substrate (Vector Laboratories) for 10 minutes,
prepared according to the manufacturer’s guidelines. To remove excess DAB substrate,
slides were washed in running water for 5 minutes, and then counter‐stained in
haematoxylin for 30 seconds. After washing in water, sections were dehydrated in a graded
ethanol series of 70 %, 95 % and 100 % ethanol, for 1 minute each, cleared in Histoclear as
before and mounted with DePex.
2.4.8 Assessment of apoptosis by TUNEL assay
Fourth (abdominal) mammary glands were isolated from age‐matched (all 10 weeks of age
and virgins at mating) and litter size‐matched females 48 hours after a forced wean at
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postnatal day 15. As before, glands were spread over APTS‐subbed slides to preserve
architecture and shape. Glands were fixed in 10 % neutral‐buffered formalin (Sigma Aldrich)
overnight at 4°C. Cells undergoing apoptosis were labelled using the ApopTag peroxidase in
situ apoptosis detection kit (Chemicon International Inc., USA), as described in the
associated manual. Working strength peroxidase substrate (Vector Laboratories) was
prepared as directed. Counter‐staining was achieved with methyl green (Vector
Laboratories), then sections were dehydrated in xylene and mounted with DePex, as
instructed in the ApopTag peroxidase in situ apoptosis detection kit literature.
For a quantitative assessment of TUNEL‐positive cells, one representative section from each
sample was photographed at 400x magnification at four randomly‐selected, non‐
overlapping sites, using a Nikon Eclipse E800 microscope. TUNEL‐positive nuclei were
counted as a proportion of the total number of nuclei, and a mean proportion calculated
for each sample. Glands from five different females were analysed for each genotype (wild
type and Grb10KOm/+); the mean value for each genotype was compared by Students’ T‐
test, using Prism software.
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2.5 Morphological analyses
2.5.1 Assessment of the placenta
Measurement of cell layer thickness
Ten placentae of each genotype were sectioned and stained with haematoxylin and eosin.
One representative section close to the midline was randomly‐selected from each sample
and photographed at 10x magnification, such that the entire section could be visualised in
one field. Using Image ProPlus software, the distance from the labyrinth‐junctional zone
boundary to the foetal edge of the chorionic plate was measured at the centre of each
section, as well as the distance from the labyrinth‐junctional zone boundary to the
junctional zone‐decidua boundary. Data was analysed for each measurement using one‐
way ANOVA with Tukey’s post‐hoc test, and manipulated using Prism software.
Morphometric analysis
Images of the ten randomly‐selected placental sections for each genotype were overlaid
with a 8 x 4 grid, dividing the sections into 32 discrete areas. One area was chosen by
random number generation. This area, and seven of the surrounding areas, were
consistently analysed for each sample. Viewed at 100x magnification, each area was
overlaid with a counting grid, and cell type was scored as ‘labyrinth’, ‘spongiotrophoblast’,
‘glycogen cell’ or ‘blood vessel’, essentially as described (Charalambous et al, submitted).
The total number of scored cell types per window was pooled for each sample, and used to
calculate mean values for each genotype.
Blood vessel area analysis
Images of placental sections were taken at 40x magnification to assess foetal vasculature
occupancy. All images had 100 % occupation by labyrinth. First, Image ProPlus was used to
manually define the edges of foetal blood vessels through which a cross‐section had been
taken. This was used to calculate the total area of foetal vasculature, in arbitrary units.
Secondly, the number of discrete foetal blood vessels was counted. One representative
section from each of ten placentae per genotype, close to the midline, was analysed in this
manner. Statistical analyses were performed using Prism software.
2.5.2 Assessment of the mammary gland
Fourth (abdominal) mammary glands isolated at gestational day 12.5 (G12.5) were fixed
and stained with carmine alum. Females were 10 weeks of age at mating and previously
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virgins. Wholemount glands were consistently photographed at 20x magnification,
positioning the edge of the lymph node closest to the leading edge such that it was just
visible at the top centre of the image. The number of primary branch points within the
window was counted. Five wild type and three Grb10KOm/+ glands, from separate females,
were analysed in this manner.
The distance from the lymph node to the leading edge was also measured, by
photographing the same mammary gland wholemounts adjacent to a ruler.
For both measurements, results were analysed with Students’ T‐test using Prism software.
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2.6 In silico analyses
2.6.1 Sequence conservation at the Grb10 locus
The genomic sequences of the orthologous Grb10 sequences for mouse, human,
chimpanzee, cow, Xenopus tropicalis, chicken and opossum were retrieved from Ensembl
(www.ensembl.org). The relevant Ensembl IDs are provided in the legend to Figure 5.4.
ExactPlus (available for public use at http://research.nhgri.nih.gov/exactplus; Antonellis et
al, 2006) was used to identify short conserved sequences. First, a MultiPipMaker alignment
(acgt) file was generated for each of the separate comparisons to be made, and the ‘very
verbose text (ASCII, compressed)’ output submitted to ExactPlus for analysis. The first
nucleotide base of the murine Grb10 sequence was used as the start coordinate to enable a
graphical depiction of the alignment on the UCSC Genome Browser
(http://genome.ucsc.edu/). The minimum length of exact match to seed was 6 bp. The
minimum number of species to seed was equivalent to the number of species for that
particular alignment; all species must thus possess at least 6 identical base pairs in
sequence for a hit to be reported. The minimum number of species to extend a hit was
consistently set at 2; this represented the number of species in which an alignment was
required to extend a hit both 5’ and 3’ to the initial sequence identified. An exons file was
submitted to exclude murine exons 1, 2, 3, 4 and 5 from the alignment. Exons 6 to 18 were
included as positive controls for sequence conservation. Custom tracks were submitted to
the UCSC Genome Browser and viewed in squish format.
2.6.2 Identification of predicted regulatory modules at the Grb10 locus
The mouse Grb10 Ensembl gene ID was submitted to PReMod, available for public use at
http://genomequebec.mcgill.ca/PReMod/welcome.do. No search restrictions were
imposed. Output was viewed as a html file. Details of the software are provided in
Blanchette et al (2006).
2.6.3 Allen Brain Atlas
The atlas is available for public use at www.brain‐map.org. Known sites of Grb10 expression
in the CNS (Garfield et al, submitted) were identified in the images of sagittal sections
which had been challenged with in situ probes to Stat5a, Stat5b, Pax1‐9 and Tcf11. Sites of
Grb10 expression which corresponded with higher levels of in situ signal than background
noise for each of these transcription factors were recorded.
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2.7 Mammary gland function analyses
2.7.1 Mice
For all matings, males were wild type animals. All females used in the cross‐fostering study
were 7 weeks of age and virgins at mating. On the morning of the observation of a cervical
plug, males were removed from females, and prior to giving birth, females were housed
individually. On the day of birth, pups were weighed and tattooed on the pads of the paws
to permit future identification. This was achieved by injecting a small volume of India ink
sub‐cutaneously. Litters were normalised to 5‐7 pups on the day of birth by arbitrary pup
selection, unless an obviously unhealthy pup was apparent. Where appropriate, litters were
exchanged between mothers on the day of birth; see Figure 6.3 for the directions of
transfer. Provided the genotypes did not compromise the experiment, individual pups were
exchanged if it helped to normalise litter size. Pup weight was recorded every subsequent
day at approximately the same time until postnatal day 15. During this period, females
were permitted unlimited access to food and water. Once culled, pups were genotyped
from a tissue biopsy, as described for adult ear clips (Section 2.1.3).
2.7.2 Milk isolation
On postnatal day 15, pups were culled. Mothers were left for ~4 hours to permit milk
accumulation and injected intraperitoneally with 0.1 % (w/v) xylazine, 0.5 % (w/v) ketaset in
0.9 % (w/v) NaCl, at 16 µl/g of mouse to induce anaesthesia. Once fully anaesthetised, mice
were injected intraperitoneally with 200 µl oxytocin (Sigma Aldrich) at 10 IU/ml, diluted in
0.1 % PBS, to aid milk letdown. After 2‐3 minutes, nipples were swabbed with 70 % ethanol
to make them erect, and gentle vacuum pressure was applied in combination with
massaging of the gland. The vacuum was provided by a pipette aid electric pump,
connected to a 1.5 ml collecting tube, which in turn was connected to a shortened yellow
pipette tip sitting comfortably around the nipple (see Figure 6.7a and b). Up to 150 µl milk
could be collected per mouse. Females were culled by cervical dislocation under terminal
anaesthesia, and pituitary glands isolated and snap‐frozen.
2.7.3 Milk analysis
A small volume (~20 µl) of each milk sample was centrifuged in a plugged borosilicate glass
capillary tube (Harvard Apparatus Ltd., Kent, UK) for 20 minutes at 3000 rpm in a Sorvall
Biofuge Pico microcentrifuge, to separate fat from protein. The relative proportion of fat in
the sample was measured using a ruler. Data was analysed using Prism software and
statistical analysis performed by one‐way ANOVA with Tukey’s post‐hoc test. Capillary
tubes were sliced to remove the fat. Protein was retrieved from the capillary tube and
diluted 1/5 in buffer (50 mM Tris HCl pH 8.0, 150 mM NaCl, 1 % (v/v) Igepal CA‐630).
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Samples were boiled for 10 minutes with an equal volume of 2x reducing sample buffer
(recipe in Section 2.2.10) and loaded onto a 15 % Criterion Tris‐HCl gel (Bio‐Rad
Laboratories) alongside pre‐stained molecular weight standards, as described for Western
blotting.
After suitable protein separation, the gel was fixed in 50 % ethanol, 10 % acetic acid for 1
hour at room temperature, rocking gently, and then transferred to 50 % methanol, 10 %
acetic acid overnight, again rocking gently. The following day, the gel was stained with
Coomassie blue (0.1 % (w/v) Coomassie blue (Raymond Lamb), 20 % (v/v) methanol, 10 %
(v/v) acetic acid) at room temperature for 3 hours with gentle agitation. Destaining was
performed using 50 % methanol, 10 % acetic acid. Solution was changed frequently until
most background staining had been eliminated. Gels were stored in 5 % acetic acid and
photographed with an AlphaImager 3400.
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Genetic characterisation of the Grb10KO
allele and its influence during early mouse
development
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3.1 Introduction
Many of the early analyses of murine Grb10/human GRB10 employed yeast two‐hybrid
assays and in vitro manipulations to elucidate potential binding partners. Indeed, Grb10
was first identified in a bacterial expression library screen, using the tyrosine‐
phosphorylated carboxy‐terminus of the epidermal growth factor receptor (EGFR; Ooi et al,
1995). Later screens identified further potential binding partners of Grb10, including other
tyrosine kinase receptors, such as the insulin and insulin‐like growth factor I receptors (He
et al, 1998), and Bcr‐Abl (Bai et al, 1998). More recently, two intracellular binding partners,
termed Grb10 interacting GYF proteins 1 (GIGYF1) and GIGYF2, have been identified using
yeast two‐hybrid screening with the N‐terminus of Grb10 (Giovannone et al, 2003). Grb10,
as an adaptor protein, appears to link the GIGYFs with the IGF1 receptor, thereby
modulating IGF1 signalling. Other intracellular signalling partners have been identified by
biochemical means, including the growth hormone receptor (GHR), insulin receptor (IR),
MEK1, ELK and Tec, as discussed in Chapter One (Stein et al, 1996; Frantz et al, 1997; Mano
et al, 1998; Moutoussamy et al, 1998; Nantel et al, 1998).
Such biochemical studies have been key in shaping the direction of research on the cellular
functions of Grb10, but they have an important limitation. The artificial conditions in which
the experiments are performed can force associations which might otherwise occur only
weakly in a cell, or indeed, not at all if two proteins exhibit different tissue distributions.
Therefore, some of the identified ‘binding partners’ might not be physiologically relevant. In
vitro analyses can often confirm or argue against a molecular interaction; for example, such
experiments have failed to identify Grb10 as a true binding partner of the EGFR, despite
being a strong candidate from biochemical analyses.
One shortcoming of both biochemical and in vitro analyses is that they may provide limited
information about the physiological relevance of an interaction. As discussed in Chapter
One, several in vitro studies have described Grb10 as a negative regulator of insulin
signalling (Liu and Roth, 1995; Wick et al, 2003). However, these experiments fail to answer
several important questions about the functions of Grb10 in a physiological context: How
significant is Grb10 in regulating insulin signalling? Does Grb10 act in all insulin target
tissues? Is Grb10 over‐expression a risk factor for diabetes?
Transgenic animal models can complement biochemical and in vitro analyses, and can often
help to address some of these shortcomings, providing important information about the
physiological relevance of molecular interactions. Shiura et al (2005) describe a mouse
model in which ectopic Grb10 is expressed under the control of the chicken  β‐actin
promoter, increasing transcripts of this gene by 1.2 to 1.4‐fold in tissues examined, relative
to wild type controls. Growth retardation manifested 4 weeks after birth, with a 10‐15 %
reduction in weight compared with wild type controls at 4 months. Adult mice also
exhibited insulin resistance, with blood glucose levels remaining significantly higher than
wild type controls 60 minutes after insulin administration. The result correlated with an
impaired ability to clear glucose following glucose injection. This study supported the
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findings of in vitro experiments, suggesting that Grb10 negatively regulates insulin
signalling, but only the transgenic model enabled the function of Grb10 to be described in a
physiological context, demonstrating the important homeostatic role for Grb10 in
maintaining circulating blood glucose levels.
The function of Grb10 as a modulator of insulin signalling was also confirmed from in vivo
knock‐out experiments. Smith et al (2007) utilised a transgenic mouse line in which Grb10
protein had been ablated by the incorporation of a gene‐trap cassette in the endogenous
Grb10 locus (Grb10Δ2‐4). Converse to results reported for Grb10 over‐expression mice,
animals inheriting the Grb10Δ2‐4 allele through the maternal line (Grb10Δ2‐4m/+),
effectively ablating Grb10 from peripheral tissues, displayed improved whole‐body glucose
tolerance and insulin sensitivity. Dual X‐ray absorptiometry performed on whole 6‐month
old Grb10Δ2‐4m/+ animals revealed an increase in muscle mass with a concomitant reduced
adiposity, also confirmed by the wet weights of individual muscles and fat depots. Whilst an
increase in the mass of muscle, a key glucose deposition tissue, might partially account for
the improved ability to clear circulating glucose, Grb10Δ2‐4m/+ mice exhibited higher levels
of IR in both skeletal muscle and fat than wild type counterparts. RNAi‐mediated
suppression of Grb10 activity suggests that, whilst the levels of IR message are not
influenced by Grb10, insulin‐stimulated ubiquitination of the IR may be the mechanistic
basis for this in vivo observation, with Grb10 acting to promote receptor internalisation and
presumably proteasomal‐targeting (Ramos et al, 2006). The absence of Grb10 in Grb10Δ2‐
4m/+ animals also correlated with an increased proportion of phosphorylated insulin
receptor substrate‐1 (IRS‐1). Taken together, these results confirm the role of Grb10 in
peripheral tissues as a negative regulator of insulin signalling, but also highlight the
importance of transgenic models in extrapolating in vitro observations to the whole‐
organism level.
In addition to ablating full‐length transcripts, the gene‐trap cassette integrated at the Grb10
locus to generate the Grb10Δ2‐4 allele includes a LacZ reporter gene, expression of which is
driven by the endogenous promoter (Charalambous et al, 2003). This genetic tool offers the
opportunity to track sites of Grb10 expression during development and in adulthood.
Whilst this can also be achieved using in situ hybridisation and immunohistochemistry,
these latter techniques offer limited scope for the study of uniparental expression, being
indiscriminate in their recognition of protein or mRNA derived from each parental allele.
Transmission of an integrated reporter gene, however, can be parent‐specific. Transmitting
Grb10Δ2‐4 through the maternal line reported widespread embryonic expression at e14.5,
including skeletal and cardiac muscle, liver and bronchioles, as well as pancreatic buds and
developing tubules in the kidney (Charalambous et al, 2003). Expression of LacZ from a
paternally‐inherited copy of Grb10Δ2‐4 reported a more restricted profile, including some
cells of the heart, gut, umbilicus, lungs and tongue. A contribution from both alleles was
apparent in cartilage tissue, although expression from the maternally‐inherited allele
appeared greater.
Interestingly, immunohistochemistry identified Grb10 protein in the developing central
nervous system (CNS), a site not reported following inheritance of Grb10Δ2‐4 through
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either parental line (Charalambous et al, 2003). A second transgenic allele, created in the
same gene‐trapping experiment, also ablated full‐length Grb10 transcripts and reported
Grb10 expression. This allele, herein referred to as Grb10KO, confirmed the embryonic
expression profile identified previously, but also reported expression in the developing CNS
following paternal inheritance (Garfield et al, submitted). Strikingly, this identifies Grb10 as
the only gene with such a reciprocal imprinting pattern, in which peripheral expression is
predominantly from the maternally‐inherited allele, while the paternally‐derived copy is the
near‐exclusive source of transcripts in the CNS. Other genes display imprinted expression in
a tissue‐specific manner, but not a complete switch from one imprinted allele to the other.
Murine Blcap_v1a, for example, is expressed broadly but only imprinted in the brain (Schulz
et al, 2008). Conversely, Igf2 is expressed and imprinted in most tissues, but in the choroid
plexus epithelium is expressed from both parental alleles (DeChiara et al, 1991;
Charalambous et al, 2004).
The inability of Grb10Δ2‐4 to report expression in the CNS is addressed in Chapter Five.
Sites of Grb10 expression during adulthood are relatively restricted, being predominant in
skeletal muscle, adipose tissue and endocrine cells of the pancreas, thus correlating with
the role for Grb10 in mediating insulin signalling. Expression is also detected in the Leydig
cells of the testis, the oviduct and uterine horns of the female reproductive system, and
some cell populations of the CNS (Smith et al, 2007; Garfield et al, submitted). The
reciprocal imprinting pattern, however, persists into adulthood, with transcripts in the CNS
continuing to arise almost exclusively from the paternally‐inherited allele, with the
exception of the epithelium of the choroid plexus, the ventricular ependymal layers and the
meninges (Garfield et al, submitted).
Whilst the gene‐trap cassette in the Grb10Δ2‐4 allele has been mapped (Charalambous et
al, 2003), the exact position of the same cassette in Grb10KO remained to be elucidated. 5’
RACE data suggested the LacZ reporter gene splices onto the end of exon 7 in transcripts
originating from the Grb10 promoter, thereby implying the reporter cassette must lie 3’ of
this exon. Knowing the site of cassette integration is critical to understanding the
relationship between gene and phenotype. An integration site between exons 1A and 1C,
for example, from which peripheral‐  and brain‐specific transcripts initiate, respectively,
might fail to ablate functional Grb10 in the CNS.
This Chapter describes the mapping experiments performed to identify the integration site
of the  β‐geo cassette into the Grb10 locus, thereby creating the Grb10KO allele. The
efficacy of the gene‐trap in ablating full‐length Grb10 transcripts is demonstrated. With
detailed knowledge of the allelic structure, a key phenotypic difference between mice
inheriting Grb10KO and Grb10Δ2‐4 is addressed.
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3.2 Results
3.2.1 Mapping of the gene‐trap cassette integration site in the Grb10KO allele
Both the Grb10Δ2‐4 and Grb10KO alleles were generated in a commercial gene‐trapping
experiment, in which a  β‐geo cassette was randomly integrated into the genome of
embryonic stem (ES) cells (Stryke et al, 2003). This cassette consists of four key features: a
5’ splice acceptor (SA) sequence, onto which transcripts initiating upstream splice; a LacZ
reporter gene, enabling characterisation of the expression profile of the trapped gene; a
neo resistance gene for ES cell selection; and a 3’ poly‐adenylation (poly‐(A) or pA)
sequence to prematurely terminate host gene transcripts. Transgenic mice harbouring the
Grb10KO or Grb10Δ2‐4 allele were generated as described in Section 2.1.2. Southern
blotting and polymerase chain reaction (PCR)‐based mapping experiments for Grb10Δ2‐4
demonstrated that the  β‐geo cassette had replaced ~38 kb of the Grb10 locus, including
exons 2‐4 (Charalambous et al, 2003).
5’ RACE experiments performed from Grb10KO ES cells, utilising a primer complimentary to
the 5’ end of the LacZ reporter gene, indicated that β‐geo splices onto the end of exon 7 of
transcripts arising at the Grb10 locus (Bay Genomics, University of California). This
suggested the cassette had integrated between exons 7 and 8, and provided a focus for
initial mapping experiments.
The first mapping strategy employed in the present study involved the use of nine primer
pairs, each with an amplicon size of between 470 bp and 680 bp, which together provided
complete coverage of intron 7. At the site of cassette integration, one or more of these
primer pairs would fail to amplify from DNA homozygous for the Grb10KO allele. Embryos
at 14.5 days post‐coitum (e14.5), based on the observation of a cervical plug, were isolated
from Grb10KOm/+ x Grb10KOm/+ crosses. Bisected embryos were stained for LacZ expression
and Grb10KOm/p conceptuses identified by the presence of staining in both the central
nervous system and mesodermally‐derived tissues (indicating paternal and maternal
inheritance of the Grb10KO allele, respectively). DNA isolated from tissue biopsies from
these and wild type embryos was subjected to PCR using the nine primer pairs spanning
intron 7. Amplicons, however, were observed from all nine primer pairs using both wild
type and Grb10KOm/p DNA as template (data not shown). Additionally, semi‐quantitative
PCR failed to detect a difference between wild type and Grb10KOm/+DNA (data not shown),
together suggesting the cassette integration site may not lie in intron 7.
To allow for the possibility that the integration site may be further downstream, Southern
blotting was performed on wild type, Grb10KO+/p and Grb10KOm/p DNA, using digest
strategies which would enable screening of the genomic region from 984 bp upstream of
exon 7 to the 3’ end of exon 9 (Figure 3.1a). First, BamHI‐digested genomic DNA was
challenged with a radiolabelled probe (probe A) spanning the exon 7/intron 7 boundary. A
4.5 kb digestion fragment was identified in DNA from all three genotypes, indicating that
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the  β‐geo cassette had not integrated upstream of the intron 7 BamHI recognition site
(Figure 3.1b).
A second digest strategy, utilising PstI, identified a restriction fragment length
polymorphism (Figure 3.1c). Probing of wild type DNA generated the 6.7 kb PstI digestion
fragment expected from the endogenous sequence (Figure 3.1a). An additional digestion
fragment was apparent from the probing of Grb10KO+/p genomic DNA, estimated to be ~10
kb. This fragment was also present in DNA isolated from a Grb10KOm/p embryo, whilst the
6.7 kb fragment was absent, suggesting these represent the Grb10KO and wild type alleles,
respectively.
The 5’‐most PstI site in the  β‐geo cassette is positioned 4.7 kb into the  β‐geo sequence,
putting the start of the cassette ~5.3 kb downstream of the endogenous PstI site in intron 6
(Figure 3.1a). This result implied that the integration site is close to or within exon 8. Using
a similar approach to that described previously, overlapping primer pairs were designed to
span the 3’ end of intron 7 to the 5’ end of intron 9, and PCR amplification performed on
wild type and Grb10KOm/p DNA isolates (Figure 3.2a). Whilst primer Sets A and C
successfully amplified DNA of both genotypes, primer Set B failed to amplify from
Grb10KOm/p DNA (Figure 3.2b). The absence of an amplicon from DNA homozygous for the
Grb10KO allele, suggested this 392 bp region might contain the site of cassette integration.
In order to map the integration site to the base pair resolution, PCR amplification was
performed on Grb10KOm/p DNA using the forward primer of primer Set B in combination
with two reverse primers complimentary to sites within the β‐geo cassette (β‐R1 and β‐R2,
Figure 3.2a). Both of these primer combinations produced amplification products, neither
of which were observed using wild type DNA as a template (not shown). Both products
were cloned into the pGEM‐T Easy vector, as described in Section 2.2.7, and sequenced.
The sequencing results from both clones corroborated, indicating that the 5’ end of the
integration site is within exon 8, 11 bp from the 3’ end (Figure 3.2c).
The integration of the β‐geo cassette to generate the Grb10Δ2‐4 allele caused the deletion
of ~38 kb of the endogenous Grb10 locus (Charalambous et al, 2003). To confirm whether
Grb10KO was generated by a simple insertion event, or if it too was subject to a sequence
deletion, the current study next mapped the 3’ end of the β‐geo cassette by PCR. A forward
primer located close to the 3’ end of the cassette (β‐F1, Figure 3.2a), with the reverse
primer from primer Set B, produced an amplicon from Grb10KOm/p embryo DNA which was
cloned and sequenced, as before. This confirmed that the insertion of the β‐geo cassette
had deleted 12 bp of the Grb10 locus, including 11 bp from exon 8 and 1 bp from intron 8
(Figures 3.2a and 3.2c).
Additionally, 825 bp at the 5’ end of the β‐geo cassette sequence were deleted during the
integration. However, 707 bp 5’ to the splice acceptor sequence were retained, and 5’ RACE
experiments confirmed correct splicing of the  β‐geo cassette onto Grb10 exon 7 (Bay
Genomics, University of California).
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3.2.2 The Grb10KO allele effectively ablates full‐length Grb10 transcripts
Mice inheriting the Grb10KO allele through the maternal line demonstrate similar
embryonic growth and adult metabolic phenotypes to those previously described for
Grb10Δ2‐4m/+ animals (Charalambous et al, 2003; Smith et al, 2007; Garfield, 2007; Garfield
et al, submitted), suggesting effective ablation of functional Grb10 protein. However, a
demonstration of the absence of full‐length Grb10 transcripts was required to confirm the
efficacy of the β‐geo cassette insertion.
Total RNA isolated from wild type e14.5 embryos, as well as embryos inheriting the
Grb10KO allele through each of the parental lines, was size‐fractionated on a denaturing gel
and probed for full‐length Grb10 transcripts, using a cDNA probe spanning exons 11‐16
(probe B; Figure 3.3a; Charalambous et al, 2003). Grb10 transcripts of 5.5 kb were detected
in wild type RNA and with a similar intensity in RNA isolated from Grb10KO+/p embryos
(Figure 3.3b). The expression of Grb10 transcripts in a Grb10KOm/+ embryo was considerably
reduced, confirming both the effective ablation of full‐length Grb10 transcripts and the
imprinted nature of the gene. A low level of signal representing 5.5 kb transcripts was
apparent in this RNA sample, presumably reflecting Grb10 expression from the paternally‐
inherited allele in the central nervous system and other discrete sites of both mesodermal
and endodermal origin (see Section 3.1). The same samples were challenged with a probe
hybridising to Gapdh transcripts, confirming equal loading.
A lower molecular weight species of ~2.5 kb was apparent in both wild type and Grb10KO+/p
RNA samples, which was also detected on a Northern blot probing placental RNA at e14.5
(data not shown). This could represent non‐specific probe hybridisation, but this is unlikely
due to the absence of this product in Grb10KOm/+ RNA. This implies that a shorter transcript
of Grb10, yet to be described, may exist, which forms a small proportion of the total pool,
at least in whole embryo and placental isolates. Key, however, is that this transcript is
ablated from the Grb10KO allele. Potential functional redundancy with full‐length Grb10
will not, therefore, compromise the phenotypic characterisation of mice inheriting this
allele.
3.2.3 Grb10 is expressed from the paternally‐derived allele in adult brain
Whilst mice inheriting the Grb10Δ2‐4 allele did not report Grb10 expression in the CNS,
immunohistochemistry experiments suggested active transcription and translation of this
gene in the brain (Charalambous et al, 2003). Corroborating this, analysis of the LacZ
reporter expression profile from adult mice harbouring the Grb10KO allele, demonstrated
Grb10 expression in a subset of neurons, including some cells of the thalamus,
hypothalamus, midbrain and hindbrain, as well as the ventral spinal cord (for a complete
list, see Garfield et al, submitted). Specifically, expression of the LacZ reporter was
observed only following inheritance of the Grb10KO allele through the paternal line.
To confirm the imprinted status of Grb10 in this tissue, RNA isolated from the brains of
adult mice inheriting the gene‐trap allele through each of the parental lines, as well as a
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wild type control, was probed for Grb10 (Figure 3.4a). Probe B (Figure 3.3a) detected 5.5 kb
transcripts in RNA from wild type and Grb10KOm/+ adult brain samples, but not from a
Grb10KO+/p brain, confirming the reciprocal imprint between peripheral tissues and the
CNS.
Previous experiments have demonstrated that Grb10 and its neighbouring gene Dopa
decarboxylase (Ddc) form an imprinted cluster, sharing regulatory domains (Menheniott et
al, 2008; Shiura et al, 2009). To confirm that the insertion of a β‐geo cassette at the Grb10
locus, and indeed the ablation of Grb10 transcripts, does not influence the expression of
Ddc in the adult brain, Northern blotting was performed on adult brain RNA samples using a
probe specific to Ddc. No changes in the level of expression of the characterised 2.0 kb Ddc
transcript, or of a higher molecular weight species, were observed following the inheritance
of Grb10KO or Grb10Δ2‐4 through either parental line (Figure 3.4b).
3.2.4 Grb10KOm/p mice do not conform to the expected Mendelian ratio at e14.5
The mapping strategies employed to locate the integration site of the β‐geo cassette in the
Grb10KO allele, utilised DNA purified from Grb10KOm/p embryos (Section 3.2.1). Embryos
isolated from Grb10KOm/+ x Grb10KOm/+ crosses were genotyped initially on the basis of
LacZ reporter expression. Those reporting expression from both the maternally‐  and
paternally‐inherited alleles appeared to occur infrequently at e14.5. This was initially
attributed to the limitation of genotyping embryos in this manner, in which reporter
expression in the brain can be obscured by that in the surrounding mesodermal tissue.
Identification of the  β‐geo cassette integration site permitted derivation of a genotyping
strategy which could discriminate between the wild type and Grb10KO alleles, thus
enabling definitive identification of heterozygous and homozygous embryos. The
genotyping strategy utilised primer Set B (Figure 3.2a and b) to indicate the presence of a
wild type allele. The forward primer of Set B with a reverse primer in the β‐geo cassette (β‐
R1; Figure 3.2a) were used to amplify from the Grb10KO allele. Table 3.1 presents the
numbers of offspring of each genotype isolated at e14.5 from Grb10KOm/+ x Grb10KOm/+
crosses. Chi‐squared analysis confirmed that the ratio of genotypes deviated significantly
from that expected under Mendelian laws of inheritance (p = 0.017). Chi‐squared analysis
(not shown) performed on the same data set, but excluding Grb10KOm/p embryos,
confirmed that the ratio of wild type and heterozygous animals conformed to that expected
(χ2 = 0.8; p = 0.670), implying a lethality effect in Grb10KOm/p conceptuses.
3.2.5 The Grb10KO allele is predicted to give rise to a truncated Grb10 polypeptide
Intriguingly, mice inheriting two copies of the Grb10Δ2‐4 allele do conform to the expected
Mendelian ratio (Table 3.2; p = 0.709, Chi‐squared analysis), and have been studied, as
adults, in metabolic experiments (Smith et al, 2007). The complete ablation of functional
Grb10 protein is, therefore, an insufficient explanation for the scarcity of Grb10KOm/p
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Table 3.1 – Number of offspring of each genotype produced from Grb10KOm/+ x
Grb10KOm/+ crosses at e14.5
Isolated embryos were initially screened for LacZ reporter expression to identify those with
the Grb10KO+/p genotype. Tissue biopsies were genotyped by PCR as described in the text
to differentiate Grb10KOm/p from Grb10KOm/+ embryos (χ2 = 10.19; p = 0.017).
Genotype Observed number
of embryos
Expected number
of embryos
Wild type 12 10.5
Grb10KOm/+ 12 10.5
Grb10KO+/p 16 10.5
Grb10KOm/p 2 10.5
Total 42 42
Table 3.2 – Number of offspring of each genotype produced from Grb10Δ2‐4m/+ x
Grb10Δ2‐4m/+ crosses surviving to adulthood
Adult mice from Grb10Δ2‐4m/+ x Grb10Δ2‐4m/+ crosses were genotyped from ear biopsies by
PCR as described in Smith et al, 2007 (χ2 = 0.6875; p = 0.709). Refer to Table 2.1 for relevant
primer sequences.
Genotype Observed number
of mice
Expected number
of mice
Wild type 10 8
Grb10Δ2‐4m/+ and
Grb10Δ2‐4+/p
15 16
Grb10Δ2‐4m/p 7 8
Total 32 32
67
Exon 7
GAUGUCAAAGUCUUUAGUGAAGAUGGGACCAGCAAAGUGGUGGAGAU
--D--V--K--V--F--S--E--D--G--T--S--K--V--V--E--
UCUAACCGACAUGACAGCCAGGGACCUGUGCCAGCUGCUGGUUUACA
I--L--T--D--M--T--A--R--D--L--C--Q--L--L--V--Y-
AAAGUCACUGUGUGGAUGACAACAGCUGGACUCUGGUGGAACACCAC
-K--S--H--C--V--D--D--N--S--W--T--L--V--E--H--H
CCACAACUGGGAUUAGGUCCCAGGUCCCGAAAACCAAAGAAGAAGAA
--P--Q--L--G--L--G--P--R--S--R--K--P--K--K--K--
CGCAGAUCGCAUCGAUAACUUCGUAUAG
N--A--D--R--I--D--L--F--V--STOP
RA SH2P PH BPS
3 4 5 6 7 8 9 10 1211 13 14 15 16 17 18
5’ 3’
RAP
Grb10
Grb1029.4
a
b
68
Chapter Three
embryos at e14.5. Mapping of the two gene‐trap alleles, however, revealed a key
difference. Integration of the β‐geo cassette in Grb10KO is downstream of the endogenous
translational start site in exon 3, whereas this has been abolished in Grb10Δ2‐4 (Figure
3.3a). Therefore, whilst the LacZ reporter is under the control of the endogenous Grb10
promoter in both transgenic alleles, only the Grb10KO allele would be expected to produce
a Grb10‐LacZ fusion protein. The presence of an in‐frame stop codon created by gene‐trap
integration might terminate translation early for a subset of transcripts arising from the
Grb10KO locus, potentially producing a truncated Grb10 protein species. Clearly, such
premature termination could not occur for all transcripts, given the ability of LacZ to report
sites of Grb10 expression. This ‘skipping’ of a stop codon is referred to as translational read
through, and has been documented at several loci in mammals, as well as bacteria and
yeast (Williams et al, 2004; Tate et al, 1995).
The size of such a truncated protein species was predicted from the known sequence of the
Grb10KO allele, based on the position of the first in‐frame stop codon downstream of exon
3 (Figure 3.5a). This analysis predicted a polypeptide of 267 amino acids, consisting of 248
residues to the 3’ end of exon 7 in the endogenous Grb10 sequence, and an additional 19
residues from the β‐geo cassette. The molecular weight of such a species was predicted to
be ~29.4 kDa, assuming a mean molecular weight of 110 per amino acid molecule, and is
herein referred to as Grb1029.4. The only functional motifs predicted within this translated
sequence would be the proline‐rich and Ras‐associating domains (Figure 3.5b).
Western blotting of whole wild type, Grb10Δ2‐4m/+ and Grb10KOm/+ neonate lysates was
performed, using a N‐terminal antibody raised against Grb10, aiming to detect this
truncated protein species. Such a protein should be absent from wild type and Grb10Δ2‐
4m/+ samples. Western blotting failed to detect this predicted protein (data not shown).
3.2.6 Grb1029.4 may be biallelically expressed in the developing heart
As embryos inheriting just one copy of Grb10KO from either parental line were viable, it
followed that this truncated molecule must only confer lethality when present as two
copies. The imprinted nature of Grb10 restricts the number of sites at which biallelic
expression would permit sufficient levels of Grb1029.4 for such an effect. The scarcity of
foetuses homozygous for Grb10KO at e14.5 implied a site of biallelic expression prior to this
developmental stage. Sanz et al (2008) describe expression of Grb10 from the paternally‐
derived allele at the anterior visceral endoderm (AVE), an early patterning centre partly
responsible for establishing anterior‐posterior polarity (Thomas and Beddington, 1996). It is
unclear from this published work whether AVE expression is exclusively from this allele, or
if there is also a contribution from the maternally‐inherited copy.
To address this issue, LacZ reporter expression was examined in e8.0 embryos inheriting
the Grb10KO allele from one parent. Examination of whole embryos revealed apparently
widespread expression in foetal tissue from the maternally‐derived allele, whereas the
paternal contribution was localised to a population of cells close to the early headfold
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region (Figure 3.6a and b). These stained embryos were resin‐embedded, sagittally‐
sectioned and counter‐stained with nuclear fast red to permit a more detailed analysis of
reporter expression. Sectioning of both embryos revealed a morphology consistent with
Theiler Stage late 11/early 12. The Grb10KO+/p embryo showed a more marked headfold
than the Grb10KOm/+ embryo (Figure 3.6c and d), suggesting the Grb10KO+/p conceptus was
further developed by a few hours. LacZ expression from the paternally‐derived allele was
indeed restricted to a few cells (position of the sections shown is illustrated in Figure 3.6f).
However, the position of these cells was inconsistent with the location of the anterior
visceral endoderm, being situated in the mesodermal layer adjacent and posterior to the
presumptive neural ectoderm (Figure 3.6e). These cells represented endocardial or
myocardial cells of the heart tube, the primordia of the embryonic heart. Expression
appeared strongest in the right heart tube (Figure 3.6b), suggesting a possible involvement
of Grb10 in establishing or maintaining left‐right asymmetry in this tissue.
Reporter expression was readily detected in the mesodermal layer of the sectioned
Grb10KOm/+ embryo (Figure 3.6d). Expression was strongest in the anterior mesoderm,
becoming weaker towards the centre of the embryo, but could also be readily detected in
the posterior mesoderm. Anterior mesodermal cells were presumed to include those of the
developing heart tube, and the strong  β‐galactosidase activity detected in all cells in the
region suggested Grb10 may be biallelically‐expressed in this structure. No reporter
expression was apparent in the AVE, although weak activity could be detected in a subset
of ectodermal cells.
3.2.7 Grb10KOm/p embryos are viable at e7.5
To help elucidate the mechanism responsible for embryonic lethality in Grb10KOm/p
conceptuses, the viability of embryos at e7.5 was examined. Embryos were collected from
Grb10KOm/+ x Grb10KOm/+ crosses and genotyped by PCR as described in Section 2.1.3. Table
3.3 presents the number of embryos of each genotype generated in these crosses. Chi‐
squared analysis confirmed no significant deviation from the expected ratios, implying that
all genotypes were viable at this developmental stage (p = 0.243).
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Table 3.3 – Number of offspring of each genotype produced from Grb10KOm/+ x
Grb10KOm/+ crosses at e7.5
Embryos from Grb10KOm/+ x Grb10KOm/+ crosses were isolated at e7.5 and genotyped by
PCR, as described in the text (χ2 = 2.83; p = 0.243).
Genotype Observed number
of embryos
Expected number
of embryos
Wild type 5 8.75
Grb10KOm/+ and
Grb10KO+/p
22 17.5
Grb10KOm/p 8 8.75
Total 35 35
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3.3 Discussion
Despite numerous biochemical and in vitro studies of Grb10 identifying potential binding
partners and implicating the protein in various intracellular signalling cascades, the
relevance of these interactions to physiological processes require further investigation.
Indeed, many such assays have demonstrated the involvement of Grb10 in insulin
signalling, an example for which there is support for a corresponding in vivo role, yet at face
value even these studies fail to agree on whether Grb10 is a positive or negative modulator.
Chinese hamster ovary cells over‐expressing human Insr (CHO/IR) exhibited reduced
tyrosine phosphorylation of two downstream effector molecules, insulin receptor
substrate‐1 (IRS‐1) and GTPase‐activating‐protein‐associated protein, following insulin
stimulation, when Grb10 was stably transfected and expressed (Liu et al, 1995). The
reduced activity of these effector molecules implied a role for Grb10 in attenuation of
insulin signalling, and was corroborated by the increased tyrosine phosphorylation of IRS‐1
in muscle of Grb10Δ2‐4m/+ mice (Smith et al, 2007). Further in vitro analyses provided a
mechanistic basis for this role, demonstrating reduced insulin‐stimulated IR ubiquitination
and internalisation following RNAi‐mediated suppression of endogenous Grb10 (Ramos et
al, 2006). Conversely, Wang et al (1999) implicated Grb10 as a positive mitogenic mediator
of insulin signalling. NIH/3T3 fibroblasts, over‐expressing the human IR, were micro‐
injected with the Grb10‐SH2 domain as a dominant negative competitor of endogenous
Grb10‐mediated signalling. Following a period of starvation, insulin treatment of these cells
failed to stimulate DNA synthesis at a rate comparable with micro‐injected controls. This
effect of Grb10‐SH2 was explained as an interference with normal mitogenic signalling,
mediated by the full‐length Grb10 protein.
Such shortcomings of in vitro experimentation can be often be addressed using in vivo
models. Transgenic models are often the most valuable, in which a specific gene or
regulatory element can be manipulated, phenotypic consequences observed and the
subsequent normal function elucidated. This is the case for mice inheriting the Grb10Δ2‐4
allele, used to demonstrate both the developmental and metabolic effects of Grb10
expressed from the maternally‐derived allele in peripheral tissues (Charalambous et al,
2003; Smith et al, 2007). However, the integrated LacZ reporter in this transgenic model did
not fully recapitulate endogenous Grb10 expression, failing to match immunohistochemical
detection of Grb10 protein in the brain. Integration of the LacZ reporter elsewhere at the
locus, generating the Grb10KO allele, did confirm expression in the CNS, but only following
inheritance through the paternal line (Garfield et al, submitted). In contrast to its role in
peripheral tissues, Grb10 was shown to modulate social dominance in the brain.
To confirm that the LacZ gene in Grb10KO was indeed reporting Grb10 expression, and that
ablation of transcripts at this locus was responsible for the observed social dominance
phenotype, it was first necessary to map the integration site of the  β‐geo cassette.
Southern blotting and PCR‐based strategies identified a deletion of 12 bp of the
endogenous sequence at the exon 8/intron 8 boundary, which were replaced by the β‐geo
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cassette. Such a short deleted sequence is in contrast with the ~38 kb removed in the
generation of the Grb10Δ2‐4 allele (Charalambous et al, 2003), but is more consistent with
the integration of the  β‐geo cassette at other loci (for example, Beigneux et al, 2006).
Interestingly, two other studies have described the insertion site in Grb10KO, with both
reporting integration in intron 7 (Wang et al, 2007; Sanz et al, 2008), inconsistent with that
identified in the present study. However, few published details of the mapping experiments
are provided in the latter publication, whilst those described in Wang et al (2007) rely solely
upon 5’ RACE sequencing, demonstrating splicing of the LacZ reporter onto exon 7. No
mapping at the level of genomic sequence is reported. Indeed, the absence of exon 8 in
transcripts initiating at the Grb10 promoter from the Grb10KO allele is initially surprising,
but can be most likely accounted for by the strength of the β‐geo splice acceptor sequence,
which might out‐compete that of exon 8 for recognition by spliceosomes. The 3’ splice
acceptor sequences do differ for exon 8 and  β‐geo. Whilst the consensus sequence is 10
consecutive pyrimidine residues, followed by any base (N), then a cytosine (C) and
invariably adenine‐guanine (AG), the acceptor sequence for exon 8 consists of only 8 initial
pyrimidines. β‐geo, on the other hand, possesses an initial run of 8 pyrimidines, but this run
is interrupted by two guanines. The close physical proximity of the two acceptor sequences,
and the possibility that this sequence difference increases the probability of spliceosome
recognition for  β‐geo, might account for the absence of exon 8 in transcripts from the
Grb10KO allele. Although 825 bp at the 5’ extreme of the  β‐geo cassette were deleted
during integration, the splice acceptor sequence was fully retained, and thus the deletion
does not apparently affect its ability to splice, a result supported by both 5’ RACE and
visualisation of reporter gene activity.
The failure of RNA polymerase to generate full‐length transcripts from the Grb10KO allele,
thus demonstrating the efficacy of the gene‐trap, was confirmed by Northern blotting.
Consistent with previous reports, the majority of embryonic expression during mid‐
gestation arose from the maternally‐inherited allele, although a contribution from the
paternally‐derived copy was also detected, presumably representing transcripts in the CNS
and other specific peripheral tissue sites. The detection of a ~2.5 kb transcript from both
embryonic and placental RNA isolates cannot be explained by the current literature,
implying an as‐yet uncharacterised transcript variant of Grb10. This might be produced
from an alternative transcription initiation site, or arise through splicing out of several
exons, although at least some of exons 11 to 16 must remain to be detected by the probe.
Alternatively, a weak poly‐(A) signal within an exon might cause premature termination in a
subset of transcripts. Whilst elucidation of the structure and function of the ~2.5 kb
transcript would be of interest, it is important to note that its contribution to the Grb10
transcript pool is relatively small. Additionally, the effective ablation of this transcript in
Grb10KOm/+ embryos discounts the possibility of redundancy with full‐length Grb10
influencing functional characterisation of the protein.
The reversal of the Grb10 imprint in both the developing and adult mouse CNS has thus far
been demonstrated only by use of the LacZ reporter gene. To confirm this result at the
genetic level, Northern blotting was performed on adult brain tissue, with full‐length Grb10
transcripts being readily detected in wild type and Grb10KOm/+ brain, but undetected in
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Grb10KO+/p brain, a pattern opposite to that demonstrated in whole embryo. These results
support the recent demonstration of biased expression from the paternally‐derived allele in
human foetal brain and spinal cord (Monk et al, 2009). Interestingly, expression in other
human foetal tissues is apparently biallelic, an observation inconsistent with that observed
in mouse. This might be attributable to the differences in mating habits of mouse and
human. A female of the former species will carry litters of multiple paternities throughout
her lifetime, and thus there is an evolutionary argument for antagonism between the two
parental genomes (see Section 1.1.2 for further details of the parental conflict hypothesis).
Multiple paternities are less frequent in humans, with a single male generally siring the
offspring of one female, and thus the basis for conflict is reduced. Alternatively, the
limitations of assessing allele‐specific expression using RT‐PCR, which is highly susceptible
to contamination and may amplify a low level of leakage from the ‘silent’ allele, might mask
the retention of Grb10 imprinting in humans.
Disrupting the expression of Grb10, using either Grb10KO or Grb10Δ2‐4, did not affect
expression of the neighbouring gene Ddc, at least in adult brain. This was predicted as the
germline differentially methylated region (DMR) at the Grb10 locus, shown also to regulate
Ddc imprinting (Shiura et al, 2009), is not removed in either allele, and indeed the
imprinting status of Grb10 itself is not disrupted. Additionally, only a specific transcript of
Ddc, referred to as Ddc_exon1a, is imprinted, and expression is localised to trabecular
cardiomyocytes in the developing heart (Menheniott et al, 2008). Indeed, no parent‐of‐
origin specific expression was detected in neonatal brain. Although both the Ddc and
Ddc_exon1a transcripts are ~2 kb, the probe used in Northern blotting also detected a
higher molecular weight transcript in all RNA samples. A similar species was previously
detected in Northern blotting for Ddc (Menheniott et al, 2008) although its nature was not
described. The transcript probably represents a variant of Ddc, because its expression
profile during development mirrors that of the full‐length message (Menheniott et al,
2008), and could be a result of poly‐(A) run‐on.
The demonstration that both the Grb10KO and Grb10Δ2‐4 alleles ablate functional Grb10
protein suggested that mice inheriting either of these alleles through the same parental line
would display identical phenotypes. One difference, the inability of Grb10Δ2‐4 to report
expression in the CNS, has already been observed, and is the subject of Chapter Five.
However, the observation that embryos homozygous for the Grb10KO allele deviated
significantly from the predicted Mendelian ratio at e14.5, supported through both LacZ
staining experiments and PCR genotyping, was unexpected given that Grb10Δ2‐4m/p animals
are viable (Smith et al, 2007). This observation was also reported by another group utilising
mice carrying the Grb10KO allele, but no mechanistic explanation was provided (Cao et al,
2008). Integration of the β‐geo cassette in Grb10KO is 3’ to the translation initiation site,
which is deleted in Grb10Δ2‐4, therefore potentially enabling a small protein species to be
generated. Identification of the first in‐frame stop codon in the  β‐geo cassette sequence
predicted a ~29.4 kDa protein, referred to as Grb1029.4. This protein could not be detected
in lysates of Grb10KOm/+ neonates using Western blotting. This might reflect a high turnover
of the protein species, or its accumulation in a tissue‐  and/or stage‐specific manner.
Alternatively, the result might be a consequence of the limitations of the antibodies
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employed. The majority of antibodies commercially‐available for Grb10 and described in
the literature are raised against the C‐terminus of the protein, and were thus inappropriate
for detection of Grb1029.4. Two N‐terminal antibodies were sourced but these failed even to
differentiate between wild type and Grb10KOm/+ samples for full‐length Grb10, suggesting
non‐specific epitope recognition. An alternative approach might be to perform
immunoprecipitation using an antibody raised against proline‐rich domains, for example,
followed by Western blotting for the Grb10 N‐terminus, thereby reducing the number of
protein species blotted and possibly eliminating some of the non‐specific detection. It
might also be valuable to examine protein lysates from various tissues and developmental
stages.
If the only functional domains of Grb1029.4 are a proline‐rich region and a Ras‐associating
domain, this might sequester intracellular signalling molecules, preventing their interaction
with upstream regulators or downstream targets which would otherwise be brought into
close proximity by binding to other domains of Grb10. GIGYF1 and GIGYF2 were identified
in a yeast two‐hybrid assay using the N‐terminus of Grb10 as bait, including the proline‐rich
region but not other conserved structural motifs (Giovannone et al, 2003). In fibroblasts
over‐expressing Igf1r, stimulation with IGF1 increases Grb10‐GIGYF1/2 interaction above
the basal state, and this complex transiently binds to the IGF1R, suggesting GIGYF1 and
GIGYF2 modulate IGF1 signalling via Grb10 (Giovannone et al, 2003). The interaction
between Grb10 and the IGF1R has been demonstrated in many studies (reviewed in
Morrione, 2003) and occurs through the SH2 and BPS domains of Grb10 (He et al, 1998;
Stein et al, 2001). Conceivably, Grb1029.4, which lacks the SH2 and BPS domains, might
sequester GIGYF molecules and prevent their regulation of IGF1 signalling, potentially
disrupting development.
If this system is to explain the lethality of Grb10KOm/p conceptuses, it must be correlated to
dosage. Embryos inheriting the transgenic allele from either parent are viable and born
with the expected frequency, suggesting monoallelic expression of Grb1029.4 is compatible
with life. Given the imprinted nature of Grb10, a ‘double dosage’ can only occur at one of
the few sites of biallelic expression. We considered the anterior visceral endoderm as a
candidate site, for which expression from the paternally‐inherited allele has previously
been described (Sanz et al, 2008), but a contribution from the opposite allele not
discounted. LacZ staining of a Grb10KO+/p embryo at e8.0, however, was inconsistent with
expression at this anterior signalling centre, instead localising to the myocardial or
endocardial cells of the heart tube. Analysis of LacZ‐stained whole embryos essentially
recapitulated that described in Sanz et al (2008), suggesting a misinterpretation of the site
as AVE, rather than aberrant reporter expression. Indeed, it was only possible to identify
the mesodermal origin of these cells following sectioning of stained embryos. Heart tube
expression was further supported by comparison with mouse embryos harbouring a LacZ
gene driven by the Xenopus MLC2 promoter, a gene encoding a regulatory myosin light
chain of the cardiac muscle contraction apparatus (Latinkić  et al, 2004). At e7.5, the
expression profile was very similar to that observed for Grb10 at e8.0, although Grb10
appeared to be more localised to the right heart tube, implying a possible role in the
establishment or maintenance of left‐right asymmetry in this structure. This observation is
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consistent with reporter expression from the paternally‐derived allele being restricted to a
subset of cardiomyocytes in the developing right ventricle at e14.5, but not the left
(Garfield, 2007).
Reporter expression in a Grb10KOm/+ embryo was more widespread in the mesodermal
layer than that observed for the Grb10KO+/p embryo. Importantly, this included strong
reporter expression in the anterior mesoderm, presumed to include the myocardial and
endocardial cells of the heart tube. This is consistent with the observation that expression
from the maternally‐inherited allele is widespread in the heart at e14.5, being strongest in
the myocardial cells of the atria and ventricles (Garfield, 2007). Given this, it is likely that
the right heart tube may represent a site of biallelic expression of Grb10 in wild type
conceptuses, and of Grb1029.4 in Grb10KOm/p conceptuses. This might account for the
lethality associated with homozygosity for the Grb10KO allele.
The majority of signals stimulating development of the heart tube are members of the Wnt,
FGF and BMP families, with which Grb10 has not previously been implicated. However, the
expression profile of vascular endothelial growth factor (VEGF) includes myocardial and
some endocardial cells of the heart tube, first apparent at e8.5 (Miquerol et al, 1999),
although it is interesting to note that Grb10 expression is detected earlier than this. An
interaction between Grb10 and VEGF receptor 2 (VEGF‐R2) has been demonstrated in vitro,
with Grb10 positively promoting downstream signalling cascades (Giorgetti‐Peraldi et al,
2001). At e14.5, VEGF expression is detected strongly in the ventricles and weakly in the
atria, being mostly restricted to myocardial cells, similar to Grb10. VEGF signalling therefore
represents a candidate pathway disrupted by the dominant negative protein isoform in
Grb10KOm/p foetuses. The direct interaction between VEGF receptors and Grb10 requires an
intact SH2 domain (Giorgetti‐Peraldi et al, 2001), which Grb1029.4 lacks. However, VEGF
influences a number of cellular processes through VEGF‐R2, including gene transcription in
a pathway reliant on Ras (Meadows et al, 2001). Vegfr2‐/‐ embryos die by e8.5‐9.5,
exhibiting defects in the development of endothelial and haematopoietic precursors,
suggestive of an important role in vascular development (Shalaby et al, 1995). However,
this receptor is also expressed in the heart tube at e7.5 (Yamaguchi et al, 1993). Heart‐
specific ablation of Vegfr2 has not been reported, but this might confer lethality at a later
stage. If a sufficient dose of Grb1029.4 sequesters Ras, preventing VEGF signalling in the
heart, this might represent the mechanism by which Grb10KO homozygosity confers
lethality.
The only proteins identified to‐date to interact with the proline‐rich domain are GIGYF1 and
GIGYF2. These proteins are modulators of IGF1 signalling and have not been associated
with events downstream of the VEGF receptors. An anti‐apoptotic role for IGF1 has been
documented in cultured rat cardiomyocytes (Wang et al, 1998), and has also been shown to
stimulate adult myocardial stem cell regeneration (reviewed in Opgaard and Wang, 2005).
Whether IGF1 signalling is important for stem cell differentiation or to prevent apoptosis in
the developing heart remains unclear, but might represent another candidate pathway for
disruption by Grb1029.4.
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Whilst these pathways might be perturbed by expression of Grb1029.4 from both parental
chromosomes, this does not necessarily implicate Grb10 in these pathways during normal
heart development. Nonetheless, the biallelic expression of Grb10 in the right heart tube is
intriguing, and is certainly suggestive of a role in mediating one or more signalling cascades
in this tissue. Grb10 is not crucial for heart development because Grb10Δ2‐4m/p embryos
survive to adulthood at the expected Mendelian ratio.
It would be valuable to examine heart development in Grb10KOm/p embryos. An initial
analysis might involve the use of a marker (e.g. Nkx2.5 (Komuro and Izumo, 1993)) in in situ
hybridisation to assess morphology. Perhaps compartmentalisation fails to occur. This
would be consistent with the apparent asymmetric expression of Grb10, which might be
required to establish, during looping of the heart tube, or maintain the structural
differences between the left and right heart. Additionally, further analysis of the
developmental time point of lethality would help to underpin the mechanism responsible,
although viability at e7.5 is consistent with an incorrectly developed heart being the cause.
Mice mutant for Nkx2.5, a master transcription factor required for correct heart formation,
die at e9.0‐10.0, due to the failure of looping morphogenesis which creates the left‐right
asymmetry of the organ (Lyons et al, 1995). The apparent localisation of Grb10 to the right
heart tube might also imply incorrect looping in Grb10KOm/p conceptuses. Thus, e10.0 might
be the next developmental time point at which to examine the viability of mutant embryos.
The genetic characterisation of the Grb10KO allele has enabled a clear demonstration of its
ability to accurately report parent‐of‐origin‐specific expression, and has confirmed the
opposite imprint between the central nervous system and peripheral tissues. Detailed
knowledge of the allelic structure has also aided in the explanation of a key phenotypic
difference between mice inheriting the Grb10KO and Grb10Δ2‐4 alleles. Other phenotypic
differences are discussed in subsequent Chapters and are explained in the light of this
knowledge.
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Expression and function of Grb10 in the
mature mouse placenta
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4.1 Introduction
The placenta is a transient organ arising from extra‐embryonic cell lineages, which is
essential to support development of the foetus in eutherian mammals. Placental cell
lineages arise very early in mouse development, with trophectoderm and extra‐embryonic
ectoderm cells differentiating even before implantation. The function of the placenta is to
mediate interactions between the developing foetus and the mother in two ways. Firstly,
the placenta must permit the transfer of nutrients from mother to foetus, and the
simultaneous transfer of waste products from foetus to mother. To this end, it has evolved
as a highly efficient exchange barrier. The foetal circulation is intimately associated with
the placenta; a network of endothelium‐bound capillaries branches out from the chorionic
plate into the labyrinth and are connected to the foetus by the umbilicus. Maternal blood
flows through spaces not bound by an endothelium, but directly contacts cytotrophoblast
cells of embryonic origin. In this way, foetal and maternal blood never make contact, but
are separated by just three cell layers (excluding the foetal endothelium). Nutrients can be
extracted from the maternal blood into the foetal circulation through four mechanisms:
solvent drag describes the process through which solutes are transported across
membranes by the flow of water; endo‐  and exocytosis involve the internalisation and
subsequent release of membrane‐bound proteins; diffusion of hydrophilic molecules can
occur across cell membranes; and transporter molecules can actively pump substrates
across (Sibley and Boyd, 1988). Paracellular diffusion and active transport are probably the
most significant mechanisms for nutrient transfer across the placenta (Sibley et al, 1997).
The second key function of the placenta is as an endocrine organ. A range of hormones,
including members of the prolactin and growth hormone families, are released from the
placenta into both the foetal and maternal blood circulations. Crucially, these hormones
help stimulate the preparations necessary in the mother for the processes of birth and
lactation. This system of communication between tissues of embryonic origin and the
mother is discussed in more detail later.
The structure of the human placenta is somewhat different to that of the murine placenta,
although the function is identical (reviewed in Cross et al, 2003). In both cases, the uterine
epithelium (endometrium) is invaded such that maternal blood can flow into the placenta.
This invasion is achieved by trophoblast giant cells in mouse, and extravillous
cytotrophoblast cells in human. The maternal blood makes direct contact with trophoblast
cells. The three trophoblast layers of the mouse placenta (one layer of mononucleated,
cuboidal cytotrophoblast cells, plus two layers of syncytiotrophoblast) contrast with the
single syncytial layer and underlying trophoblast stem cell layer of humans. This means that
there are four membranes lying between the maternal and foetal blood in humans, with a
six membrane exchange barrier in mouse.
The ability of a placenta to transfer nutrients from the maternal to the foetal circulation is
dependent upon five key factors, reviewed here briefly. First, the size of the placenta is
directly correlated to the surface area available for nutrient exchange and thus its
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efficiency. Larger embryos and neonates are associated with increased placental wet
weights in a range of species, including mouse (Fowden, 2006). However, the size of the
placenta can, in turn, be dictated by the demands of the foetus, as well as environmental
factors. Nutritional restriction in pregnant sheep during mid‐gestation, when the placenta
shows the most rapid growth, reduces placental expansion, but towards the end of
gestation, the placenta compensates by becoming larger than those of sheep with
sufficient access to nutrients (Oliver et al, 2005). Such a compensation is presumably
demanded by the foetus at a critical point to prevent abortion.
The morphology of the placenta can also dramatically influence nutrient transfer capacity.
Indeed, the mouse placenta achieves its maximum wet weight at e16.5, but the labyrinth
continues to expand up to e18.5, with a concomitant reduction in the proportion of the
placenta occupied by the junctional zone (Coan et al, 2004). This correlates with increased
foetal growth until term. Additionally, the barrier thickness between the maternal blood
and foetal blood circulation is reduced between mid‐  and late‐gestation, effectively
increasing the theoretical diffusion capacity of the mouse placenta by 15‐ to 20‐fold (Coan
et al, 2004).
As the transfer of some molecules is dependent on active transport, the availability of
transporter molecules, as well as their affinity and localisation, also influences placental
efficiency. The system A transporter family, one member of which is encoded by the
imprinted gene Slc38a4 (Smith et al, 2003), transfers small amino acids, whilst glucose is
transferred by the GLUT1 and GLUT3 glucose transporters. The activities and expression
levels of each of these transporters can be influenced by both hormonal and environmental
stimuli.
Although often overlooked, the placenta itself requires nutrients and oxygen to perform its
functions. Like the foetus, it must rely on nutrients extracted from maternal blood.
Remarkably, ruminant placental tissues utilise 50‐70 % of the glucose and oxygen taken up
by the uterus (Fowden, 1997). This is required for the metabolic activities of the placenta,
which include secondary active transport and amino acid deamination to supply the foetus
with essential amino acids. The metabolic efficiency of the placenta therefore affects its
nutrient transfer efficiency.
Finally, hormones of placental origin are key in regulating placental efficiency.
Progesterone and placental lactogen, for example, promote maternal glucose delivery to
the foetus. Proliferin is produced in the mid‐gestation human placenta and secreted into
the maternal and foetal circulations (Jackson et al, 1994). This hormone has angiogenic
properties, and thus promotes blood flow, improving the conditions for nutrient exchange.
Whilst proliferin is a circulating hormone and can potentially have a wide range of targets,
at least part of its effects are realised locally. Evidence for a paracrine signalling effect
includes the expression of proliferin receptors on labyrinth endothelial cells (Jackson et al,
1994). In such a manner, these hormones affect the rate of nutrient transfer and thus
regulate placental efficiency.
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As well as this direct mediation of placental efficiency, hormones produced by the placenta
have a broader role in the communication between foetus and mother. For example,
prolactin is secreted from the rat decidua and supplements pituitary prolactin levels,
maintaining progesterone secretion by the corpus luteum. In turn, progesterone promotes
maternal weight gain and fat deposition (Grueso et al, 2001; Freemark, 2006). Decidual
prolactin also performs a paracrine function, suppressing the expression of genes
detrimental to pregnancy within the decidua (Bao et al, 2007). Placental lactogens,
secreted from the syncytiotrophoblast of the human placenta (McWilliams and Boime,
1980), target a range of maternal organs, preparing them for birth and lactation. One
obvious target is the mammary gland, in which ductal branching is stimulated to permit
milk synthesis and let‐down after birth (Thordarson et al, 1986). However, placental
lactogens also stimulate regions of the brain; this includes the generation of new olfactory
interneurons, most likely to promote recognition of offspring by smell, critical for rearing
(Shingo et al, 2003). Placental lactogens also promote maternal care behaviours (Bridges et
al, 1996). The placenta is thus important in priming the mother for rearing.
Genes subject to genomic imprinting appear to play central roles in controlling the supply
of, and demand for, maternal nutrients. Paternally‐expressed Igf2 is a classic paradigm,
whose role has been elegantly demonstrated by both in vivo knockout and over‐expression
studies. Igf2 is expressed in all extra‐embryonic cell types of the mature mouse placenta, a
significant proportion of which is derived from a placental‐specific promoter element, P0.
These Igf2P0 transcripts are particularly abundant in the placental labyrinth (Constância et
al, 2002). Their significance to the total pool of Igf2 is clearly apparent given that Igf2P0‐
specific knockout mice exhibit a placental growth restriction very similar to that of total
Igf2 null animals (DeChiara et al, 1991; Constância et al, 2002; Reik et al, 2003). The growth
restriction is dramatic, with a 30‐40 % reduction in placental wet weight. Conversely, Igf2
over‐expression engenders placentomegaly. This is most dramatically achieved in
transgenic mouse models exhibiting loss of imprinting of Igf2 together with ablation of
Igf2r, which degrades excess IGF2; in such cases, placentae can range from 140 % to 230 %
of the wild type mass (Eggenschwiler et al, 1997).
Whilst the loss of Igf2P0 from the placenta is associated with both placental and foetal
growth restriction, there is not a linear correlation between the two. Placental growth
restriction is observed from e11.5 onwards, with foetal growth retardation not manifesting
until the end of gestation (96 % and 78 % of wild type foetuses at e15.5 and e18.5,
respectively; Constância et al, 2002). These data implied that Igf2P0 null placentae are
more efficient during mid‐gestation. To address the exchange properties, radiolabelled
tracer compounds were injected into the jugular vein of a pregnant female mouse, and
foetuses harvested 1‐5 minutes later. Following homogenisation of the embryos, the
activity of the radiolabelled tracer was detected using a scintillation counter, thus providing
a method for quantitatively assessing placental transfer capacity. Gravid females at e15.5,
at which stage the Igf2P0 null placenta is smaller but the embryo is similar to wild type, and
at e18.5, when both are significantly smaller than wild type, were injected with 51Cr‐EDTA
and 14C‐MeAIB. 51Cr‐EDTA is a hydrophilic molecule, and can be used as a measure of
passive diffusion through the placenta. 14C‐MeAIB is an amino acid analogue, which cannot
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be metabolised, and is specifically transported by the system A transporter in the placenta.
Within embryos at e15.5, the accumulation of 51Cr‐EDTA, measured as units per gram of
placenta, was 80 % that of wild type controls. This was reduced to 60 % of wild type
controls at e18.5, suggesting that passive permeability is severely reduced in Igf2P0 null
placentae, presumably a consequence of reduced placental size. However, the
accumulation of 14C‐MeAIB in mutant embryos was 155 % that of wild type controls at
e15.5, when considered per gram of placenta. In effect, this resulted in mutant embryos
receiving the same actual amount of the amino acid analogue as wild types, consistent with
them being a similar size. This was reduced to 116 % of wild type levels per gram of
placenta at e18.5, equating to 74 % of the actual amount received by wild type foetuses.
This correlated with the foetal growth restriction recorded at this stage. Thus, whilst
passive permeability is reduced in Igf2P0 null placentae, the increased efficiency of
secondary active transport compensates at the earlier stage of gestation, maintaining
foetal mass. At the later stage, this compensation is insufficient to meet foetal demands,
resulting in growth retardation. This compensation appears to be achieved by promotion of
both amino acid and glucose transport (Constância et al, 2005).
These data imply two key points: 1) that the foetus can demand more nutrients following
placental growth restriction; and 2) that the placenta is able to respond to this demand.
Imprinted genes have also been implicated in this process. Indeed, IGF2 itself is probably
part of this mechanism. In vitro experiments have demonstrated that exogenous IGF2 can
promote amino acid transport in labyrinthine trophoblast cells in culture (Karl, 1995). This
suggests that the placenta can differentiate between IGF2 produced within the organ and
that produced by the foetus, possibly through the positioning of receptors on the
syncytiotrophoblast membrane. One prediction of this hypothesis is that mice lacking
functional Igf2 in the embryo as well as the placenta would fail to promote system A
transporter upregulation, as observed in Igf2P0 null placentae (Reik et al, 2003). In support
of this, total Igf2 null mice are growth retarded from e11.5 onwards, and indeed, do not
show increased levels of system A transporter expression (Constância et al, 2002;
Constância et al, 2005). As such, Igf2 mediates both the foetal demand for, and placental
supply of, maternal nutrients.
This conclusion can be extended to many other imprinted genes. Indeed, the imprinted
cluster on mouse distal chromosome 7, which includes Igf2, incorporates a number of
genes involved in this system. Genes of this cluster expressed from the maternally‐
inherited chromosome negatively control placental supply. Deletion of maternally‐
expressed Ipl produces a large placenta, but a ‘normal’ embryo; an increase in supply but
not demand (Frank et al, 2002). The same is true for p57KIP2 mutants, again an imprinted
gene expressed from the maternally‐derived chromosome (Takahashi et al, 2000). This
imprinting cluster therefore contains a ‘strong demand’ promoter (Igf2 expressed in the
foetus), a ‘strong supply’ promoter (Igf2, predominantly Igf2P0, expressed in the placenta),
and at least two ‘supply suppressors’ (Reik et al, 2003). This effect can be extended to
genes on other imprinted clusters. The imprinted system A transporter Slc38a4 is
expressed from the paternally‐derived chromosome. As well as being upregulated in
response to foetal demand in Igf2P0 deficient placentae (Constância et al, 2005), genetic
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ablation of Slc38a4 generates growth retarded embryos (G. Kelsey, personal
communication), identifying the gene as a supply promoter. That the positive effects on
supply and demand are mediated by paternally‐expressed transcripts (Igf2, Igf2P0 and
Slc38a4), which are antagonised by the negative influences of maternally‐expressed genes
(Ipl, p57KIP2), is strong evidence for the parental conflict hypothesis.
The placental growth effects following the transmission of a dysfunctional Grb10 allele
through the maternal line also conform to the parental conflict hypothesis. Grb10Δ2‐4m/+
placentae are overgrown from e14.5, whilst foetuses exhibit overgrowth from e12.5
(Charalambous et al, 2003). This also correlates with an increased placental efficiency
(Charalambous et al, submitted). At e17.5, the foetal:placental wet weight ratio is ~10 %
more for Grb10Δ2‐4m/+ conceptuses than for wild type or Grb10Δ2‐4+/p embryos, suggesting
that the normal function for Grb10 expressed from the maternally‐inherited allele in the
placenta is to limit efficiency. Although the mechanistic basis of this remains to be
elucidated, the labyrinthine volume of Grb10Δ2‐4m/+ placentae is disproportionately
increased. Thus, a larger surface area for nutrient exchange is probably at least partly
responsible.
This Chapter identifies an additional possible mechanism for the improved efficiency
observed in placentae lacking a maternally‐inherited functional Grb10 allele. This
mechanism is correlated with the expression profile for the gene in this organ, which is
established in detail in the present study. This work builds on our existing knowledge,
identifying Grb10 as a probable player in mediating foetal demand and placental supply.
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4.2 Results
4.2.1 Grb10 is expressed from both parental alleles in the placental labyrinth
To examine the expression profile of Grb10 in the late gestation placenta, Grb10KOm/+ and
Grb10KO+/p placentae were isolated 14 days after the observation of a cervical plug (e14.5),
cryosectioned and assayed for β‐galactosidase activity. No enzyme activity, assessed by the
presence of a blue precipitate, was detected when wild type placentae were treated in an
identical manner (data not shown), confirming the reliability of the assay in reporting LacZ,
and by inference Grb10, expression. Incubation with X‐gal substrate for 18 hours revealed
strong reporter expression in the labyrinth and chorionic plate of Grb10KOm/+ placentae, as
well as in a subset of cells in the embryonic yolk sac (Figure 4.1a and c). No reporter
expression was detected in the junctional zone or maternal decidua. Grb10KO+/p placental
sections reported expression exclusively in the labyrinth, although β‐galactosidase activity
was weaker than that detected in Grb10KOm/+ placental sections, despite being stained
simultaneously (Figure 4.1b and d). No contributions from the paternally‐inherited
chromosome were detected in the chorionic plate or yolk sac.
Higher magnification views of e14.5 Grb10KOm/+ placental sections assayed for  β‐
galactosidase activity suggested that expression might be limited to a subset of labyrinthine
cells, as some trophoblast nuclei did not appear to associate with positively‐stained
cytoplasm (Figure 4.1e). Similarly, reporter expression from the Grb10KO+/p allele appeared
to be excluded from some cells of the labyrinth (Figure 4.1f). However, these sections did
not permit more detailed analyses of cell type‐specific expression.
4.2.2 Allele‐ and cell‐specific expression of Grb10 in extra‐embryonic tissues
To enable a detailed examination of reporter expression in specific cell types, placentae
were isolated as before, stained and fixed using a different technique (Section 2.4.6), which
permitted better preservation of tissue morphology.
Consistent with the expression profile observed from cryosectioned placentae, reporter
expression was absent from the maternal tissue and junctional zone of both Grb10KOm/+
and Grb10KO+/p placentae (data not shown). Expression was detected in cells of the
labyrinth and chorionic plate following maternal transmission of the gene‐trap allele, but
was absent from the chorionic plate after paternal transmission (Figure 4.2a and b).
In Grb10KOm/+ placental sections, positive LacZ expression was detected in the cytoplasm of
foetal endothelial cells and syncytiotrophoblast cells (Figure 4.2c). The cytoplasm of
cytotrophoblast cells, identifiable by their larger nuclei, did not report expression.
The foetal endothelial cells of Grb10KO+/p placentae were also positive for LacZ expression,
suggesting a contribution from both alleles to the transcriptome in this cell type (Figure
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4.2d). Intriguingly, trophoblast expression appeared to be reciprocal to that from the
maternally‐inherited chromosome. Positive staining was detected in the cytoplasm
associated with the large nuclei of cytotrophoblast cells, whilst LacZ could not be detected
around at least some of the syncytiotrophoblast nuclei, suggesting one or both syncytial
layers may not express Grb10 from the paternally‐inherited chromosome.
4.2.3 Allelic bias of Grb10 expression in the placental labyrinth
Comparative staining performed on cryosections of Grb10KOm/+ and Grb10KO+/p placentae
suggested the contribution from the paternally‐inherited chromosome in this organ was
smaller than that from the maternally‐derived copy. To assess the relative contribution in a
quantitative manner, quantitative real‐time PCR (qPCR) analysis was performed on total
placental RNA using primers amplifying full‐length Grb10 transcripts in the context of one
deleted allele.
We chose to perform this analysis on e17.5 placentae, to correlate with the improved
placental efficiency associated with ablation of Grb10 on the maternally‐inherited
chromosome (Charalambous et al, submitted). Analyses of reporter expression performed
in the present study confirmed the persistence of a contribution from both parental alleles
at this stage, with an expression pattern consistent with that observed at e14.5 (data not
shown). To integrate with unpublished data from other studies, placentae inheriting the
Grb10Δ2‐4 allele through each of the parental lines, as well as wild type controls, were
analysed.
Amplification was performed using two primer pairs. The first pair was complimentary to
sequences within exons 3 and 4, situated within the deleted endogenous sequence of the
allele, and thus represented expression exclusively from the wild type copy (see Figure 3.3a
for details of the genomic structure of the Grb10Δ2‐4 allele). The second pair amplified
exons 11 to 16, downstream of the deletion. Any differences in amplification between the
two primer pairs might suggest splicing of transcripts from the Grb10Δ2‐4 allele onto
downstream exons, and thus ineffective trapping. Expression from each placenta was
normalised to that of Hprt, a housekeeping gene, the expression of which did not differ
between the genotypes (data not shown).
Similar results were obtained using both primer pairs (Figure 4.3a and b). When normalised
to total Grb10 expression levels in wild type placentae, maternal transmission of the
Grb10Δ2‐4 allele resulted in a 70 % reduction in transcripts, confirming that the maternally‐
inherited chromosome is the source of the majority of Grb10 transcripts in this organ.
Amplification from Grb10Δ2‐4+/p placentae produced a complimentary 30‐40 % reduction in
transcripts. This provided quantitative support for the differing levels of  β‐galactosidase
activity detected in Grb10KOm/+ and Grb10KO+/p placental sections (Figure 4.1). Additionally,
the additive levels of expression from each of the parental alleles in the context of a
deleted copy are similar to that from wild type placentae, suggesting the wild type allele is
unable to compensate for Grb10 deletion by upregulating its transcription.
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4.2.4 The expression of imprinted genes associated with improved placental efficiency
is unaffected by the loss of Grb10
A previous study identified an enhanced placental efficiency phenotype following maternal
transmission of Grb10Δ2‐4 (Charalambous et al, submitted). This was first detected at
e17.5, at which stage the ratio of foetal:placental wet weight was 10 % greater than that of
wild type or Grb10Δ2‐4+/p controls. To begin to dissect the mechanism for this enhanced
efficiency, qPCR was performed on e17.5 placentae of all three genotypes, using primers
complimentary to imprinted genes previously associated with influencing placental
efficiency.
In wild type mice, elevated levels of the placental‐specific Igf2P0 transcript are associated
with improved placental efficiency (Coan et al, 2008). An opposite phenotype is observed
upon deletion of the Igf2P0 transcript (Constancia et al, 2002). No differences were
observed in the levels of Igf2P0, nor of total Igf2, between wild type, Grb10Δ2‐4m/+ and
Grb10Δ2‐4+/p placentae (Figure 4.3c and d). Similarly, expression of the imprinted system A
transporter Slc38a4, which partially compensates for a reduced efficiency in Igf2P0 null
placentae, was not affected by Grb10 ablation (Figure 4.3e).
These results suggested that Grb10 does not mediate placental efficiency through the
molecular pathway involving Igf2P0 and Slc38a4.
4.2.5 Grb10KOm/+ placentae and embryos exhibit overgrowth
To permit further investigation of the mechanism responsible for the enhanced placental
efficiency phenotype, placentae inheriting the Grb10KO allele through each of the parental
lines were isolated at e14.5. Although a statistically significant improvement in efficiency is
not detected until e17.5 (Charalambous et al, submitted), previous studies have confirmed
that both embryo and placenta are overgrown at e14.5 when inheriting a dysfunctional
Grb10 allele through the maternal line. This is true for both Grb10Δ2‐4m/+ (Charalambous et
al, 2003) and Grb10KOm/+ (Garfield et al, submitted) conceptuses. Consistent with these
reports, Grb10KOm/+ embryos isolated in the present study were 18 % larger than wild type
controls at e14.5 (Figure 4.4a), a statistically significant increase. According to these data,
Grb10KO+/p embryos were also significantly larger than wild type controls at this stage, a
result inconsistent with previous analyses (Garfield et al, submitted). There was greater
variance within this data set, which also had a smaller population size than that of the
other data sets, providing the most likely reason for this discrepancy.
Consistent with previous reports, Grb10KOm/+ placentae were larger than wild type and
Grb10KO+/p controls at this stage (Figure 4.4b). However, this did not correlate with an
improved placental efficiency, as assessed by the ratio of foetal:placental wet weight
(Figure 4.4c). Grb10KO+/p placentae also failed to show a difference in efficiency. These
results are supported by previous studies using Grb10Δ2‐4 animals, in which an enhanced
efficiency was not observed until later in gestation (Charalambous et al, submitted).
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4.2.6 Overgrowth persists in Grb10KOm/+ day 1 neonates
The overgrowth of Grb10KOm/+ pups in utero, first detected at e12.5, persists into the
neonatal period. On the day of birth, Grb10KOm/+ neonates were significantly heavier than
wild type littermates (Figure 4.4d), a result consistent with previous reports. In the current
study, Grb10KO+/p neonates were not examined as they have previously been shown not to
exhibit a growth phenotype (Garfield et al, submitted). At least part of the overgrowth was
attributed to an increased axial length on the day of birth (Figure 4.4e), suggesting a
possible involvement of Grb10 in long bone growth or formation. Both the increased size
and length of Grb10KOm/+ pups relative to wild type littermates was clearly apparent from a
visual comparison (Figure 4.4f).
4.2.7 The labyrinth is disproportionately overgrown in Grb10KOm/+ placentae
Next, we examined the basis of the overgrowth observed at e14.5 in Grb10KOm/+ placentae.
Imaging software was utilised to measure the depth of the labyrinth and junctional zone
close to the centre of the placenta, as described in Section 2.5.1. Specifically, the distance
from the labyrinth‐junctional zone boundary to the foetal edge of the chorionic plate was
measured, as well as the distance from the labyrinth‐junctional zone boundary to the
junctional zone‐decidua boundary (‘labyrinth and chorionic plate’ and ‘junctional zone’,
respectively; Figure 4.5a). One randomly‐selected section from each of ten placentae was
analysed for each genotype, but the analysis was performed without knowledge of
genotype‐section correlation. Representative wild type and Grb10KOm/+ sections are shown
in Figure 4.5c. The differences in labyrinth depth are clearly illustrated. Although the
junctional zone of this Grb10KOm/+ section is thinner, this was not a statistically significant
result when comparing ten samples of each genotype.
Both wild type and Grb10KO+/p placentae exhibited similar properties, with the labyrinth
and chorionic plate contributing 56 % of the wild type and 58 % of the Grb10KO+/p total
placental depth. There was also no significant difference in the actual placental depth
between these two genotypes. When Grb10 was ablated on the maternally‐derived
chromosome, however, the labyrinth and chorionic plate were disproportionately
enlarged. Together, these contributed to 64 % of the total placental depth, whilst the
actual depth of the junctional zone did not differ significantly from that of wild type and
Grb10KO+/p placentae. This resulted in an increase in the total placental depth of
Grb10KOm/+ placentae.
Morphometric assessments, in which labyrinthine cells in a fixed number of windows were
counted, confirmed the increased size of the labyrinth in placentae inheriting the Grb10KO
allele through the maternal line (Figure 4.5b). An identical analysis was performed for
Grb10KO+/p placentae, which also exhibited a small but highly significant increase in
labyrinthine volume relative to wild type.
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4.2.8 Grb10KOm/+ placentae exhibit an increased foetal vasculature
Given that Grb10 is expressed from the maternally‐derived allele on the foetal side of the
labyrinthine trophoblast, as well as in foetal endothelial cells, we hypothesised that the
improved placental efficiency, associated with ablation of maternally‐inherited Grb10,
might be mediated by an increased surface area of foetal vasculature. Again,
representative sections from ten placentae were analysed for each genotype, without
knowledge of genotype‐section correlation. First, the total surface area of foetal blood
vessels was measured in a fixed window, as described in Section 2.5.1. This was
significantly increased in Grb10KOm/+ placentae relative to wild type and Grb10KO+/p
samples (Figure 4.6a).
These data were supported by counts of discrete cross‐sections through foetal capillaries.
Only inheritance of a dysfunctional Grb10 allele through the maternal line resulted in a
significantly higher number of foetal blood capillaries, suggestive of more extensive foetal
vascularisation (Figure 4.6b).
Whilst the Grb10KOm/+ placental sections had 34 % more discrete cross‐sections through
foetal capillaries than wild type controls, the total foetal vasculature surface area was
increased by 43 %, suggesting that foetal blood vessels are both larger and more numerous
in Grb10KOm/+ placentae. This might increase the surface area for nutrient exchange,
providing a possible mechanism for improved placental efficiency.
4.2.9 No evidence for compensation by Grb7 following ablation of the maternally‐
derived Grb10 allele
Whilst the molecular pathways within which Grb10 operates in the placenta are unknown,
both Grb10 and its homolog Grb7 have been implicated in common signalling pathways,
including that of the insulin receptor (Smith et al, 2007; Shiura et al, 2005; Kasus‐Jacobi et
al, 2000). This raises the possibility of partial functional redundancy, such that one protein
may compensate for the loss of the other. This can inhibit the dissection of in vivo function
following a gene knockout.
To assess the possibility that Grb7 might partially compensate for the absence of Grb10 in
Grb10KOm/+ placentae, the expression profile of Grb7 in this organ was first determined.
Unlike Grb10, which is restricted to the chorionic plate and a subset of labyrinthine cells,
Grb7 protein was detected in all extra‐embryonic layers of the mature wild type mouse
placenta, using immunohistochemistry (Figure 4.7a(i)). This included very strong expression
in the chorionic plate and labyrinth (Figure 4.7a(ii)). Indeed, all cell types of the labyrinth
appeared to express Grb7, although this was strongest in the foetal endothelium and the
cytotrophoblast layer immediately adjacent to the maternal blood spaces (Figure 4.7a(iii)).
No protein was detected in the maternal decidua (data not shown), nor in a control sample
in which primary antibody was omitted (Figure 4.7a(iv)).
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Western blotting utilising an anti‐Grb7 antibody revealed no differences in the levels of the
65 kDa Grb7 protein in Grb10KOm/+ placental homogenates, relative to wild type (Figure
4.7b). Signal representing α‐tubulin was also consistent in each sample, confirming equal
loading of protein. Thus, although Grb7 and Grb10 are strongly expressed in foetal
endothelial cells, and display co‐expression in other cell types of the mature mouse
placenta, Grb7 protein levels are unaffected by the considerable reduction in Grb10
transcripts in Grb10KOm/+ placentae.
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4.3 Discussion
The function of Grb10 in the mature mouse placenta has already been described by our
group (Charalambous et al, submitted). In effect, Grb10 limits placental efficiency, thereby
controlling embryonic growth. The present study aimed to extend this work in two ways:
firstly, to obtain a more detailed understanding of allele‐specific contributions in each cell
type of the placenta; and secondly, to begin to address the mechanistic basis for an
improved placental efficiency phenotype, following ablation of Grb10 on the maternally‐
inherited chromosome.
Previous analyses of Grb10 expression in the placenta utilised the Grb10Δ2‐4 allele, from
which expression of the LacZ reporter is relatively weak, most probably due to the deletion
of an enhancer element which is active in this organ (see Chapter Five for more details).
Parent‐specific transmission of the Grb10KO allele circumvented this issue, and revealed a
significant contribution from the paternally‐inherited copy in the placental labyrinth,
although this appeared weaker than expression from the maternally‐derived chromosome.
No reporter expression had previously been detected from Grb10Δ2‐4+/p placentae. To
confirm that this was not a result of ineffective trapping of Grb10 transcripts by the β‐geo
cassette, quantitative real‐time PCR (qPCR) was performed using primers amplifying full‐
length Grb10 transcripts, on wild type, Grb10Δ2‐4m/+ and Grb10Δ2‐4+/p total placental RNA.
Consistent with LacZ staining of Grb10KO placental sections, the maternally‐inherited
Grb10 allele was found to contribute ~70 % of transcripts, and accordingly, 30‐40 % of
transcripts arose from the paternally‐derived copy. This result was achieved using primers
situated within the deleted endogenous sequence of the Grb10Δ2‐4 allele, as well as
primers downstream of the  β‐geo cassette, confirming effective trapping of Grb10
transcripts arising from the transgenic allele.
In conclusion, the parent‐of‐origin specific LacZ reporter expression profile from the
Grb10KO allele matches that obtained through qPCR from the Grb10Δ2‐4 allele, suggesting
that both transgenic mouse lines are suitable models for studying Grb10 expression and
function in the placenta.
The poor morphology of cryosectioned and LacZ stained placentae did not permit a cell‐
specific examination of Grb10 expression. An alternative preparation technique improved
the preservation of tissue morphology, whilst still enabling visualisation of LacZ reporter
expression. In these sections, consistent with the analysis of cryosectioned placentae,
Grb10 was expressed from the maternally‐inherited chromosome in the labyrinth,
chorionic plate and a subset of cells in the yolk sac. The paternal chromosome did not
contribute any Grb10 transcripts to the chorionic plate or yolk sac, but was detected in
some cells of the labyrinth.
Within the labyrinth, both alleles were expressed in the foetal endothelium, lining the
foetal capillaries. In the trophoblast layers, expression appeared to be reciprocal. Grb10
from the maternally‐inherited chromosome was excluded from the mononucleated
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cytotrophoblast cells, but appeared to be expressed in both syncytiotrophoblast cell layers.
Paternal expression, on the other hand, appeared to be more closely associated with large
nuclei, implying expression in the cytotrophoblast layer. Most of the cytoplasm surrounding
the smaller nuclei of the syncytial layers was devoid of staining, suggesting Grb10 is not
expressed from the paternally‐inherited chromosome in one or both syncytial layers.
Indeed, reporter expression in Grb10KO+/p placental sections appeared more restricted to
the boundaries of foetal vessels and maternal blood spaces, consistent with this
observation, whilst Grb10KOm/+ placentae showed more diffuse LacZ reporter expression,
which was relatively weak around the edges of maternal blood spaces.
The structure of the human placenta is different to that of the mouse. Grb10 expression in
the human villous trophoblast is exclusively from the maternally‐derived allele (Monk et al,
2009), and it is this layer which is associated with the regulation of nutrient transfer,
suggesting the conservation of the Grb10 imprint is coupled to this function. However, the
human placenta as a whole demonstrates an approximate 1:1 ratio of maternal:paternal
expression (Monk et al, 2009), contrasting with the ~2.3:1 ratio revealed in the present
study for mouse. It is not clear whether this 1:1 ratio reflects biallelic Grb10 expression or
cell‐specific imprinting. Clearly, this cannot be addressed in human tissue using a LacZ
gene‐trap, and would require single cell RT‐PCR analysis.
Having deduced the expression profile in greater detail, we next confirmed that mice
inheriting the Grb10KO allele through the maternal line demonstrated a similar growth
phenotype to Grb10Δ2‐4m/+ animals. Both Grb10KOm/+ placentae and embryos were
significantly larger than wild type controls at e14.5, and this persisted on the day of birth.
Interestingly, we attributed part of this increased wet weight at the neonatal stage to an
extended axial length, suggesting Grb10may be involved in the formation or growth of long
bones. Since Grb10Δ2‐4m/+ adult mice also have more muscle and less fat (Smith et al,
2007), Grb10 might possibly be involved in the fate decision of mesenchymal stem cells,
which give rise to myocytes, adipocytes and osteocytes, among others (reviewed in Liu et
al, 2009).
We next used the Grb10KO model to investigate the mechanistic basis for an improved
placental efficiency phenotype following ablation of the gene on the maternally‐derived
chromosome. The increased placental wet weight at e14.5 correlated with a
disproportionate overgrowth of the labyrinth, an effect also recorded for Grb10Δ2‐4m/+
placentae at a later stage (Charalambous et al, submitted). This was initially demonstrated
by measuring the thickness of the labyrinth and junctional zone in cross‐sections close to
the midline of placental samples. The highly significant increase in labyrinth and chorionic
plate depth in Grb10KOm/+ placentae was not matched by a concomitant reduction in
junctional zone depth. In a previous study, the wet weight of the junctional zone in
Grb10Δ2‐4m/+ placentae remained comparable to wild type controls (Charalambous et al,
submitted). A larger labyrinth might, therefore, be expected to spread the junctional zone
more thinly across its surface, but the effect may be too subtle to detect using this
approach.
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The increase in labyrinthine volume was further supported by morphometric analysis,
which confirmed that labyrinthine cells were over‐represented in Grb10KOm/+ placentae. A
small, but highly significant, increase in labyrinthine volume was detected in Grb10KO+/p
placentae using this technique. Such an effect has not previously been observed
(Charalambous et al, submitted). Given that the associated embryos of this dataset were
also significantly larger than wild type controls, again a result not reported in previous
studies, the effect is perhaps not surprising. It is possible that some of the Grb10KO+/p
embryos and placentae were isolated at a stage closer to e15.0 or even e15.5, which
compromises the comparison. As pregnancy is detected in females by the examination of
cervical plugs only once per day, there is a large window within which mating may have
been performed. In support of this, there is a much greater variance in this dataset than
the wild type and Grb10KOm/+ datasets, and indeed, the variance is significantly different (p
= 0.0056; Bartlett’s test for equal variances). As the embryos were isolated from two
separate litters, one litter may have been at e14.5, with the other a few hours older,
explaining this difference. Embryos should be accurately staged at isolation, using key
features which define specific developmental time points.
Whilst a disproportionately enlarged labyrinth has been reported in Grb10Δ2‐4m/+ mice at
e17.5, a whole placental overgrowth effect is apparent from e14.5 onwards. The current
study confirmed that the earlier stages of the effect are also a consequence of labyrinthine
overgrowth, although morphometric analysis on cells of the junctional zone was not
performed. With this knowledge, plus the data demonstrating that Grb10 is expressed from
the maternally‐derived allele in the cell layers closest to the foetal capillaries, we
hypothesised that the improved placental efficiency phenotype might arise from an
increased area of foetal vasculature. The total surface area of foetal capillaries in cross‐
sections through Grb10KOm/+ placentae was significantly higher than in wild type or
Grb10KO+/p controls. Interestingly, this was reflected by an increased number of discrete
foetal vasculature spaces, implying that the greater surface area is, at least in part, a
consequence of increased capillary branching. The mean cross‐sectional surface area of
capillaries in each placental section was not established, but would be valuable in deducing
the relative significance of more capillaries versus larger capillaries.
This represents the first indication of a mechanistic basis for improved placental efficiency
in Grb10 mutant mice. The ablation of functional Grb10 from the maternally‐derived
chromosome would reduce Grb10 transcripts in the foetal endothelium, and remove most
or all transcripts from the two multinucleated syncytiotrophoblast layers. This is associated
with an increase in mass of the placental labyrinth, which is, at least in part, caused by
enhanced foetal vascularisation, presumably a result of endothelial cell proliferation. This
results in a larger surface area for nutrient exchange, either by active transport or passive
diffusion. Inversely, this implies that the normal role of Grb10 is to restrict endothelial cell
proliferation, and so limit the nutrient transfer capacity, or efficiency, of the placenta. The
predominance of Grb10 expression in the endothelium suggests a response to factors in
the foetal circulation. This is supported by immunohistochemistry experiments which show
Grb10 protein localising to the capillary side of endothelial cells (Charalambous et al,
submitted).
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This role for Grb10 in the placenta fits our existing knowledge of Grb10 on three levels.
Firstly, Grb10 is typically a negative regulator of growth factor signalling, and thus could act
to dampen hormonal demands from the foetal circulation, restricting the extraction of
nutrients from the maternal blood. Secondly, the protein is an inhibitor of cell proliferation.
Grb10KOm/+ primary mouse embryonic fibroblasts grow more rapidly than their wild type
counterparts (Garfield, 2007). Thus, in its normal role, Grb10 might restrict endothelial cell
proliferation, and by extrapolation vascularisation, again limiting nutrient transfer by
restricting the surface area available for nutrient exchange. Finally, our model is consistent
with the parental conflict hypothesis, which predicts that maternally‐expressed genes in
the placenta will function to limit nutrient exchange, thereby maximising the lifetime
reproductive success of the mother. Further evidence of this role comes from the retention
of the Grb10 imprint in the human villous trophoblast layer, an essential cell layer involved
in nutrient transfer (Monk et al, 2009).
Whilst Grb10 is predominantly expressed from the maternally‐inherited chromosome in
the mouse placenta, a significant minority is derived from the other copy. That no growth
phenotypes have been associated with ablation of the paternally‐inherited Grb10 allele
might be a reflection of its relatively low contribution to the Grb10 transcript pool, or might
be a consequence of cell‐specific expression. We found that expression in at least one of
the syncytiotrophoblast layers, if not both, is exclusively from the maternally‐inherited
allele, which also accounts for the majority of endothelial expression (Charalambous et al,
submitted). The syncytiotrophoblast in particular is associated with a nutrient transfer
function. The role of paternally‐expressed Grb10 remains to be elucidated, but this study
suggests it may play a minor role in influencing growth.
If the ratio of cell‐type contributions to the labyrinth remained the same, but the
labyrinthine volume was simply increased in Grb10KOm/+ placentae, it is possible that this
increased volume would be adequate to explain the improved efficiency. However, we
were unable to associate all of the foetal overgrowth to the increase in labyrinthine volume
in Grb10KOm/+ embryos (Charalambous and Cowley, unpublished data), suggesting this is an
insufficient explanation to account for the phenotype. This adds weight to the hypothesis
that an increased foetal vasculature is the mechanistic basis. This preliminary study needs
to be extended by performing stereological assessments of Grb10KOm/+ placentae, as
defined previously (Coan et al, 2004). Subtle differences in placental morphology can be
detected in this way, and, by inference, can say much about nutrient transfer capacities.
This could potentially be followed up with radiolabelled tracer transfer assays, such as
those performed on Igf2P0 null mice (Constância et al, 2002), to directly measure transfer
capacity.
Additionally, we noted that levels of Igf2P0, total Igf2 and Slc38a4 did not differ between
wild type, Grb10Δ2‐4m/+ and Grb10Δ2‐4+/p placentae at e17.5. Igf2P0 mutant placentae
exhibit growth restriction from e12.5, but associated embryos remain the same size as wild
type littermates until e16.5, from which point they are growth retarded (Constância et al,
2002). As such, mutant placentae are more efficient at these earlier stages. This somewhat
paradoxical finding is explained by an increase in active transport, which acts to
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compensate for the reduced surface area limiting passive nutrient diffusion. Slc38a4 is a
key mediator of this compensation, a gene which is also imprinted (Smith et al, 2003). That
the expression of these genes was not altered by ablation of Grb10 suggests the
mechanism is independent of Igf2. This is supported by genetic experiments which
demonstrated that ablation of Grb10 from the maternally‐inherited chromosome
promoted embryonic and placental overgrowth, even in the absence of Igf2 (Charalambous
et al, 2003). The growth pathway through which Grb10 mediates its effects is yet to be
identified, although preliminary data suggests Grb10 might be epistatic, and antagonistic,
to the paternally‐expressed gene Dlk1 in some tissues (Madon, Cowley, Garfield and Ward,
unpublished data). The in vivo function of Dlk1 is to promote embryonic growth (da Rocha
et al, 2009). However, this may not be the predominant growth pathway involving Grb10 in
the placenta. Firstly, Dlk1 expression is limited to the foetal endothelium (Yevtodiyenko
and Schmidt, 2006), whilst Grb10 is also present in the trophoblast. Secondly, genetic
experiments have demonstrated that Grb10Δ2‐4m/+/Dlk1KO+/p double mutant mice display
a compound placental growth phenotype with additive effects of both mutations, whereas
embryonic growth of double mutants is similar to Grb10Δ2‐4m/+ single mutants (Madon,
Cowley, Garfield and Ward, unpublished data). Therefore, the pathway(s) within which
Grb10 acts in the placenta remain to be elucidated.
The larger labyrinth resulting from maternal transmission of a dysfunctional Grb10 allele
might be expected to engender increased levels of Igf2 expression. However, the
predominant Igf2 transcript in the labyrinth is Igf2P0; the ablation of this transcript results
in a placental growth deficit close to that for total Igf2 null mice, demonstrating the
importance of Igf2P0 in this organ (DeChiara et al, 1991; Constância et al, 2002). The
expression of this transcript is restricted to trophoblast cells, and is absent from the
endothelium. Therefore, if the increased labyrinthine volume in Grb10Δ2‐4m/+ and
Grb10KOm/+ placentae is a consequence of increased foetal vasculature and
hyperproliferation of endothelial cells, Igf2 levels would most likely remain unaffected.
We found no evidence of compensation for Grb10 depletion by the homolog Grb7. This
adaptor protein displayed a more widespread expression profile in the placenta, including
cells of the junctional zone. Within the labyrinth, Grb7 protein was most strongly expressed
in the foetal endothelium, where Grb10 is expressed from both alleles, and the
cytotrophoblast layer, in which Grb10 is monoallelically‐expressed from the paternally‐
inherited chromosome. Whilst this profile potentially enables partial functional
redundancy, we detected no changes in the levels of native Grb7 protein following ablation
of 70 % of Grb10 transcripts. This could be extended to examine the levels of
phosphorylated Grb7, as an indication of activated protein (Chu et al, 2009). The
assessment of placental size in Grb10KOm/+/Grb7KO‐/‐ double mutants might also be more
helpful in revealing the extent of compensation. Whilst Grb10 and Grb7 have both been
implicated in mediating insulin signalling, there is also evidence of redundancy between
Grb10 and Grb14 (Holt et al, 2009). Again, the expression profile of Grb14 in the placenta is
unknown, and would be the first step towards identifying any redundancy. Like Grb10, the
pathways within which Grb7 and Grb14 act in the placenta remain unclear.
102
Chapter Four
Finally, the Grb10KOm/+ (or Grb10Δ2‐4m/+) placenta is the first example, to our knowledge,
of an overgrown placenta which is more efficient. The ablation of other maternally‐
expressed genes can cause placental hyperplasia, without an associated improvement in
efficiency. The Ipl mutant placenta, for example, exhibits hyperplasia but associated
embryos are the same size as wild type littermates (Frank et al, 2002). This phenotype was
interpreted as an increase in supply but not demand, suggesting Ipl is a supply suppressor.
As a maternally‐expressed gene, Ipl conforms to the parental conflict hypothesis. Whilst
ablation of Grb10 from the maternally‐inherited chromosome similarly confers
placentomegaly, it also engenders embryonic overgrowth. Interpreted in the same manner,
this identifies Grb10 as both a supply suppressor and a demand suppressor. At first glance,
the expression of a demand suppressor in the embryo might not appear to be in the
embryo’s best interests. However, this is based on the assumption that the greater the
nutrients extracted from the mother, the more advantageous for the embryo. This is
certainly not the case. Studies of human births indicate that the optimal birth weight (i.e.
that associated with least risk of mortality) is just above the mean birth weight for a
population (Sansing and Chinnici, 1976). The risk of mortality increases beyond this
threshold. Indeed, overgrowth following ablation of Grb10 from the maternally‐derived
allele results in a 12 % neonatal lethality (Charalambous et al, 2003). As such, there exists a
threshold of nutrient demand beyond which the embryo would be disadvantaged. In
normal situations, this threshold is presumably not usually reached because the
maternally‐expressed genes in the placenta act first to limit nutrient transfer, in the
interests of the mother. In unusual situations, where nutrients are in excess (such as due to
a very efficient placenta), demand suppressors are activated at a higher threshold to
dampen demand, and prevent dangerous embryonic overgrowth.
Being able to dissect the relative contributions of placental Grb10 and embryonic Grb10 to
the control of growth would, therefore, be of considerable value. Ablation of Grb10
specifically in one or the other would enable this. Depletion of Grb10 exclusively in the
embryo could be achieved by a tissue‐specific rescue, in which Grb10 expression is driven
from a placental‐specific promoter on a Grb10KOm/+ background, although recapitulating
endogenous levels of expression would be challenging. Alternatively, the technique of
tetraploid rescue could be employed (Nagy and Rossant, 1993). This permits the
development of a ‘wild type’ placenta associated with an embryo carrying a targeted
mutation. Thus, the individual contributions of placenta and embryo to the embryonic
phenotype can be determined.
Additional evidence for Grb10 as a demand suppressor comes from the investigation of
postnatal nutrient demand. Cross‐fostering experiments involving wild type and
Grb10KOm/+ mothers and pups essentially enable a dissociation of mother and pup
genotype. This allows the influence of the pup genotype on nutrient demand to be
considered in isolation. These experiments are detailed in Chapter Six, and will be discussed
in the context of Grb10 in the placenta in Chapter Seven.
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5.1 Introduction
Sir Francis Crick enunciated what is now commonly referred to as the ‘central dogma of
molecular biology’ in 1958 (Crick, 1958). He postulated that information flowed from
deoxyribonucleic acid (DNA) to protein, through a messenger ribonucleic acid (mRNA)
intermediate. Key to this model was that the information flow was unidirectional, such that
the sequence information of a protein, or more specifically the chain of amino acids
forming a polypeptide, could not be used to synthesise DNA. This hypothesis has since
been extended to include the system of reverse transcription, in which sequence
information can be passed ‘backward’ from mRNA to produce complimentary DNA (cDNA)
under certain conditions.
Although Crick’s model accounted for the majority of the experimental evidence of the day,
and was accurate in its interpretation, it tells us nothing about the mechanisms through
which this information flow is achieved. However, the publication of the central dogma
model was highly influential in shaping the direction of subsequent research in molecular
biology, and as a result, has unearthed a highly complex and delicately tuned system
responsible for regulating this transfer of information. Here, we address briefly how the
system is initiated: what regulates, both spatially and temporally, the initiation of
transcription?
The polymerisation of RNA molecules to generate mRNA is catalysed by the enzyme RNA
polymerase, of which there are three classes in eukaryotes. Polypeptide‐encoding mRNA is
synthesised by RNA polymerase II. When a gene is to be transcribed, this enzyme binds to
the promoter sequence, normally situated 5’ to the transcription start point, and recruits
co‐factors to produce the basal transcription apparatus (reviewed in Thomas and Chiang,
2006). A minimal set of co‐factors are an absolute requirement for transcription initiation.
The TATA‐binding protein (TBP), for example, recognises a consensus sequence ~25 bp
upstream of most promoters, referred to as the TATA box because of its high content of AT
pairs. The substitution of a single base pair within the TATA box strongly reduces the
efficiency of transcription from the associated promoter, and therefore represents one
crude mechanism by which the number of transcripts arising can be controlled. TBP recruits
various, typically ~11, TBP‐associated factors (TAFs). Some TAFs are tissue‐specific,
representing the first mechanism through which differences in the transcriptome may be
achieved between differentiated cell types. The basal transcription apparatus consists of
many more proteins, including TFIIH, an enzyme with helicase, ATPase and kinase activities.
Its helicase activity separates the double stranded DNA template to permit transcription by
RNA polymerase II, a function requiring ATP hydrolysis using its ATPase activity.
More refined levels of gene expression are achieved in each differentiated cell type
according to their requirements. For example, whilst proteins involved in the cytoskeleton
are expressed at comparable levels in most cell types (‘housekeeping’ genes), a
differentiated β cell of the pancreas requires high levels of insulin transcript relative to all
other cell types. Enhancer elements in the DNA sequence are partially responsible for this
105
Chapter Five
additional control of transcription. Enhancers are consensus sequences which recruit
transcription factors. A transcription factor, when bound to a target sequence, may alter
the structure of the DNA molecule, making it more accessible to the basal transcription
unit, or may provide an entry site for RNA polymerase II which associates with the DNA and
migrates along the molecule until it encounters TBP bound to a TATA box. Enhancer
sequences may be situated immediately adjacent to a promoter, or can be several
kilobases away, either up or downstream. Transcription factors bound to distal enhancers
may physically interact with proteins of the transcription apparatus which are bound to the
promoter, through chromatin looping. Indeed, specific sequences between different
chromosomes are found to physically associate more frequently than would be expected
by chance, suggesting enhancers may influence gene transcription in an inter‐chromosomal
manner (Ling et al, 2006).
Silencers can function to reduce the rate of transcription to below that of the basal level.
This may be necessary where expression of a gene might be detrimental to a cell. In a
manner similar to that for enhancers, proteins are recruited to silencers, which can
physically block the passage of RNA polymerase II along the DNA molecule.
A further mechanism for the control of transcription initiation may be achieved by DNA
sequences which do not bind proteins per se, but instead are ‘permissive’ for the process.
This is exemplified by CpG islands, regions of sequence rich in CpG dinucleotides, which
overlap 72 % of human gene promoters (Saxonov et al, 2006). Indeed, CpG islands are
typically associated with a permissive chromatin structure; in other words, a conformation
which permits access by transcription factors and ultimately RNA polymerase II. Evidence
for the importance of CpG islands in this role includes the relatively high frequency with
which sequences similar to promoters, TATA boxes and enhancers occur in the genome.
Perhaps CpG islands help to differentiate ‘real’ from ‘bogus’ transcription factor binding
sites.
This also suggests that, as well as DNA sequence information, chromatin structure is an
important contributor to the regulation of gene transcription. This influence is commonly
observed in Drosophila melanogaster; genes which are juxtaposed to heterochromatic
regions are often silenced, and this effect is heritable. This is referred to as position‐effect
variegation (PEV). Whilst the traditional view is that such an effect is achieved by
compacting the gene in question, green fluorescent protein (GFP) tagging experiments
have demonstrated that silent chromatin is highly dynamic over a short time period, with
an overall reduction in its accessibility to transcription factors (Festenstein et al, 2003;
Cheutin et al, 2003). This implies that factors affecting nucleosome stability are key in
regulating chromatin structure, and by extrapolation, the initiation of gene transcription.
It is well‐established that transcription factors typically bind at sites devoid of nucleosomes,
a property exploited in DNase I hypersensitivity assays. Such nucleosome eviction can be
achieved through several means. First, nucleosomes exhibit a preference for certain
nucleotide sequences, such that left alone, they would not be evenly spaced along the DNA
molecule (Drew and Travers, 1985; Stockdale et al, 2006). Put another way, this means a
DNA sequence can discourage the association of a nucleosome. Second, chromatin
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assembly proteins can shift nucleosome positioning. The ISW2 protein in budding yeast
appears to manipulate nucleosomes into energetically unfavourable positions, at which
they can actively interfere with transcription (Whitehouse and Tsukiyama, 2006). The
histone composition of nucleosomes can also influence positioning. Nucleosomes are
composed of an octamer of histones, consisting of two copies each of H2A, H2B, H3 and
H4. However, there are subtypes, or variants, of each histone molecule, which typically
associate with heterochromatic or euchromatic regions. The H2 histone variant, H2A.Z, for
example, localises to active chromatin at the c‐myc locus, and might ‘mark’ a nucleosome
for eviction (Farris et al, 2005). Finally, histone tail modifications are extensive in the
genome and highly dynamic. The most important are those of the (H3‐H4)2 tetramer.
Acetylated H3 tails prevent interactions with other nucleosome components, resulting in
destabilisation (reviewed in Henikoff, 2007). Conversely, methylation of a histone 3
molecule on lysine 9 (H3K9) recruits heterochromatin protein 1 (HP1), which interacts with
the methylated K9 residue of another histone 3 molecule, either within a nucleosome or
that of an adjacent complex, stabilising the structure (Jacobs and Khorasanizadeh, 2002;
Motamedi et al, 2008). Tail modifications therefore strengthen or weaken anchoring of a
nucleosome to the chromatin and thus influence its susceptibility to eviction.
Together, these mechanisms enable gene transcription to be controlled in a well‐refined
manner, such that each gene is transcribed at a different rate according to how many
transcripts are required. Imprinted genes require an additional level of regulatory
complexity: they must be expressed monoallelically in a parent‐of‐origin specific manner.
This is achieved by using a similar arsenal of mechanisms to those described for biallelically‐
expressed genes, but in the context of one active and one silent allele. For imprinted genes,
therefore, the key questions are: 1) how are the parental alleles differentiated; and 2) how
is this information used to engender monoallelic expression?
CpG islands, as discussed previously, are common to many gene loci, both imprinted and
non‐imprinted. Although a CpG island alone is, therefore, insufficient to distinguish
between the two, the majority of CpG islands in the genome are hypomethylated.
Imprinted genes have exploited this property; associated CpG islands are differentially‐
methylated on the two parental alleles, marking them out from biallelically‐expressed
genes. Such differentially methylated regions (DMRs) may be shared between two or more
imprinted genes located in a cluster, such as in the H19/Igf2 reciprocally‐imprinted gene
pair. Indeed, this locus exemplifies many of the mechanisms utilised by imprinted genes to
achieve monoallelic expression, and the considerable extent to which these have been
dissected makes H19/Igf2 a good example with which to illustrate imprinted gene
regulation.
H19 is situated ~80 kb downstream of Igf2 on mouse chromosome 7, and this clustering is
conserved on human chromosome 11. H19 is expressed from the maternally‐inherited copy
in most tissues, whereas Igf2 transcripts arise predominantly from the paternally‐derived
allele. The locus contains four DMRs, although one is tissue‐specific and not required for
establishing this reciprocal imprint in the majority of somatic tissues. A germline
differentially methylated insulator element (termed the H19 differentially methylated
domain (DMD)) is positioned 2‐4 kb upstream of the H19 locus, and is methylated on the
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paternally‐inherited chromosome. A germline DMR is one whose differential methylation is
established during germ cell development and persists in all developmental stages and
somatic tissues, as discussed in Chapter One. DMR1 and DMR2 are positioned adjacent to
the Igf2 promoter, and both are paternally hypermethylated. DMR0 is a placental‐specific,
maternally hypermethylated DMR, giving rise to the Igf2P0 transcript, whose function is
discussed in Chapter Four.
The H19 DMD contains several binding sites for the zinc finger protein CCCTC‐binding factor
(CTCF; Bell and Felsenfeld, 2000). On the unmethylated maternally‐inherited allele, CTCF
associates with these binding sites, and recruits other proteins to form a complex. This is
likely to include the cohesion proteins RAD21 and SMC1, which have been shown to
associate with CTCF at the H19/Igf2 locus in a parental‐allele specific manner, but a
function has not been confirmed (Stedman et al, 2008). This complex prevents access of
downstream enhancer elements to the promoter region of Igf2, thereby functioning as a
boundary element (Bell and Fesenfeld, 2000). Specifically, this is achieved by a physical
interaction between proteins bound at the DMD and those at DMR1, adjacent to the Igf2
promoter (Murrell et al, 2004). Such distal interactions occur through chromatin looping, as
demonstrated by chromosome conformation capture. As a consequence, Igf2 is silenced on
the maternally‐derived chromosome and H19 expressed.
On the paternal allele, the H19 DMD is hypermethylated, abrogating CTCF binding and
functioning of the boundary. In the absence of CTCF, the DMD physically interacts with the
methylated DMR2, also positioned close to the Igf2 promoter. This interaction, again
demonstrated by chromosome conformation capture (Murrell et al, 2004), suggests the
importance of proteins other than those of the CTCF complex in this system. As a result of
the DMD‐DMR2 interaction, the Igf2 promoter is brought into close proximity to the
downstream enhancer elements, and the gene transcribed. In this way, DMR2 can be
considered an activator element, whilst DMR1 is a silencer. This is supported by deletion
studies, in which ablation of maternal DMR1 confers biallelic Igf2 expression, whereas
DMR2 disruption does not influence imprinting, but reduces transcriptional activation
(Constancia et al, 2000; Murrell et al, 2001).
The silencing of H19 on the paternally‐inherited chromosome is achieved by a mechanism
independent of the reciprocal H19/Igf2 imprint, although remarkably, involves a 1.2 kb
genomic element situated within the germline DMD. Deletion of this element resulted in
the relaxation of H19 silencing following paternal transmission, but did not interfere with
Igf2 expression or imprinting (Drewell et al, 2000). Similarly, the patterns of DNA
methylation at the locus were unaffected.
A further level of regulation at this locus was suggested by a modification of the
chromosome conformation capture technique which permitted identification of previously
unknown remote interacting sequences (Ling et al, 2006). This screen pulled out an
intergenic sequence on mouse chromosome 11, between the Wsb1 and Nf1 genes, which
physically interacted with the DMD, implying an inter‐chromosomal interaction. This was
confirmed using fluorescent in situ hybridisation, in which co‐localisation between the two
regions was identified in 30‐40 % of nuclei examined. Further, this interaction was allele
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specific, involving exclusively maternally‐inherited chromosome 7, and paternally‐inherited
chromosome 11. No such localisation was detected following CTCF depletion,
demonstrating the importance of this protein in mediating the physical interaction. CTCF
depletion reduced Wsb1 and Nf1 transcription from paternal chromosome 11 by ~50 %,
while expression from the other copy was unaffected. As would be expected, loss of
imprinting of Igf2 also resulted from ablation of CTCF. These results are intriguing, as they
suggest long‐range chromatin interactions need not be confined to the same chromosome,
but that regulatory sequences on different chromosomes can contribute to the finely tuned
system of gene transcription. Assessing the effect of deleting the Wsb1‐Nf1 intergenic
region on H19/Igf2 expression and imprinting status, in the presence of functional CTCF,
would be of great interest. Nf1 and Wsb1 are also clustered on human chromosome 17,
suggesting this inter‐chromosomal interaction may be conserved between species.
The imprinting mechanisms described for H19/Igf2 act in concert with the ‘usual suspects’
to regulate spatial and temporal expression. This includes an array of endodermal and
mesodermal enhancer elements, as well as those specific to terminally‐differentiated cell
types (reviewed in Arney, 2003). Although not characterised for Igf2 and H19, histone
variants and tail modifications are likely to associate with the promoter regions in a parent‐
of‐origin specific manner. These are likely to be both permissive and repressive, consistent
with the imprinted expression patterns of the two genes. Indeed, in some situations,
histone tail modifications alone have been shown to regulate imprinting, entirely
independent of DNA methylation. This is exemplified by MEDEA, an endosperm‐specific
imprinted gene in Arabidopsis. Unlike the examples described previously, MEDEA
transcription is kept active on the maternally‐inherited chromosome by demethylation
(Gehring et al, 2006). This process is catalysed by DEMETER, a glycosylase/lyase which
excises methyl‐cytosine residues and subsequently repairs the DNA, with the effect of
actively demethylating nucleotides. The paternally‐derived allele is silenced in a mechanism
reliant solely upon histone tail modification. The allele is enriched in the repressive
methylation of H3 lysine 27 (H3K27me), controlled by Polycomb group proteins expressed
from the maternal chromosome, including the product of the MEDEA gene itself. It is
believed that histone modification is an evolutionarily more ancient imprinting mechanism,
and that DNA methylation, which is more stable, evolved later as a maintenance mark (Reik
and Lewis, 2005).
This Chapter describes the identification and characterisation of a tissue‐specific enhancer
element at the Grb10 locus, which acts independently of the imprinting status of the gene
to regulate transcription. This discovery explains a key phenotypic difference between mice
inheriting the Grb10KO and Grb10Δ2‐4 alleles. Finally, we identify a novel tissue in which
Grb10 is imprinted in the adult mouse, which has implications for understanding the
physiological significance, and thus the evolution, of genomic imprinting.
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5.2 Results
5.2.1 Grb10Δ2‐4 fails to report Grb10 expression in the developing central nervous
system
Immunohistochemistry experiments on sagittally‐bisected mouse embryos at 14.5 days
post‐coitum (e14.5) revealed the presence of Grb10 protein in the developing brain
(Charalambous et al, 2003). The LacZ reporter expressed from the Grb10Δ2‐4 allele,
however, did not report expression in this tissue in bisected embryos. Conversely, the
Grb10KO allele fully recapitulated endogenous Grb10 expression, including mirroring
antibody staining in the developing CNS (Garfield, 2007). Specifically, expression in this
tissue was almost exclusively from the paternally‐inherited allele, despite the majority of
transcripts in embryonic tissues arising from the other copy (Figure 5.1a and b). This
reciprocal imprinting pattern persisted into adulthood (Figure 3.4a).
A direct comparison between foetuses inheriting the two reporter alleles through the
maternal line revealed an essentially identical expression profile, with an abundance of β‐
galactosidase in most tissues of both mesodermal and endodermal origin, including heart,
cartilage of the ribs, tongue and lungs, as described previously (Figure 5.1a and c; Section
3.1; Charalambous et al, 2003). The contribution from the maternally‐inherited allele was
also apparent in the choroid plexus in both transgenic lines.
The apparent absence of reporter expression in the CNS following paternal transmission of
Grb10Δ2‐4 is striking when compared with a matched conceptus inheriting the Grb10KO
allele (Figure 5.1b and d). Indeed, the Grb10Δ2‐4+/p foetus presented in Figure 5.1d was
incubated in X‐gal substrate for longer than the Grb10KO+/p counterpart, explaining the
apparent increase in levels of reporter expression in peripheral tissues, including tongue,
cartilage of the ribs and ventricles of the developing heart. Despite this extended staining
period, no reporter expression was detected in any cells of the midbrain, hindbrain or
ventral spinal cord, at the resolution of a bisected embryo.
5.2.2 Two models could account for Grb10KO and Grb10Δ2‐4 reporter differences
The observation of differences in reporter expression profiles following paternal
inheritance of Grb10KO and Grb10Δ2‐4 was initially unexpected, given that both alleles
were generated from the integration of a β‐geo cassette into the same locus. The genomic
structures of the two alleles were analysed and models devised to account for the
observed differences. Figure 5.2a presents the structure of the wild type Grb10 allele, and
displays the alternative initiation exons utilised for brain‐specific transcripts, as discussed in
Chapter One (Arnaud et al, 2003; Hikichi et al, 2003; Sanz et al, 2008).
Our first model described splicing around the β‐geo cassette in transcripts arising from the
Grb10Δ2‐4 allele (Figure 5.2b). Detailed mapping of the Grb10KO allele (Section 3.2.1)
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revealed a deletion of 825 bp at the 5’ end of the  β‐geo cassette, although this did not
include the splice acceptor sequence. Such a deletion, perhaps including the splice
acceptor, might also have occurred during the integration to create the Grb10Δ2‐4 allele.
As a consequence, transcripts arising from the Grb10 promoter region would fail to splice
onto the LacZ reporter, either terminating prematurely or splicing onto a downstream
exon. The latter option appeared unlikely due to the inability to detect transcripts in
Grb10Δ2‐4m/+ embryo RNA using a probe complimentary to exon 18, 3’ to the  β‐geo
cassette (Charalambous et al, 2003). Moreover, neither option could account for the
accurate reporting of Grb10 transcripts in tissues outside of the central nervous system; a
deletion of the splice acceptor sequence at the genomic level would persist in all tissues. A
modification of this model proposed that splicing around the β‐geo cassette might be an
event specific to the CNS, such that the splice acceptor sequence is retained and utilised
only in peripheral tissues (Figure 5.2b).
An alternative model proposed the deletion of an enhancer element following integration
of the β‐geo cassette to generate the Grb10Δ2‐4 allele (Figure 5.2c). The activity of such an
element may be restricted to the CNS, such that the levels of transcripts in peripheral
tissues are not affected by its deletion. About 38 kb of genomic sequence was lost in the
creation of Grb10Δ2‐4 (Charalambous et al, 2003), within which an enhancer element may
reside.
5.2.3 No evidence for splicing around the β‐geo cassette in the Grb10Δ2‐4+/p brain
To address the possibility that the  β‐geo cassette failed to trap brain‐specific transcripts
initiating at the Grb10Δ2‐4 allele, semi‐quantitative RT‐PCR was performed on wild type,
Grb10Δ2‐4m/+ and Grb10Δ2‐4+/p total brain RNA. Primers were designed to anneal to the
Grb10 cDNA sequence downstream of the β‐geo cassette, specifically amplifying a 505 bp
region spanning exons 11 to 16 (Figure 5.2b, horizontal bar).
Amplification using primers specific to the housekeeping gene  β‐actin demonstrated
comparable concentrations of cDNA for all samples analysed, and no amplification
products could be detected in samples from which reverse transcriptase was omitted (–RT),
confirming the absence of genomic DNA (Figure 5.3). Grb10 primers amplified to a similar
extent from wild type and Grb10Δ2‐4m/+ cDNA, consistent with our findings that most
transcripts in the brain are not expressed from the maternally‐inherited chromosome
(Figure 3.3; Figure 5.1a and c). Amplification from Grb10Δ2‐4+/p cDNA was considerably
reduced, demonstrating the effective trapping of the majority of Grb10 transcripts in the
brain following paternal inheritance of the Grb10Δ2‐4 allele. If transcripts were splicing
around the  β‐geo cassette in the brain, amplification from Grb10Δ2‐4+/p cDNA would be
expected to be comparable to that from wild type cDNA. The low level of Grb10 transcripts
detected in Grb10Δ2‐4+/p brain supports the observation of transcription from the
maternally‐derived allele in non‐neural sites (choroid plexus, ependymal layers and
meninges), utilising the LacZ reporter in Grb10KO mice (Figure 5.1a; Garfield, 2007). In
conclusion, the result argues against the splicing model as an explanation for the absence
of LacZ transcripts in the brains of Grb10Δ2‐4+/p mice.
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5.2.4 Conserved intronic sequences represent potential enhancer elements
We addressed the possibility that the deleted endogenous sequence from the Grb10Δ2‐4
allele might harbour a CNS‐specific enhancer element. Initially, sequence alignments
between different mammalian species were performed. The programme ExactPlus
(Antonellis et al, 2006) was utilised to identify short (≥ 6 bp) conserved sequences at the
Grb10 locus, which might represent transcription factor binding sites. To prevent
interference from exonic sequences, which would be expected to retain a high degree of
conservation, exons 1 to 5 were eliminated from the alignment. Exons 6 to 18 were
included as positive controls for the detection of conserved sequence. Similarly, the 5’ and
3’ extremities of introns can display a high degree of conservation, due to the presence of
splice recognition sequences. Thus, 15 bp at both ends of introns 1, 2, 3 and 4 were also
excluded from the analysis. Further details of the parameters employed are described in
Section 2.6.1.
An initial alignment between the mouse and human Grb10 sequences revealed extensive
conservation. Figure 5.4 provides a graphical depiction of the alignment, created by
importing the ExactPlus output into the UCSC Genome Browser as a custom track. Genomic
regions in which two or more short conserved sequences are clustered (that is, positioned
within a few base pairs of each other) are represented by vertical dark red bars. The height
of a bar is a reflection of the total number of conserved base pairs within that cluster.
Clusters of short conserved sequences included a considerable proportion of most introns,
as well as exons 6 to 18, confirming the suitability of the parameters in detecting
homology. The addition of the chimpanzee Grb10 sequence made a negligible difference to
the comparison, but the close evolutionary relatedness of human and chimpanzee might
account for this. Inclusion of the Grb10 sequence from a fourth mammal, namely cow,
revealed a much smaller number of short conserved sequence clusters, which were a
subset of those identified from the mouse‐human‐chimpanzee alignment. Most of the
conserved intronic clusters were positioned in introns 1‐4, several of which were within the
limits of the deleted endogenous region (Figure 5.4, lower bar) and therefore candidates
for further investigation.
Using the same parameters, the murine Grb10 sequence was aligned with the frog
ortholog. Clusters of conserved intronic sequences between these two species formed a
subset of those identified from the alignment of the four eutherian mammals. Similarly,
comparison of the mouse and chicken Grb10 sequences identified conserved sites already
determined from previous alignments. Finally, the mouse Grb10 sequence was compared
with the ortholog from opossum. The conservation profile for this alignment incorporated a
larger number of clusters identified from the mouse‐human‐chimpanzee‐cow alignment
than for the mouse‐frog or mouse‐chicken comparisons, consistent with a closer
evolutionary relatedness between mouse and opossum than frog or chicken.
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5.2.5 Identification of a conserved sequence with consensus transcription factor
binding sites
Whilst a sequence alignment between homologous genes separated through speciation
can highlight possibilities for further analyses, the result does not permit conclusions to be
drawn about the biological significance, if any, of conserved regions. In order to specifically
search for regulatory elements, the entire Grb10 locus was screened against a database of
known consensus transcription factor binding sites, using the programme PReMod
(Blanchette et al, 2006). This screen identified a single cis‐regulatory module (CRM)
candidate at the locus, which did not map to any previously described regulatory elements.
The structure of this CRM, herein referred to as cis‐regulatory module 1 (CRM1), is shown
in Figure 5.5. The 70 bp sequence consists of several potential transcription factor binding
sites, which have been ranked in relative order of similarity to their consensus recognition
sequence; thus, numeric scores (Figure 5.5, right), calculated using an algorithm in the
PReMod software, reflect the likelihood that a transcription factor binds at the site.
The highest scoring ‘hit’ consisted of two sequences, in tandem repeat, which show
similarity to the consensus recognition sequence for Signal transducer and activator of
transcription (Stat)5b. Other potential binding sites within the cluster included two
sequences similar to a generic Pax protein consensus site. The tandem repeat sequences
potentially recognised by Stat5b are also similar to those bound by the closely‐related
protein Stat5a, although a lower numeric score reflects a greater dissimilarity with the
Stat5a consensus. Sequences related to those recognised by the bZIP transcription factor
Tcf11 and the POU‐domain transcription factor Tst‐1 were also identified, but achieved the
lowest likelihood scores. Worthy of note is that several of these potential recognition sites
overlap.
The 70 bp CRM1 region incorporated or overlapped with three of the short conserved
sequences identified using ExactPlus, which formed a cluster (Figure 5.4, black arrowhead
and Figure 5.6), suggesting much of this regulatory module has been retained in the
genome through multiple speciation events. Indeed, a large proportion of the module was
highly conserved between five of the orthologs examined; this included the Grb10
sequences of the four eutherian mammals, as well as chicken. Despite some variation
within CRM1, the putative recognition sequences for Stat5b, identified as the most likely
active candidates by PReMod because of their similarity to the consensus, were perfectly
conserved between the five species (Figure 5.6).
The position of CRM1 within the deleted endogenous sequence of the Grb10Δ2‐4 allele
suggested it was a suitable candidate for the CNS‐specific enhancer element proposed in
the model in Figure 5.2c.
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5.2.6 Cis‐regulatory module 1 is hypersensitive to DNase I in brain chromatin
The tissue‐specific activity of promoter and enhancer sequences is often achieved through
differences in chromatin conformation; a transcription factor may only be capable of
binding to a recognition sequence if such a site is physically accessible. The ability of
chromatin to adopt ‘open’ and ‘closed’ states is thus responsible for many of the
differences in gene expression observed between differentiated tissues.
To examine the accessibility of CRM1 to transcription factors, and thus assess its potential
as a transcription factor binding site in vivo, chromatin isolated from adult wild type brain
and liver samples was exposed to varying concentrations of DNase I. This enzyme possesses
endonuclease activity, but is restricted in its digestion of genomic DNA by the presence of
nucleosomes. Following a 20 minute incubation with DNase I, DNA was purified, cleaved
with BamHI, and subsequently prepared for Southern analysis using a probe
complimentary to CRM1 and the surrounding genomic sequence (probe C; Figure 5.7a).
A 6 kb BamHI digestion fragment was apparent in all samples exposed to DNase I,
regardless of tissue origin (Figure 5.7b). A species of smaller molecular weight was
observed in the brain chromatin sample challenged with the highest amount of DNase I
(200 Units (U)). This fragment maps to the 3.8 kb DNase I digestion fragment expected if
CRM1 was in an ‘open’ conformation (Figure 5.7a). Probe C did not detect this digestion
fragment in brain samples exposed to 0 or 120 U of DNase I. Moreover, this fragment was
not detected in samples of liver chromatin exposed to the same conditions, consistent with
the hypothesis that CRM1 is a CNS‐specific enhancer, and is inaccessible to transcription
factors in the liver. Although probe C was complimentary to genomic sequence both 5’ and
3’ to CRM1, it did not detect a fragment consistent with the expected 2.2 kb DNase I
digestion product.
5.2.7 Grb10 and Stat5b are co‐expressed in the mature mouse brain
Potential binding sites for several transcription factors were identified within CRM1 (Figure
5.5). To validate which of these, if any, were likely candidates for regulating transcription of
Grb10 in the CNS, an examination of their expression profiles in the brain was performed.
Grb10 protein is not ubiquitous in this organ, being restricted to specific cell populations of
the midbrain and hindbrain (Garfield et al, submitted). We utilised the comprehensive
database of in situ hybridisation images collated in the Allen Brain Atlas, available for public
use at www.brain‐map.org, and systematically screened all known sites of Grb10
expression in the brain for in situ signal representing each of the candidate transcription
factors.
120
BamHI BamHI
6 kb
3.8 kb
2.2 kb
probe C
DNase I
units (U)
DNase I
units (U)
Brain Liver
6.0
4.0
3.0
Molecular weight
standards
(kb)
3.8 kb
a
b
0 200120 0 200120
121
Chapter Five
Stat5b
Within CRM1, the transcription factor binding sequence with closest similarity to its
consensus was that for Stat5b. Use of the expression summary graphs available from the
Allen Brain Atlas revealed a similar profile of expression to Grb10, with strong signal for
both apparent in the hypothalamus. Sites at which Grb10 expression was essentially
undetectable, including the cortex and hippocampus, demonstrated the lowest levels of
Stat5b, with the single exception of the cerebellum, in which Stat5b signal was relatively
strong.
To examine sites of expression at a more detailed resolution, in situ hybridisation images
for Stat5b and Grb10, from coronal sections, were manually screened. Like Grb10, Stat5b
was not ubiquitous within the regions identified from the expression summary graphs, but
was restricted to specific cell populations. Indeed, Stat5b could be detected in the majority
of sites at which Grb10 expression has previously been described, including, for example,
the locus coeruleus and the Edinger‐Westphal and arcuate nuclei. A striking overlap was
revealed from a direct comparison of Stat5b in situ images with those of the LacZ reporter
in Grb10KO+/p brain sections, representing Grb10. Three representative sites are presented
in Figure 5.8. The medial habenular nucleus, located in the epithalamus, contained high
levels of β‐galactosidase relative to surrounding neuronal cells, and this was mirrored by a
more intense in situ signal for Stat5b at this site (Figure 5.8a and b). Similarly, cells of the
dorsal raphe nucleus demonstrated high levels of LacZ expression, and in situ signal for
Stat5b was higher than the general background levels (Figure 5.8c and d). Perhaps the most
convincing demonstration of co‐expression was at the substantia nigra, wherein Grb10 is
restricted to the pars compacta and almost entirely absent from the pars reticulata (Figure
5.8e). Consistent with this, Stat5b was clearly detected in the substantia nigra pars
compacta, but no signal above the level of background noise could be detected in the pars
reticulata (Figure 5.8f).
A section‐by‐section analysis was performed for all other candidate transcription factors
shown in Figure 5.5, but none displayed such a tight co‐expression with Grb10 as Stat5b.
Outlined below is an overview of expression of the remaining candidates, using the
expression summary graphs available from the Allen Brain Atlas (images not shown).
Pax
The Pax recognition sequence identified within CRM1 was a generic consensus sequence,
potentially capable of being bound by any member of the Pax transcription factor family.
Screening was therefore performed for all nine described Pax genes. Consistent with
previously published reports (Blake et al, 2008 and references therein), Pax6 was found to
have the widest expression profile in the adult brain, with in situ hybridisation signal
strongest in cells of the cerebellum, hypothalamus, thalamus and olfactory bulb. The
profile for Pax1 was similar to that for Pax4, with apparently highest expression in the
olfactory bulb, cerebral cortex and hippocampal region for both. In situ hybridisation for
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the remaining Pax genes revealed relatively low levels of expression, a result matched by
the manual examination of sagittal sections.
Stat5a
Despite significant structural similarity with Stat5b, the expression of Stat5a was strongest
in the medulla and cortex, sites at which both its homolog and Grb10 are expressed weakly.
Additionally, Stat5a expression was almost undetectable in the hypothalamus, a key site of
Grb10 transcription. Thus, although Figure 5.5 identifies both Stat5a and Stat5b as being
potentially able to recognise the same 9 bp sequence, the expression profile of Stat5a
essentially eliminates it as a candidate.
Tcf11
The expression summary graph for this transcription factor implied an ubiquitous profile,
with high levels of in situ signal detected in all regions of the brain. However, the protein is
encoded by the gene Nfe2l1, previously described as being transcriptionally active in
erythrocytes (Caterina et al, 1994), but not identified in neurons. This explained the
widespread distribution of the transcription factor in the brain and, further, excluded it as a
candidate for regulating Grb10 expression.
Tst‐1
In situ hybridisation images of this POU‐domain transcription factor were unavailable from
the Allen Brain Atlas, but its expression profile in the rat brain has been characterised in
some detail (He et al, 1989). Transcripts were most abundant in the cortex and
parabigeminal nucleus of the mature rat brain, representing a subset of the cells in which
Tst‐1 was detected during embryonic development. This restricted adult expression profile
rendered Tst‐1 an unlikely candidate for regulating the transcription of Grb10 in the brain.
5.2.8 CRM1 has enhancer capacity in the presence of constitutively active Stat5b
Comparison of the expression profiles of each of the transcription factors shown in Figure
5.5 identified Stat5b as the strongest candidate for regulating Grb10 transcription in the
CNS. To confirm that CRM1 is indeed an enhancer element, and that its activity can be
controlled by the binding of Stat5b, an in vitro luciferase assay was performed using
NIH/3T3 mouse fibroblasts.
A 799 bp region, containing the 70 bp CRM1, was amplified by PCR from wild type DNA
(Section 2.3.1). The resulting fragment was cloned upstream of the minimal SV40 promoter
sequence in the pGL3‐Promoter vector (Figure 5.9a), creating a construct herein referred to
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as pGL3‐Pro‐CRM1. This vector also contained the gene encoding firefly luciferase,
positioned immediately downstream of the minimal promoter and thus under the influence
of CRM1.
First, empty vector (pGL3‐Pro; Figure 5.9a) or pGL3‐Pro‐CRM1 were co‐transfected with
pRL‐SV40, a construct expressing Renilla luciferase, into NIH/3T3 fibroblasts. The activity of
firefly luciferase was detected 48 hours later and normalised to levels of Renilla luciferase,
thereby controlling for any variability in transfection efficiency and cell viability. The
presence of CRM1 upstream of firefly luciferase did not, on its own, significantly influence
transcription of this reporter, with no difference observed from transfecting empty vector
(Figure 5.9b).
Next, the influence of a constitutively active Stat5b mutant (pRSVpuro‐STAT5B1*6; Onishi
et al, 1998) on luciferase expression was examined. As before, cells were transfected with
pGL3‐Pro or pGL3‐Pro‐CRM1 alongside pRL‐SV40, but 0.5 µg or 1 µg of pRSVpuro‐
STAT5B1*6 was also introduced. Neither amount of constitutively active Stat5b influenced
luciferase activity when co‐transfected with empty vector (Figure 5.9b). 0.5 µg
constitutively active Stat5b appeared to increase luciferase activity in the presence of
CRM1, although this did not reach statistical significance. Co‐transfecting 1 µg of the
constitutively active Stat5b construct with pGL3‐Pro‐CRM1 increased luciferase activity to
2.2 times the level of that achieved with empty vector, a statistically significant change.
These results suggested that the combination of active Stat5b with the presence of CRM1
enhanced reporter gene expression, and that this response appeared to be dose‐
dependent.
This established that CRM1, in vitro, was an element with enhancer properties which could
be stimulated by the presence of active Stat5b.
5.2.9 CRM1 may also be active in the placenta
Chapter Four characterised both the transcriptional activity and phenotypic influence of
Grb10 on the late‐gestation placenta, using the Grb10KO allele as a tool. Previous,
unpublished, experiments had suggested that the Grb10Δ2‐4 allele was a poor reporter of
Grb10 expression in this organ, but a direct comparison with the Grb10KO allele had not
been performed. We wished to examine relative reporter expression from the two alleles
in the placenta, with a view to determining whether this might be another site at which
CRM1 could be active.
As described in Section 4.2.1, both the parental alleles contribute to the Grb10 transcript
pool in the placental labyrinth and chorionic plate, with biased expression from the
maternally‐inherited chromosome (images reproduced in Figure 5.10a and b). Placentae
developing from the extraembryonic tissues of Grb10KOm/+, Grb10KO+/p, Grb10Δ2‐4m/+ and
Grb10Δ2‐4+/p embryos were isolated at e14.5, cryosectioned and stained simultaneously for
LacZ expression for 18 hours. Figure 5.10d confirms both the profile and allelic‐bias of
Grb10 expression in the late‐gestation placenta, as described in Chapter Four, using
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Grb10KO as a reporter. Reporter expression in Grb10Δ2‐4m/+ placentae was considerably
reduced, with only a few trophoblast cells staining positive for LacZ, despite the use of
identical conditions and substrate solution. Grb10Δ2‐4+/p placentae were entirely devoid of
positive staining.
Whilst Grb10Δ2‐4+/p brains stained in situ in a sagittally‐bisected embryo appeared not to
express any LacZ reporter, staining of sectioned adult brains revealed a weak activity which
mapped to the sites of expression described for Grb10KO (Garfield, 2007; Garfield et al,
submitted). To determine whether this was also the case for the placenta, Grb10Δ2‐4m/+
and Grb10Δ2‐4+/p sections were incubated in X‐gal substrate for 60 hours. This extended
incubation time revealed correctly localised positive reporter expression, but only for the
placenta carrying the maternally‐inherited Grb10Δ2‐4 allele (Figure 5.10c). No signal could
be detected from Grb10Δ2‐4+/p placentae (not shown), reflecting the significantly smaller
contribution of this allele to the Grb10 transcript pool (Figure 4.3).
5.2.10 Stat5 is expressed in extra‐embryonic tissues of the late‐gestation placenta
Whilst the expression of Stat5b in the adult brain appeared to mirror that for Grb10 closely,
no published reports describe the sites of Stat5 expression in the mouse placenta, although
one study has identified the presence of Stat5b transcripts in a human placental cDNA
library (Sawka‐Verhelle et al, 1997). Wild type embryos were sacrificed at e14.5 and their
corresponding placentae embedded in wax and sectioned. Immunohistochemistry, using a
pan‐Stat5 primary antibody, detected protein in all extra‐embryonic layers of the placenta,
including labyrinth, chorionic plate and spongiotrophoblast (Figure 5.11a). No staining was
detected in the absence of primary antibody (Figure 5.11d). A detailed view of the labyrinth
identified Stat5 in the cytoplasm of all cell types, excluding foetal and maternal red blood
cells (Figure 5.11b). Nuclear localisation, indicating Stat5 actively promoting gene
transcription in response to hormonal stimulus, was varied. Whilst all foetal endothelial
cells examined demonstrated nuclear as well as cytosolic localisation of Stat5, only a subset
of cytotrophoblast and syncytiotrophoblast nuclei were positive for the protein.
Stat5 was detected in both the cytoplasm and nuclei of the majority of spongiotrophoblast
cells, whereas the nuclei of trophoblast giant cells and glycogen cells rarely stained positive
(Figure 5.11c). No signal was detected in the decidua, forming the maternal contribution to
this organ.
The widespread expression of Stat5 in the late‐gestation placenta is consistent with this
protein regulating Grb10 transcription, although its presence in cells which are not positive
for Grb10 implicate other gene targets.
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5.2.11 Grb10 depletion does not influence Stat5 protein levels in the placenta
If Grb10 is a transcriptional target of Stat5, its expression may be required to maintain
Stat5 levels in a positive feedback loop. Western blotting of protein isolates from two wild
type and two Grb10KOm/+ e14.5 placentae was performed using a pan‐Stat5 antibody
(Figure 5.12). No differences in levels of the 93 kDa native protein, nor in the levels of α‐
tubulin, employed as a loading control, were observed between any of the samples. This
suggested Grb10 does not influence Stat5 protein levels in the placenta.
5.2.12 Stat5 regulates Grb10 transcription in the mammary gland in a pregnancy‐
dependent manner
A previous study identified Grb10 as a likely transcriptional target of Stat5a in mammary
epithelial cells (Clarkson et al, 2006). In that study, a conditionally active Stat5a protein
construct was transduced into an immortal mammary epithelial cell line, and a microarray
experiment performed to compare the transcriptomes of induced and uninduced cells.
Upon induction of Stat5a, Grb10 expression was increased 3.6‐fold, making it the gene with
the fifth most‐altered expression level in the microarray. This supported our current model
of a transcriptional level interaction, and suggested that Stat5 binding at CRM1 might be
required for Grb10 expression in the mammary epithelium. A related study, utilising
microarrays, characterised the expression profile of Grb10 through gestation, lactation and
involution (Clarkson et al, 2003). Grb10 appeared to be activated in a pregnancy‐dependent
manner.
These data provided two testable hypotheses: 1) that mice inheriting the Grb10KO allele
should report an expression profile in this tissue similar to that characterised by microarray
analysis; and 2) that LacZ expression from the Grb10Δ2‐4 allele should be weaker, due to
the deletion of CRM1.
First, mammary glands were excised from wild type, Grb10KOm/+ and Grb10KO+/p virgin
females, fixed and stained for LacZ expression. No reporter expression was observed,
implying an absence of Grb10 in post‐pubertal but pre‐gestation females (data not shown).
Next, the expression of Grb10 in the adult mammary gland was characterised at three
stages, corresponding to early gestation (gestational day 7.5; G7.5), mid‐gestation (G12.5)
and postpartum (postnatal day 6; P6). Fourth (abdominal) mammary glands were isolated
from the right side of wild type, Grb10KOm/+ and Grb10KO+/p females, all age‐matched to 10
weeks at conception. These were fixed and stained for LacZ expression for 18 hours. The
mammary gland undergoes dramatic branching morphogenesis during gestation, so glands
from the left side were excised from wild type females at the same stages, and stained with
carmine alum to correlate expression with structure.
At G7.5, no reporter expression was apparent in glands of any genotype (Figure 5.13),
consistent with that seen for virgin animals. At this stage, the extent of branching was
limited, with the majority of tissue composed of adipocytes (Figure 5.13, left panel). By
G12.5, cell proliferation had produced a denser network of branches, and individual
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clusters of epithelial cells were clearly apparent. Reporter expression at this stage was
observed in a subset of epithelial cells in the Grb10KOm/+ gland, spreading out from the
lymph node. Cells located closer to the nipple stained negative for LacZ at this stage.
Glands excised from wild type and Grb10KO+/p females did not report expression,
confirming the validity of the stain and the retained imprint of Grb10, respectively. The
imprinted nature was further confirmed at P6, with all epithelial cells appearing to report
positive LacZ expression when the transgenic allele was inherited maternally, but no
expression from Grb10KO+/p glands. Similarly, wild type glands remained devoid of staining.
At this stage, dense clusters of milk‐secreting epithelial cells were observed from carmine
alum staining.
To test the hypothesis that deletion of CRM1 will result in reduced reporter expression in
Grb10Δ2‐4m/+ mammary epithelial cells relative to Grb10KOm/+, staining was repeated at all
stages on glands excised from Grb10Δ2‐4m/+ females, again 10 weeks old at conception.
After 18 hours of incubation, no reporter expression was observed at any stage, including
P6 when expression from Grb10KO is greatest. This was consistent with the proposed
model, and, alongside data from previous studies, confirmed mammary epithelial tissue as
an additional site at which Stat5 regulates Grb10 transcription.
132
G
7.
5
G
12
.5
W
ild
ty
pe
G
rb
10
KO
m
/+
G
rb
10
KO
+/
p
G
rb
10
Δ2
‐4
m
/+
P6
X‐
ga
ls
ta
in
fo
rr
ep
or
te
r
ex
pr
es
si
on
W
ild
ty
pe
Ca
rm
in
e
st
ai
n
133
Chapter Five
5.3 Discussion
Using a range of tools, we have identified a highly conserved intronic sequence at the
Grb10 locus, which may bind Stat5 in a tissue‐specific manner and can promote Grb10
transcription.
Previous work from our laboratory determined the presence of Grb10 protein in the
developing mouse brain using immunohistochemical analysis, but this was not
recapitulated by assaying for  β‐galactosidase activity in mice possessing a copy of the
Grb10Δ2‐4 allele (Charalambous et al, 2003). Studies utilising Grb10KO mice found that
LacZ reporter expression from this allele matched all sites at which Grb10 protein was
detected, but showed a requirement for both parental alleles to be expressed. In particular,
reporter expression in the CNS was only detected when the Grb10KO allele was inherited
through the paternal line (Garfield, 2007; Garfield et al, submitted). Figure 5.1 presents
LacZ stained, sagittally‐bisected embryos to permit a direct comparison between these
genotypes. Inconsistent fixation techniques are responsible for the differences in quality
observed, but the key results are plainly illustrated.
Firstly, maternal transmission of both transgenic alleles produced identical reporter
expression profiles, with an abundance of β‐galactosidase in most tissues of mesodermal
and endodermal origin, as described previously. Although not presented here, expression
from both alleles, when maternally‐inherited, was detected in the epidermis (Garfield,
2007). The most striking observation is the absence of reporter staining in the majority of
the CNS. One clear exception is the epithelium of the choroid plexus, although staining of
coronally‐sectioned brains also revealed a contribution from the maternal allele in
ventricular ependymal layers and the meninges (Garfield et al, submitted). All three sites
consist of non‐neural cells, and indeed, the choroid plexus epithelium is synonymous with
unusual patterns of imprinted gene expression. Of particular interest is the absence of
imprinting at the H19/Igf2 locus in this tissue (DeChiara et al, 1991). As a consequence, H19
is biallelically‐silenced, whilst Igf2 is biallelically‐expressed. This escape from imprinting
appears to be achieved through biallelic hypermethylation of some CpG dinucleotides
within the germline differentially methylated domain (DMD), the differential methylation
of which is responsible for establishing imprinting at the locus. This hypermethylation
results in the exclusion of CTCF from these sites on both alleles and a subsequent de‐
regulation of the imprint (Menheniott et al, submitted). Interestingly, Igf2 retained its
imprint within closely‐associated stromal cells of the choroid plexus (Charalambous et al,
2004), cells in which Grb10 is expressed from the paternally‐derived allele (Garfield, 2007).
Thus, unlike the H19/Igf2 locus, Grb10 does not escape imprinting but is reciprocally‐
imprinted between the epithelium and the stroma. This pattern is limited to embryonic
development, as in adulthood, the maternally‐inherited Grb10 allele does not contribute
any transcripts to the CNS. Further dissection of the developmental and mechanistic basis,
as well as the function, of this reciprocal imprint between two intimately related tissues is
required.
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Secondly, a comparison of Grb10KOm/+ and Grb10KO+/p foetuses confirmed that the
paternally‐inherited allele is the predominant contributor of transcripts in the CNS, thereby
establishing a reciprocal imprint between the CNS and peripheral tissues (Garfield et al,
submitted). Unlike the reciprocal imprint between the epithelium and stromal cells of the
choroid plexus, the CNS/peripheral tissue imprinting pattern persists in adulthood, as
demonstrated by Northern blotting in the present study (Figure 3.4a) and LacZ staining of
adult tissues (Smith et al, 2007; Garfield et al, submitted). Intriguingly, this correlates with
differences in the function of maternally‐ and paternally‐expressed Grb10, with the former
regulating insulin metabolism and the latter modulating social dominance. The
evolutionary basis for such a system is still unclear, but given that Grb10 is the only
identified gene to exhibit allele‐specific imprinting in both directions, a system conserved in
humans (Arnaud et al, 2003; Monk et al, 2009), further investigation is necessitated. This
should include further dissection of the signalling pathways which Grb10 mediates in the
brain and peripheral tissues.
The final key observation is from the comparison of Grb10Δ2‐4+/p and Grb10KO+/p embryos;
specifically, the failure of Grb10Δ2‐4 to report expression in the CNS. Assaying for  β‐
galactosidase activity apparently revealed no such reduction in the peripheral sites of
paternal expression, including the ventricles of the heart, tongue and others. This
suggested that, in the developing embryo, the mechanism responsible for the difference
was specific to the CNS. To address this, the structures of the two alleles were compared.
This was possible as a result of the mapping experiments for Grb10KO described in Chapter
Three, and the published details for Grb10Δ2‐4 (Charalambous et al, 2003). Based on this
comparison of the Grb10KO and Grb10Δ2‐4 alleles, two models were proposed to account
for the differences in CNS reporter expression, whilst retaining similar peripheral tissue
expression profiles.
One model described differences in splicing between transcripts arising from Grb10Δ2‐4 in
the CNS and elsewhere. Brain‐specific transcripts initiate at alternative leader exons, and
epigenetic systems are responsible for regulating this promoter switch (Arnaud et al, 2003;
Sanz et al, 2008). These, in turn, confer higher order chromatin conformation
rearrangements, potentially interfering with the ability of transcripts to splice onto the β‐
geo cassette. The promoter switch at the Grb10 locus is achieved in part by differential
methylation at a brain‐specific DMR; in other tissues, this site is biallelically
hypermethylated (see Section 1.2.3). One of the brain‐specific leader exons, 1C, initiates
within this DMR and thus its accessibility to the transcription machinery may be directly
regulated by methylation at this site. However, exons 1B1 and 1B2 are located within the
germline DMR, which retains its maternal hypermethylation in the brain as in all tissues.
Thus, a different epigenetic system, histone tail modifications, is also responsible for
regulating the promoter switch. In particular, the repressive histone modification
H3K27me3 was found to associate with the unmethylated paternal allele within the
germline DMR, but this was dissociated in the brain (Sanz et al, 2008). These two regulatory
systems, differential DNA methylation and histone tail modification, ensure that differential
promoter usage is tightly coupled to reciprocal imprinting.
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The higher order chromatin conformation changes induced by such epigenetic systems
result in the exclusion or inclusion of transcription factors, or indeed distal enhancers
through chromatin looping (Murrell et al, 2004), from promoter sites. These higher order
structures might adversely affect the accessibility of small nuclear ribonucleoprotein
particles, which catalyse splicing, to the β‐geo splice acceptor in the brains of Grb10Δ2‐4+/p
mice. This may force splicing around the cassette, onto a downstream exon, and could
account for the successful splicing of transcripts onto the β‐geo cassette in other tissues.
However, the considerable reduction in full‐length Grb10 transcripts detected in the brains
of Grb10Δ2‐4+/p animals, relative to wild type and maternal transmission controls, argues
against this model.
Further evidence arguing against the influence of chromatin conformation causing splicing
around the β‐geo cassette, is derived from the observation that Grb10Δ2‐4 fails to report
expression in the mammary epithelium, a site at which expression is exclusively from the
maternally‐inherited chromosome. Although no study has characterised the exon structure
of Grb10 transcripts in the mammary epithelium, and thus it is not possible to rule out that
the initiation exons 1B1, 1B2 or 1C are utilised, this seems an unlikely scenario given that
the mechanisms for initiating transcription at these exons are tightly coupled to silencing of
the maternal and activation of the paternal alleles. This suggests that Grb10 transcripts in
the mammary tissue initiate at exon 1A, and chromatin conformation is therefore different
to that in the brain. This makes the sharing of a splicing event by brain and mammary
epithelium, as a consequence of such epigenetic modifications, seem unlikely.
An alternative explanation proposed the existence of an enhancer element at the Grb10
locus, situated within the deleted region of Grb10Δ2‐4. If this enhancer was active only in
the CNS of the developing embryo, it might account for the failure of Grb10Δ2‐4+/p embryos
to report CNS expression. To this end, an alignment between the Grb10 orthologs of
various species was performed, using software called ExactPlus (Antonellis et al, 2006),
which enabled the identification of short conserved sequences which might represent
enhancer elements. Both the mouse‐human and mouse‐human‐chimpanzee alignments
revealed extensive intronic conservation, suggesting relatively limited sequence evolution
since the divergence of the rodent and primate lineages 61.7 million years ago (MYA;
Benton and Donoghue, 2007). Indeed, very few differences were observed between these
two alignments, reflecting the ~99 % genomic sequence similarity between human and
chimpanzee (Kehrer‐Sawatzki and Cooper, 2007; and references therein). The addition of
the bovine Grb10 sequence resulted in a ‘filtering’ effect of conserved sites, such that
clusters of short conserved sequences formed a subset of those identified from the
aforementioned comparisons. Grb10 is imprinted in human and mouse, and the high
degree of genome similarity between human and chimpanzee would predict the retention
of imprinting in this species, although this is yet to be confirmed. Imprinting is also active in
the cow, and although Grb10 expression has been detected in parthenogenetic peri‐
implantation bovine embryos, the status of the paternally‐inherited allele remains
unknown (Tveden‐Nyborg et al, 2008). Assuming retention of imprinting at this locus in
these four eutherian mammals, conservation of DMRs might be expected. However, the
only short conserved sequence between the four species at the 5’ end of the locus mapped
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to a run of GT repeats, situated between the germline and somatic DMRs. A function for
these repeats has not previously been described, although other repeat sequences specific
to the 5’ end of mouse Grb10 have been shown to bind CTCF, and are thus implicated in
regulating imprinting at the locus (Hikichi et al, 2003). The current study failed to detect
conserved CTCF binding sites between mouse and human, consistent with the observation
that these are specific to murine Grb10. The apparent lack of conservation of DMRs might
reflect the importance of epigenetic, rather than sequence‐based, regulation of imprinting,
such that there is evolutionary pressure to retain a high GC content, but not to conserve
the intermediate sequence.
Alignments of Grb10 orthologs between more distantly related species, using Xenopus
tropicalis and chicken as representatives of the amphibian and bird classes, and opossum
as a representative of marsupials, revealed a fewer number of conserved intronic sites.
Interestingly, those identified in the mouse‐frog comparison were a subset of those found
in the eutherian mammal alignment. That these sites have retained conservation through
~330 million years (Benton and Donoghue, 2007) potentially implies a functional
significance, and might perhaps represent other regulatory elements worthy of future
investigation.
Many imprinted genes retain their monoallelic expression status in marsupials; studies of
the tammar wallaby, Macropus eugenii, have shown that IGF2, IGF2R, Insulin, PEG1/MEST
and PEG10 are all imprinted in both foetus and placenta (Suzuki et al, 2007; Renfree et al,
2008). Whilst wallaby is the archetypal marsupial for examining imprinted genes, the status
of Grb10 has not yet been revealed, although characterisation is in progress (M. Renfree
and J. Stringer, personal communication). The most overwhelming limitation is that the
wallaby genome sequence is still to be completed. This also prohibits inclusion of wallaby in
the ExactPlus alignment, and thus the opossum sequence presented a suitable alternative
(although in this species too, the imprinting status of Grb10 has not been defined). The
mouse‐opossum alignment represented an ‘intermediate’ between the mouse‐frog and
mouse‐human‐chimpanzee‐cow comparisons, reflecting the opossum’s closer relatedness
to eutherian mammals.
A single intronic sequence was conserved between the eutherian mammals examined and
chicken. That there is no other intron sequence similarity in the entire Grb10 locus suggests
a functional significance for this site. In support of this, the sequence mapped to the only
cis‐regulatory module identified in the mouse Grb10 sequence using PReMod. Indeed, a
direct comparison between the PReMod and ExactPlus outputs for this region, referred to
as cis‐regulatory module 1 (CRM1), revealed a 73 % base pair conservation of CRM1 across
all five of these species. Of further interest is that CRM1 was positioned within the portion
of the Grb10 locus deleted during the creation of the Grb10Δ2‐4 allele, and was therefore a
strong candidate for the predicted missing enhancer.
CRM1 included several putative transcription factor binding sites; the PReMod software
identifies clusters of sequences with similarity to consensus sites registered in the TransFac
7.2 database, and subsequently filters them with an alignment between mouse and rat
(Blanchette et al, 2006). The overlapping nature of these sequences is intriguing, and
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supports previous analyses that transcription factor recognition sequences tightly cluster;
in evolutionary terms, this might permit greater opportunity for the emergence of co‐
regulation by multiple factors and thus more refined control of expression, or in situations
of more than one copy of the same transcription factor binding sequence, might simply
assist transcription factors in finding their target sites (Zhang et al, 2006).
It is pertinent to note that the analyses performed using ExactPlus and PReMod are not
entirely independent, although they address different questions. PReMod filters noise after
identifying candidate clusters by aligning them between the mouse and rat orthologous
sequences. This additional level of screening is the basis for the ExactPlus analysis, and thus
it is not surprising that CRM1 was also identified using this programme. However, the two
approaches are complimentary, and in fact, PReMod overcomes a considerable limitation
of the ExactPlus analysis. Exons 1 to 5 were excluded from the ExactPlus alignment such
that the strong conservation expected within exons would not cloud the search for
potential enhancer elements. Enhancer elements can reside within exons (Reed, 1996), and
this exclusion is thus a limitation. PReMod, on the other hand, does not discriminate
between exonic and intronic sequence.
Following the identification of CRM1 from bioinformatic analyses, the present study
progressed to characterise its properties and to identify Stat5 as a highly likely candidate
for binding. Initially, CRM1 was examined in vivo. A DNase I hypersensitivity assay
confirmed that the site was hypersensitive to endonuclease digestion, and thus devoid of
nucleosomes, in the brain. This was not the case for the liver, consistent with the prediction
that CRM1 is a CNS‐specific enhancer. Whilst this demonstration of tissue‐specific activity is
clear, adult liver was not the most suitable control tissue, as Grb10 transcription is switched
off in the neonatal liver and not reactivated in adulthood (Smith et al, 2007). A more
suitable comparison might be drawn between brain and kidney, for example, in which
Grb10 continues to be expressed in adulthood but would be predicted to be independent
of CRM1 (due to no loss of reporter activity in the kidneys of Grb10Δ2‐4m/+ mice).
Manual screening of an extensive database of in situ hybridisation images in the adult
mouse brain was subsequently performed, cataloguing the expression profiles of each of
the transcription factor candidates identified by PReMod. A prerequisite for activating
Grb10 transcription is co‐expression. Only Stat5b displayed considerable overlap with
Grb10, and this was the transcription factor whose putative binding sites were most closely
related to the consensus. Stat5b expression was apparent in almost all sites of the brain at
which Grb10 has been characterised (Garfield et al, submitted), although the high level of
Stat5b expression in the cerebellum is inconsistent. The expression profiles of the other
candidates corresponded with previously published analyses (Blake et al, 2008; He et al,
1989).
The roles of Stat5b as a signal transducer are well‐characterised. Following the binding of a
cytokine to a cell surface receptor, Stat5b is phosphorylated by Janus kinases (JAKs),
dimerises and translocates to the nucleus, wherein it binds to recognition sequences of
target genes and promotes their transcription. Studies have demonstrated a role for Stat5
in mediating signalling downstream of prolactin (Wakao et al, 1994), growth hormone,
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interleukins and erythropoietin (Gouilleux et al, 1995), but the relative contributions of
Stat5a and Stat5b to each of these pathways depends on the tissue in question. Generally,
Stat5b plays a more prominent role in hepatocytes and regulatory T cells. It also plays a
critical role in the hypothalamus. Stat5b‐deficient mice showed an impaired ability to
respond to circulating prolactin, but also displayed grossly elevated levels of prolactin
secretion (Grattan et al, 2001). This somewhat paradoxical finding was explained by the
role of Stat5b in regulating prolactin secretion, forming part of a negative feedback loop
between the pituitary and hypothalamus.
Conversely, Stat5a has a more significant role in the response of mammary epithelial cells
to prolactin and, by extrapolation, is fundamental for mammary alveolar development and
milk secretion (Liu et al, 1997). Although Stat5b deficiency does not produce the same
phenotype, compound mouse mutants (Stat5a‐/‐/Stat5b‐/‐) have an even more dramatic
phenotype, suggesting some functional redundancy in this system, and the ability for
Stat5a to compensate for Stat5b (Udy et al, 1997; Teglund et al, 1998).
Although the expression profile in the adult brain renders Stat5a an unlikely candidate for
activating Grb10 in this tissue, we cannot rule out the possibility that this protein binds at
CRM1 in the mammary epithelium, or indeed, in the placental labyrinth. Elucidation of the
function of Grb10 in the mammary epithelium, described in Chapter Six, did not help to
determine whether Grb10 is activated by Stat5a or Stat5b. This remains an issue to be
resolved. Perhaps Stat5 proteins bind indiscriminately to CRM1 in this tissue, or CRM1
might show a higher affinity for one protein over the other.
We next confirmed the enhancer capacity of CRM1, and its ability to respond to Stat5b, in
vitro using a luciferase assay. The presence of CRM1 cloned upstream of a minimal
promoter driving luciferase had no influence, on its own, on luciferase expression as
assessed by assaying for enzyme activity. Whilst NIH/3T3 cells express endogenous Stat5
protein (Chen et al, 1997), phosphorylated dimers may have been at a level insufficient to
drive luciferase expression above that detectable from the empty vector control. Co‐
transfection with a constitutively active Stat5b mutant, pRSVpuro‐STAT5B1*6 (Onishi et al,
1998), increased luciferase activity levels in cells containing pGL3‐Pro‐CRM1, but not pGL3‐
Pro. This effect appeared to follow a dose‐dependent trend, although co‐transfection of 2
µg of the constitutively active mutant did not produce as strong an effect as that observed
with 1 µg (data not shown). This is probably a consequence of toxic levels of mutant
protein, which had a detrimental effect on normal cellular processes.
Whilst the effect of constitutively active Stat5b is dramatic and clearly demonstrates the
capacity of CRM1 to bind Stat5b, this result may not necessarily extrapolate to in vivo
systems. CRM1 might, for example, bind a Pax family transcription factor in vivo, identified
as a candidate from the PReMod screen. The retention of a Stat5b binding site due to the
clustering effect discussed previously might enable an interaction between Stat5b and
CRM1 to be ‘forced’ in an in vitro manipulation. However, when considered in light of
additional evidence, including the perfect conservation of the Stat5 binding site in chicken
and four eutherian mammals, and the co‐expression of Stat5b and Grb10 in the adult brain,
Stat5 emerges as a strong candidate for regulating Grb10 expression in vivo. The luciferase
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assay could be extended to examine the effects of over‐expressing the other candidate
transcription factors. Additional benefit might be derived from mutating the conserved
Stat5 binding sites within the pGL3‐Pro‐CRM1 construct, predicting loss of the enhanced
luciferase activity when 1 µg pRSVpuro‐STAT5B1*6 is also transfected.
A demonstration of the tissue‐specific nature of this interaction might be achieved by
performing similar luciferase assays in different cell lines. A prediction might be that the
interaction is effective in a neuronal cell line, such as the N2a neuroblastoma cell line, or a
placental labyrinth cell line, such as the HRP.1 cell line (Soares et al, 1987), but not a cell
line with characteristics of differentiated epidermal cells, for example. However, the nature
of this experiment, in which non‐physiological levels of activated Stat5b protein are
expressed, might not be subtle enough to differentiate such a tissue‐specific interaction.
Instead, chromatin immunoprecipitation (ChIP), using an antibody to Stat5, could be
employed on tissue isolates. This would provide a more refined method for demonstrating
tissue‐specific interaction, and, moreover, would represent binding in vivo. A further
advantage would be achieved by the use of precipitating antibodies recognising specific
Stat5 isoforms. Antibodies capable of this specificity, and with suitability to ChIP, have been
described previously (Moucadel and Constantinescu, 2005). By utilising these antibodies in
ChIP on brain, placenta and mammary gland chromatin, we could confirm which of the
proteins is responsible for Grb10 regulation in each of these tissues.
In the absence of such chromatin immunoprecipitation data, the result of effectively
deleting the CRM1 in vivo, using Grb10Δ2‐4, provides a clear demonstration of a tissue‐
specific activity. Arguably, the deletion of ~38 kb of endogenous sequence to generate this
allele might also have removed other candidate enhancer elements, and as such may be
considered unrefined. Perhaps conclusions cannot be drawn from this result alone, but
when considered alongside the data from this and other studies (discussed shortly) the
evidence is much more convincing.
In addition to the developing CNS, the inability of the Grb10Δ2‐4 allele to report expression
in the placental labyrinth, suggests CRM1 might also be utilised in this tissue. The weak
reporter expression in Grb10Δ2‐4m/+ placentae detected after prolonged incubation in X‐gal
substrate is reminiscent of that in the brain, and fits the model that transcription still
occurs from the locus, but is weak in the absence of CRM1. The role of Stat5 is not defined
in this organ, although a previous study has confirmed the presence of Stat5b transcript in
whole mouse placenta (Sawka‐Verhelle et al, 1997). We examined the placental expression
pattern of Stat5 using immunohistochemistry, although our approach did not permit
discrimination between Stat5a and Stat5b. Protein was detected in all cell types derived
from extra‐embryonic precursors in the mature mouse placenta. The maternal contribution
to the placenta, the decidua, did not contain Stat5 protein. The nuclear localisation of the
protein, suggestive of a role in promoting transcription of target genes, was variable. All
foetal endothelial cells examined showed nuclear and cytosolic localisation of Stat5,
consistent with the strong expression of Grb10 in these cells (Figure 4.2).
Syncytiotrophoblast and cytotrophoblast cells displayed a mixed result, with only some
cells reporting nuclear as well as cytosolic localisation. The reasons why only a subset of
these cells have detectable levels of Stat5 in the nucleus are unclear. In the case of the
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multi‐nucleated syncytiotrophoblast cells, transcription of Stat5 target genes from just a
few nuclei might be sufficient to maintain adequate levels of protein in the cytoplasm.
Alternatively, the antigen retrieval process may not have been sufficient to permeabilise all
nuclei and thus permit antibody access. The experiment should be repeated and the
method of antigen retrieval optimised to resolve this issue. Nevertheless, Stat5 is
expressed in all cells positive for Grb10, suggesting it could regulate Grb10 transcription in
the labyrinth. No changes in the levels of Stat5 protein could be detected in Grb10KOm/+
placentae, suggesting Grb10 does not regulate Stat5 expression in a feedback loop. This
might be expected given the range of transcriptional targets of Stat5. The persistence of
Grb10 expression from the paternally‐inherited chromosome in Grb10KOm/+ placentae
might also prevent detection of the effect; adult brain might be a more suitable tissue to
examine in this manner. It may be valuable to extend this analysis to examine
phosphorylation levels of Stat5 following Grb10 ablation, which would be indicative of the
levels of active Stat5 protein, rather than total cellular levels.
An entirely independent study is suggestive of a Stat5‐Grb10 transcriptional level
interaction. As discussed previously, Stat5a is a key mediator of mammary epithelial cell
proliferation and preparation for lactation. Clarkson et al (2006) describe an experiment in
which an inducible Stat5a construct was transduced into KIM‐2 cells, an immortal
mammary epithelial cell line. A microarray experiment comparing the transcriptomes of
induced and uninduced cells revealed a dramatic increase in Grb10 transcript levels upon
Stat5a induction. A further study, employing microarray analysis of whole mammary gland
expression during gestation, lactation and involution, demonstrated that Grb10 was
expressed in a pregnancy‐dependent manner in this tissue (Clarkson et al, 2003). We used
the observations from these two studies to create two testable hypotheses: first, that
reporter expression from Grb10KO should reflect the previously defined expression profile
for Grb10 in this tissue; and second, that mice inheriting the Grb10Δ2‐4 allele would fail to
report mammary epithelial expression because Stat5 binding to CRM1 is required to
promote transcription.
In both cases, the hypotheses were shown to be correct. No Grb10 expression could be
detected in virgin females or at day 7.5 of gestation, using Grb10KO, consistent with the
observation of low levels of transcript in the mammary glands of virgin females and at day
5 of gestation reported by Clarkson et al (2003). A subset of epithelial cells closest to the
lymph node were positive for  β‐galactosidase in Grb10KOm/+ females at day 12.5 of
gestation. The microarray published in Clarkson et al (2003) did not report much difference
between days 5, 10 and 15 of gestation, slightly inconsistent with this finding. However,
LacZ expression was restricted to a small population of cells, and further analysis of the raw
microarray data, available for public access at www.path.cam.ac.uk/
~madgroup/gene_expression.shtml, revealed that Grb10 expression at all these time points
was below the threshold value at which expression is considered to be ‘true’ (R. Clarkson,
personal communication). If a value falls below this threshold, it is not possible to
differentiate between the absence of expression and low levels of transcript. The restricted
expression of Grb10 at day 12.5 of gestation presumably reflects a gradual change in the
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transcriptome of epithelial cells which is coupled to proliferation and branching
morphogenesis, with ‘older’ cells altering their transcriptional profiles first.
At postnatal day 6, the mammary glands from lactating Grb10KOm/+ females stained
strongly for LacZ expression, consistent with the reported up‐regulation of Grb10
transcripts throughout lactation (Clarkson et al, 2003). Mammary epithelial tissue
comprises two differentiated cell types, luminal and myoepithelial cells, and whether or not
this profile of Grb10 transcription is apparent in both sub‐populations remains unclear.
Indeed, the KIM‐2 immortalised mammary epithelial cell line is a heterogeneous population
of the two, as well as some stromal cells, although luminal epithelial cells constitute 95 % of
the total (Gordon et al, 2000). Cryosectioned Grb10KOm/+ mammary glands should be
assayed for β‐galactosidase activity to resolve this issue.
As predicted, mammary glands isolated from Grb10Δ2‐4m/+ females did not report
expression at any of the stages analysed. This was reminiscent of the Grb10KO/Grb10Δ2‐4
differences observed in brain and placenta, and again implied the necessity of CRM1 to
permit transcription from the locus.
The final key observation from this experiment was the retention of the Grb10 imprint in
the mammary epithelium. This is of particular interest because the majority of the
development of this tissue occurs in adulthood (during gestation), and indeed, Grb10
transcription is not activated until this stage. The traditional view of imprinted genes,
centred around the parental conflict hypothesis, proposes that imprinting is only important
during development (or more specifically, from fertilisation to weaning). This does not
make imprinted genes redundant in adulthood, but simply implies their imprinting status is
no longer relevant. That Grb10 is silenced on the paternally‐inherited chromosome in the
mammary tissue may arise from the fact that imprinting is already established in other
peripheral tissues. In other words, the differential methylation and histone modification
patterns which distinguish the maternal and paternal chromosomes are already laid down
in mammary epithelial cells, so during gestation, the cells, requiring Grb10 protein, simply
activate the allele with permissive epigenetic marks.
A counter‐argument is that the Grb10 imprint is quite amenable to manipulation during
development. Expression in the developing heart at e8.0 appears to be biallelic (Chapter
Three). The paternal contribution is still detectable at e14.5 in the right ventricle, but
expression from the maternally‐inherited chromosome is ubiquitous in the heart at this
stage, suggesting a combination of both biallelic and monoallelic expression in one organ
(Garfield, 2007). If the imprinting status of Grb10 is not important in the adult mammary
gland, why not prepare the developing mammary mesenchyme for future biallelic
expression?
The discovery of the influence of genomic imprinting on maternal care behaviours was
originally attributed to the parental conflict hypothesis. A classic example is that of Peg3, in
which mutation impaired maternal behaviour, often resulting in neonatal lethality (Li et al,
1999). However, the conflict hypothesis is an inadequate explanation for this observation.
The Peg3 mutation, inherited through the paternal line, would influence the maternal
behaviours of the daughters, not the current mate. As such, the benefits of any paternally‐
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expressed Peg3 would be realised by the subsequent generation, but grandparental effects
are inconsistent with the hypothesis: an allele transmitted from father to daughter is as
likely to be transmitted to the daughter’s offspring (the ‘grandchildren’) as an allele
transmitted from her mother (Hurst et al, 2000). In this respect, imprinting in the
mammary gland, if it were to affect the development of suckling offspring, engenders
similar arguments to that proposed for the brain. In summary, the parental conflict
hypothesis is inadequate to explain our observation.
An alternative hypothesis, which can partially account for the influence of imprinting on
maternal behaviours, and thus, by extrapolation, might also apply to the influence on
mammary gland function, is the maternal‐offspring coadaptation theory (Wolf and Hager,
2006). There is much evidence that selection has favoured the fixation of complementary
maternal and offspring traits, which positively affect offspring development. This is not
restricted to in utero. A correlation between offspring begging behaviour and maternal
response was recorded in great tits, for example (Kölliker et al, 2000). This model describes
how genomic imprinting is favoured when a gene influences coadaptive traits in mother
and offspring. This might fit the expression of Grb10 from the maternally‐inherited
chromosome in the mammary gland. This will be discussed further in the light of data
demonstrating the function of Grb10 in this tissue, the subject of Chapter Six.
Finally, it is important to note that the Stat5‐induced transcription of Grb10 is independent
of the Grb10 imprinting status. The observation that CRM1 is active in the developing CNS
caused us to question if Stat5 might form part of the mechanism responsible for achieving
expression from the paternally‐derived allele, whilst expression was predominantly from
the maternally‐inherited copy in most other tissues. However, the discovery of its influence
in the mammary epithelium and placental labyrinth, where Grb10 is expressed from the
maternally‐derived alleles and from both alleles, respectively, argued against this role.
Instead, Stat5 simply interacts with whichever allele is active. This independence is
supported by the conservation of the Stat5 binding site in the chicken Grb10 locus, which is
not subject to imprinting.
A working model to explain the regulation of transcription from the Grb10KO and Grb10Δ2‐
4 alleles in the brain is presented in Figure 5.14, and explains the reduced levels of  β‐
galactosidase activity observed in some tissues following inheritance of Grb10Δ2‐4. The
figure shows the influence of Stat5 determined in the present study in the context of
differential methylation and promoter usage, established previously (Arnaud et al, 2003;
Sanz et al, 2008). Putative CTCF binding sites reside within the brain‐specific DMR (CGI3),
and CTCF is reported to bind in a methylation‐sensitive manner (Hikichi et al, 2003).
However, the influence of CTCF on transcription is not addressed in this model, as binding
has not been demonstrated in the brain. Whilst the model describes the situation in the
CNS, in which transcription is from the paternally‐inherited allele, it is equally applicable to
expression from the other allele, or both alleles, in the mammary gland and placenta,
although the initiation exons may differ.
The evidence that Stat5 regulates Grb10 transcription in a tissue‐specific manner is strong,
and includes a range of data from in silico, in vivo and in vitro experiments, as well as data
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from an independent study. The physiological significance of this interaction is the subject
of the next Chapter.
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Investigating the function of Grb10 in the
adult mouse mammary gland
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6.1 Introduction
The mammary gland is an unusual organ because much of its development occurs during
adulthood, in response to pregnancy. Like the placenta, it is specific to mammals, including
eutherians and marsupials, but not monotremes. Its primary function is the provision of
nutrients to suckling offspring, although in addition to milk proteins, immune factors are
also secreted, providing offspring with assistance in overcoming infections. At birth, the
sterile human foetal intestine is rapidly colonised by bacteria, many of which secrete
endotoxins which may be detrimental to neonatal health. The neonatal adaptive immune
system is relatively immature to cope with such challenges. Factors secreted in breast milk
have been shown to stimulate neonatal release of inflammatory cytokines and chemokines,
thus priming the immature immune system (Vidal et al, 2001). Indeed, breast‐fed infants
display a lower incidence of gastro‐intestinal diseases than those bottle‐fed from birth
(Howie et al, 1990). Additionally, suckling promotes mother‐offspring bonding, which may
have other developmental benefits, such as promoting learning, particularly in higher
mammals (Peaker, 2002). However, such benefits may not be directly attributed to
suckling, but simply a consequence of the extended nurture period typical of higher
mammals.
Mammary gland development is characterised by three main stages: embryonic, pubertal
and adult. This is true for both mice and humans, and whilst many of the molecular
processes are very similar, there are some key differences, such as the number of glands
developing. Two milk lines develop in the mouse embryo at e10.5, running bi‐laterally
along the anterior‐posterior axis, from the forelimb to hindlimb. These are ectodermal in
origin and are essentially multi‐layered ridges, along which ectodermal cells migrate,
congregate and grow into the underlying mesenchyme, forming the mammary placodes.
Five such placodes, which are bulb‐shaped buds, occur along each of the milk lines, and
appear in a reproducible pattern: bud pair 3 (thoracic), pair 4 (abdominal), then pairs 1 and
5 together (cervical and inguinal, respectively), and finally pair 2 (upper thoracic) (Veltmaat
et al, 2003), although this order is disputed (Eblaghie et al, 2004). Their positions are
determined by local factors, and as such, the development of each pair is independently
regulated. Mice deficient for Fgf10, or its receptor Fgfr2b, lose all bud pairs except pair 4
(Mailleux et al, 2002). Tbx3 deficient mice often lose all bud pairs, although pair 2 is
occasionally retained (Eblaghie et al, 2004). Further evidence for the importance of
paracrine signalling includes the competency of mammary epithelium to develop into a
salivary gland‐like structure, if recombined with salivary gland mesenchyme and
transplanted (Sakakura et al, 1976). However, despite producing a structure reminiscent of
a salivary gland, the recombined and transplanted mammary epithelium still retained its
ability to respond to pituitary prolactin, suggesting signals from the mesenchyme
influenced the branching pattern but not the differentiation of the epithelium. In contrast,
embryonic skin epithelium isolated at e12.5 will form milk‐producing mammary glands if
combined with mammary mesenchyme and transplanted (Cunha et al, 1995). The
instructive nature of the mammary mesenchyme is perhaps best illustrated by the
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differentiation of chick and duck epidermis, which normally form feathers, to become
branched mammary tissue when recombined with rabbit mammary mesenchyme (Propper
and Gomot, 1973). Embryonic mammary gland development also appears to be
independent of the hormonal stimuli required for pubertal and adult development, as the
ablation of the receptors for oestrogen, progesterone, growth hormone (GH) or prolactin
(PRL) appear to have no effect (Sternlicht et al, 2006).
Distinct epithelial buds are apparent at e13.5. Until this point, bud development has
proceeded identically in male and female mice, but androgen receptors are activated in
male buds, causing them to degenerate (Kratochwil and Schwartz, 1976). As a
consequence, adult male mice do not possess mammary glands, unlike the situation in
humans. At around e15.5, the epithelial buds of female mouse embryos secrete
parathyroid hormone‐related protein (PTHrP), which sensitises surrounding mesenchymal
cells to the autocrine factor bone morphogenetic protein (BMP)4. This promotes epithelial
outgrowth into the mammary fat pad precursor, and suppresses hair follicle formation
(Hens et al, 2007). Such mammary sprouts, as they are termed, produce small tree‐like
structures which spread through the fat pad precursor, bearing between 10 and 15 small
branches. This process is stochastic, such that two pair 4 glands isolated from different
individuals will show different patterns of branching (Sternlicht et al, 2006). At e18.5, gland
development is arrested until puberty, although allometric growth persists.
In humans, a single pair of mammary placodes form, which become apparent within the
first trimester of pregnancy. The structure is also somewhat different, with several
rudimentary trees converging at the nipple, rather than the single tree observed in mice.
Foetal exposure to maternal hormones causes increased branching relative to that which
might be expected, such that at birth, human breasts are competent to secrete milk. Once
outside of the womb, such stimulus is removed, triggering a phase of gland involution. This
is followed by an allometric growth phase similar to that observed for mice.
During puberty, circulating oestrogen levels rise, promoting the development of terminal
end buds (TEBs) at the duct tips. These proliferate and invade further into the mammary fat
pad. Proliferation is coupled to bifurcation, such that TEBs generate new ductal branches.
In mice, ablation of the gene encoding oestrogen receptor  α (ERα) causes failure of TEB
development and a consequential failure of invasion into the mammary fat pad (Mallepell
et al, 2006). During pubertal development, lumen are formed by apoptosis of epithelial
cells (Humphreys et al, 1996). Further side branches form with each ovarian stimulation,
such that the mammary glands of older virgin females are more developed than those of
younger females.
Growth hormone is also required for correct pubertal mammary gland development, as
demonstrated in mice deficient for the growth hormone receptor (GHR; Gallego et al,
2001). Exogenous Igf1 can rescue hypophysectomised mice (which lack a pituitary gland),
suggesting that expression of this gene is downstream of GH signalling (Kleinberg et al,
2000). Evidence for the importance of local, rather than systemic IGF1, comes from the
observation of normal mammary gland branching in mice with a liver‐specific deletion of
Igf1, which reduces circulating levels by ~75 % (Richards et al, 2004). Glands deficient for
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the Igf1 receptor (Igf1r) transplanted into wild type fat pads exhibit impaired development
(Bonnette and Hadsell, 2001), suggesting that Igf1r is required in epithelial cells, whereas
GHR is specifically required in the stroma (Gallego et al, 2001). Together, this implies that
GH secreted from the pituitary gland drives Igf1 expression in the stroma, which signals to
adjacent epithelial cells, further highlighting the intimate relationship between epithelium
and stroma (Sternlicht et al, 2006).
During pregnancy, further morphological changes occur in the mammary gland to prepare
for lactation. These are ultimately stimulated by the developing placenta, which secretes
hormones such as placental lactogens into the maternal blood circulation, as discussed in
Chapter Four. Imprinted genes have been implicated in this system; mouse placentae
deficient for the paternally‐expressed gene Peg3 fail to stimulate increased maternal
feeding and weight gain, even when the pregnant females are themselves wild type (Curley
et al, 2004). Prolactin secreted from the rat decidua promotes progesterone secretion by
the corpus luteum. This hormone promotes maternal weight gain (Grueso et al, 2001),
suggesting Peg3 might be implicated in this system. Another key role of progesterone is to
induce extensive side‐branching of the rudimentary epithelial tree in the mammary gland.
This is mediated through canonical Wnt signalling (Hiremath et al, 2007). In combination
with PRL, progesterone promotes the differentiation of epithelial cells to alveoli, the
structures responsible for synthesising and secreting milk proteins. Both progesterone and
prolactin receptors (PRLR) are required for successful pregnancy‐induced branching
morphogenesis (Ormandy et al, 1997; Brisken et al, 1998). It would be interesting to
examine the mammary glands of wild type females carrying Peg3mutant offspring, to see if
this process is also perturbed.
The PRLR on mammary epithelial cells is activated by both PRL and placental lactogens.
Upon ligand binding, the receptor activates the Jak2‐Stat5 signalling cascade, driving the
differentiation of alveoli and the expression of milk protein genes. Both β‐casein (Happ and
Groner, 1993; Wakao et al, 1994) and whey acidic protein (WAP; Li and Rosen, 1995) are
direct transcriptional targets of Stat5. Stat5a‐/‐ mice exhibit curtailed lobuloalveolar
outgrowth during pregnancy, and a failure to lactate (Liu et al, 1997). Stat5b‐/‐ mice display
a less dramatic mammary gland development phenotype, and although the relevant milk
proteins genes are expressed, milk volume is reduced (Udy et al, 1997). Compound
mutants show a more dramatic phenotype than either of the single mutants, suggesting
some functional redundancy (Teglund et al, 1998). Recently, the ETS family transcription
factor Elf5 has been revealed as a critical downstream effector of PRL signalling (Harris et
al, 2006; Choi et al, 2009). Although the homozygous Elf5‐/‐ mice exhibit embryonic
lethality, the phenotype of Elf5+/‐ mice is very similar to that of Prlr+/‐ animals, which display
haploinsufficiency and cannot successfully raise litters (Ormandy et al, 1997). Transgenic
expression of Elf5 in Prlr‐/‐ mice rescued mammary gland development and even milk
protein expression (Harris et al, 2006). Intriguingly, this was due to the promotion of Stat5a
expression, which is a downstream target of Elf5. It is not clear whether Elf5 expression
itself is activated by Stat5a, or if PRL signalling may also be mediated by a Stat5a‐
independent mechanism.
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Stat5 signalling is controlled by a negative feedback loop involving Suppressor of cytokine
signalling (Socs) proteins, the expression of which are induced by Stat5a (Harris et al, 2006).
Socs proteins, predominantly Socs1 and Socs3, bind to the PRLR and Jak2 via a central SH2
domain, and inhibit kinase activity (Hennighausen and Robinson, 2008). Caveolin‐1, a
membrane‐bound protein, also interacts with Jak2 and acts as an inhibitor of PRL signalling;
Caveolin‐1 deficiency causes elevated Stat5a levels in the mammary glands and premature
lactation during pregnancy (Park et al, 2002).
Whilst hormone release from the placenta prepares the mammary gland for lactation, such
that milk is being synthesised and secreted by the time of parturition, pituitary PRL
becomes the key determinant of milk output after birth. This, in turn, is controlled by a
milieu of factors, both environmental and reproductive. Stress, for example, will suppress
PRL secretion, as will light, causing PRL release to occur with a circadian rhythm (reviewed
in Freeman et al, 2000). Both mating and suckling promote release. All such inputs are
transduced by the hypothalamus, which secretes a range of both prolactin‐releasing factors
(PRFs) and prolactin‐inhibiting factors (PIFs). These act directly on the PRL secreting
lactotroph cells, situated in the anterior pituitary gland. Lactotrophs typically have high
spontaneous secretory activity, and thus the regulation exerted by the hypothalamus is
predominantly inhibitory (Freeman et al, 2000). Dopamine is a tonic inhibitor of PRL
secretion, and is synthesised and released by a subset of dopaminergic neurons referred to
as tuberoinfundibular (TIDA) neurons, located in the arcuate nucleus. Dopamine enters the
hypophyseal long portal vessels and is transported to the anterior pituitary. Lactotrophs in
the pituitary express the D2 subclass of dopamine receptors (Caron et al, 1978), and
suppress PRL secretion in response to ligand‐induced receptor activation. Dopamine
receptor‐blocking agents, such as haloperidol, can rescue PRL release in dopamine‐treated
pituitary glands ex vivo (MacLeod and Lehmeyer, 1974). Suckling suppresses dopamine
release from the TIDA neurons, removing the inhibition on lactotrophs and thus promoting
PRL synthesis (Callahan et al, 1996).
At weaning, the mammary gland undergoes dramatic remodelling, in which epithelial cells
apoptose and the gland regresses to a near‐pre‐pregnant state. Involution, as this
remodelling is termed, is a two‐step process. The first phase, lasting approximately 48
hours, is characterised by a down‐regulation in the transcription of Stat5‐dependent
survival factors. This is mediated by local signals. The accumulation of milk in the ducts of
the glands feeds back to suppress further milk production. The key signalling molecule in
this system is serotonin (5‐hydroxytryptamine; 5‐HT). Levels of tryptophan hydroxylase
(TPH1), the rate‐limiting enzyme for 5‐HT synthesis, increase during lactation (Matsuda et
al, 2004). This was shown to directly correlate with levels of 5‐HT, which is present in both
epithelial cells and milk (Stull et al, 2007). The negative influence of 5‐HT on the production
of milk proteins was demonstrated in primary explant cultures, in which exogenous 5‐HT
suppressed the expression of genes such as β‐casein in a dose‐dependent manner, even in
the presence of PRL (Matsuda et al, 2004). Although initial experiments suggested that
Tph1 expression was PRL‐dependent, further investigation revealed that expression is
driven by milk stasis (Pai and Horseman, 2008).
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Phase I is characterised not only by this suppression of Stat5‐mediated signalling, but the
associated switch to Stat3‐mediated gene expression. Stat3 is activated by the cytokine
leukaemia inhibitory factor (LIF; Kritikou et al, 2003), and translocates to the nucleus to
promote the expression of death‐  or remodelling‐related genes (Clarkson et al, 2006).
Other indirect gene targets include those which are antagonistic to growth‐promoting
pathways. For example, Stat3 activates C/ebpδ expression, encoding a transcription factor
which in turn induces the expression of Igfbp5, encoding the insulin‐like growth factor
binding protein 5 (Hutt et al, 2000). This molecule binds to and suppresses the activity of
Igf1, antagonising the growth‐promoting effects of this pathway (Ning et al, 2007). Other
Stat3 targets reinforce the involution pathway: transforming growth factor (TGF)  β3, for
example, is induced within a few hours of a forced‐wean, and promotes phosphorylation,
and subsequent activation, of Stat3 (Nguyen and Pollard, 2000). The involution switch is
rapid; LIF transcription increases 30‐fold within 12 hours of a forced‐wean (Kritikou et al,
2003). Lif is itself expressed from the mammary gland, and thus is an autocrine or paracrine
regulator, but the mechanism for the induction of Lif expression is not clear. During
embryonic development, Lif is probably controlled by oestrogen or progesterone (Kritikou
et al, 2003) but these are unlikely activators of mammary gland expression. It is conceivable
that the accumulation of 5‐HT is responsible for inducing Lif, but a causal link has not yet
been found.
Epithelial cell apoptosis in the mammary gland is in part triggered by the upregulation of
negative regulatory subunits of PI(3) kinase, which are direct transcriptional targets of
Stat3. This diminishes levels of phosphorylated AKT, a serine/threonine kinase, which
during lactation provides an over‐riding survival signal (Schwertfeger et al, 2001; Watson,
2006).
Whilst phase I is characterised by the highest number of terminal deoxynucleotidyl
transferase dUTP nick‐end labelling (TUNEL)‐positive cells, indicative of apoptosis, the
process remains reversible. The reintroduction of a suckling stimulus will rescue milk
protein production, by promoting pituitary PRL release and clearing 5‐HT which has
accumulated in static milk. Phase II of involution, initiated about 48 hours after a forced‐
wean, is, however, irreversible. This phase is marked by extensive tissue remodelling. The
lobuloalveolar structures collapse and epithelial cell positions are reoccupied by
adipocytes. Matrix metalloproteases (MMPs) are key to this process. Expressed by the
stroma, they breakdown the extracellular matrix (ECM), which reinforces epithelial cell
apoptosis (Pullan et al, 1996). The huge volume of cell debris produced in such a short
period of time as a consequence of apoptosis is dealt with by both professional and non‐
professional phagocytes, including mammary epithelial cells themselves (Monks et al,
2005). Such cells migrate to the involuting mammary gland in response to inflammatory
mediators, such as Growth‐related oncogene 1, a neutrophil‐attracting chemokine,
secreted early in phase I (Stein et al, 2004).
The observation that Grb10 is expressed in a pregnancy‐dependent manner in the adult
mammary gland, probably under the control of PRL‐Stat5, caused us to investigate its
associated function. The retention of the Grb10 imprint in this tissue was also intriguing, as,
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to our knowledge, this was a precedent. Despite no apparent gross morphological defects
in Grb10KOm/+ mammary glands, our investigations revealed that the gene promotes
mammary gland function, consistent with the idea that PRL/Stat5‐dependent genes are
‘survival factors’ in this tissue. Moreover, Grb10 expressed from the maternally‐inherited
chromosome mediated a supply/demand system between lactating mother and suckling
pup. This finding may have implications for understanding the evolution of genomic
imprinting.
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6.2 Results
6.2.1 Grb10 ablation does not engender gross morphological changes in the adult
mammary gland
To address the function of Grb10 in the adult mammary gland, we first examined the gross
morphology of fourth (abdominal) glands isolated from wild type, Grb10KOm/+ and
Grb10KO+/p females, during gestation and lactation. Glands were stained with carmine alum
for visualisation of ductal branching (Figure 6.1). The glands of virgin females were not
examined as Grb10 is expressed in a pregnancy‐dependent manner in this organ (Figure
5.13).
At gestational day 7.5 (G7.5), the mammary glands of all genotypes consisted of a
rudimentary ductal tree (Figure 6.1), which occupied a small proportion of the total
mammary fat pad (not shown). Terminal end buds (TEBs), with their characteristic
bifurcating structure, were observed at the ends of the ducts. These had penetrated
further into the fat pad by G12.5 and generated new primary ducts by bifurcation.
Secondary ductal branches were also visible sprouting laterally from the primary ducts.
Mammary glands isolated from lactating females (postnatal day 6; P6) consisted of dense
clusters of alveolar structures, the staining of which obscured the visualisation of ducts. At
this stage, glands occupied a large proportion of the associated mammary fat pad (not
shown). No morphological differences were observed at this resolution between glands of
any genotype at the stages examined.
Morphological characterisation was extended by quantifying the number of branch points
within a fixed window at G12.5, as described in Section 2.5.2. Only wild type and
Grb10KOm/+ glands were analysed in this manner, as Grb10 is expressed from the
maternally‐inherited chromosome in this organ, and thus a morphological difference was
not expected between Grb10KO+/p and wild type glands. No significant difference in the
number of branch points was observed between the wild type and Grb10KOm/+ glands
examined (Figure 6.2a). Similarly, the distance between the lymph node and the leading
edge was not significantly different between glands of the two genotypes (Figure 6.2b).
6.2.2 Pilot study: assessment of mammary gland morphology by Optical Projection
Tomography (OPT)
Whilst wholemount and histological analyses of mammary glands are invaluable in
examining tissue morphology, they are typically limited to an assessment in two
dimensions (2D). It can, therefore, be difficult to extrapolate this information to comment
on the three‐dimensional (3D) structure of a mammary gland. This could be useful in
addressing the total volume of ductal branches, for example, rather than inferring this from
measurements of length or number of branch points.
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To address this shortcoming, wild type mammary glands isolated at G12.5 were prepared
for Optical Projection Tomography scanning. We wished to determine if this technique
offered a suitable method for 3D mammary gland assessment. 400 2D scans of each gland
were performed; a representative scan is shown in Figure 6.2c. Primary and secondary
branches, as well as TEBs, are visible in this scan. Computer software stacked these 2D
scans to produce a 3D reconstruction of the organ, which could be manipulated on screen
to permit viewing from any angle. It was difficult to distinguish between branches and TEBs
in these reconstructions, or indeed to identify the extent of individual primary ducts (Figure
6.2d). The denser network of branches closer to the lymph node observed from the 2D scan
was apparent from the reconstruction. Viewing the reconstruction at a higher
magnification emphasised the difficulty in distinguishing specific structures, and revealed a
considerable level of noise, in which background staining had been misinterpreted as part
of the gland structure (Figure 6.2e).
6.2.3 Grb10 mediates a supply/demand system between suckling pup and lactating
mother
Work described in Chapter Five identified a likely candidate site for the binding of the
transcription factor Stat5 at the Grb10 locus. Binding of Stat5 appeared to be necessary for
the expression of Grb10 in the adult mammary gland (Figure 5.13), supporting a previous
study identifying Grb10 as a highly likely transcriptional target of Stat5 in mammary
epithelial cell cultures, a probable response to prolactin binding to cell surface receptors
(Clarkson et al, 2006). This is further supported by the observation that Grb10 is expressed
in a pregnancy‐dependent manner in the mammary gland. Further characterisation of
Grb10KOm/+ mammary glands therefore focussed on the identification of a phenotype
which might be associated with a perturbation of prolactin action. As pup growth during
the neonatal period is correlated with mammary gland function, we tracked the growth of
individual pups in litters suckled by wild type and Grb10KOm/+ females.
Cross‐fostering experiments enable the independent phenotypic examination of mother and
pup genotypes
Wild type females were mated with wild type males to produce pure wild type litters
(Figure 6.3a(i)). Grb10KOm/+ females were also mated with wild type males, producing
mixed litters of both wild type and Grb10KOm/+ offspring (Figure 6.3a(ii)). All females were 7
weeks of age at mating, and were previously virgins. Litters were normalised to between 5
and 7 pups on the day of birth. Pups were tattooed on the pads of their paws according to
a devised scheme, such that the growth of individual pups could be tracked from the day of
birth, and pups posthumously genotyped (Figure 6.5a).
Whilst it was possible from these crosses to compare the growth of wild type pups born to
a wild type mother with wild type pups born to a Grb10KOm/+ mother, those born to a
Grb10KOm/+ mother also had Grb10KOm/+ siblings. These transgenic animals are larger than
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their wild type sibs on the day of birth (Figure 4.4d and f), and thus might have indirectly
influenced the growth of wild type animals in the same litter, by outcompeting them for
access to a nipple, for example. To differentiate between the influence of maternal and
offspring genotype on pup growth, we devised a cross‐fostering strategy, outlined below.
As before, all females were 7 weeks of age at mating, and were previously virgins.
Some Grb10KOm/+ females, having given birth to both wild type and Grb10KOm/+ pups (a
‘mixed litter’), were permitted to raise their own biological offspring (Figure 6.3b(ii)). Other
Grb10KOm/+ females had their biological offspring removed on the day of birth and replaced
with pure wild type litters (Figure 6.3b(v)). The reciprocal was also performed, such that
some wild type females raised mixed litters (Figure 6.3b(iv)). To control for the process of
cross‐fostering, ensuring that this in itself did not influence pup growth, some wild type
females were permitted to raise their own biological offspring, whilst other wild type
females were given pure wild type litters from a separate mating (Figure 6.3b(i) and (iii)).
No differences in the neonatal growth of male and female pups
To determine if it was necessary to separate datasets according to pup gender, the weights
of male and female pups raised by their biological mothers were compared on the day of
birth (postnatal day 1), and at postnatal days 8 and 15. Male and female pups born to wild
type mothers displayed a similar range of weight values at all time points examined, with
no statistically significant differences in mean weight, as assessed by Students’ T‐test
(Figure 6.4). This was also the case for male and female wild type pups born to Grb10KOm/+
mothers, and male and female Grb10KOm/+ pups.
The lack of apparent difference in weight between male and female pups, both wild type
and transgenic, permitted the consolidation of data from separate genders, creating larger
sample sizes and more robust statistical comparisons.
The process of cross‐fostering does not influence pup growth
To eliminate the process of cross‐fostering as a parameter influencing postnatal pup
growth, the weights of wild type pups born to and raised by their biological wild type
mothers were compared with the weights of wild type pups cross‐fostered to non‐
biological wild type mothers (Figure 6.3b(i) and (iii)). No difference between the two
datasets was observed on the day of birth, the day after cross‐fostering (day 2) or after 15
days of suckling (Figure 6.5b), as assessed by Students’ T‐test. The growth trajectories of
the two datasets in the interim period were also very similar (data not shown). Finally, the
two datasets were compared at postnatal days 1, 8 and 15 alongside other datasets using
one‐way analysis of variance (ANOVA). No significant differences were observed at any of
the time points (Table 6.1). Together, these results confirmed that the process of cross‐
fostering itself did not affect postnatal pup growth.
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Grb10KOm/+ pups display an increased demand for nutrients
To examine growth differences in a quantitative manner, the weights of pups in each
dataset were compared at postnatal days 1, 8 and 15 by one‐way ANOVA. The results of
these comparisons are presented in Table 6.1 and can be correlated with bar graphs in
Figure 6.6. The growth trajectories of selected datasets are shown in Figure 6.5c. To aid the
reader, each dataset has been assigned a colour code, which corresponds to the coloured
boxes in Table 6.1, and the coloured lines and bars of Figures 6.5c and 6.6.
The weights of wild type pups in a pure litter (red) were indistinguishable from those of
wild type pups in a mixed litter (black) on the day of birth. When both groups were suckled
by wild type foster mothers, there was a trend towards an increased weight among wild
type pups in a mixed litter at day 8. The difference became statistically significant at day 15.
This effect was also observed when the suckling mother was transgenic. Again, wild type
pups in a mixed litter (purple) grew at a faster rate than those in a pure wild type litter
(brown). The effect was again not revealed until day 15, although there was a trend in this
direction at day 8.
These observations suggested that the presence of Grb10KOm/+ pups in a litter benefitted
wild type sibs, implying that the larger Grb10KOm/+ pups displayed an increased demand for
maternal nutrients.
Grb10KOm/+ mothers display an impaired ability to supply nutrients
To deduce more about the influence of the suckling mother’s genotype, wild type pups in a
pure wild type litter were raised by wild type (red) and Grb10KOm/+ (brown) mothers. Whilst
these were indistinguishable on the day of birth, by day 8 there was a trend towards
increased weight in the group raised by wild type mothers, which was significant on day 15
by one‐way ANOVA. This implied that Grb10KOm/+ mothers supplied less nutrients to
suckling pups than wild type control mothers.
Grb10KOm/+ mothers display an impaired response to high nutrient demand
Grb10KOm/+ pups were larger than their wild type sibs on the day of birth, but when suckled
by a Grb10KOm/+ mother (green), normalised to wild type sibling weight by day 8 (purple).
By one‐way ANOVA, these Grb10KOm/+ pups were also indistinguishable from wild type
pups in a pure litter raised by wild type mothers at days 8 and 15 (red). This normalisation
was not observed when mixed litters were raised by wild type mothers (black and blue).
Indeed, Grb10KOm/+ pups raised by wild type mothers (blue) were considerably larger at
day 15 than Grb10KOm/+ pups raised by their biological mothers (green). This suggested
that whilst wild type mothers responded well to an increase in demand, Grb10KOm/+
mothers responded relatively poorly. However, their response was not abolished entirely
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as wild type pups in a mixed litter raised by a Grb10KOm/+ mother (purple) still grew at a
faster rate than wild type pups in a pure litter raised by a Grb10KOm/+ mother (brown).
The benefits to a wild type pup of having Grb10KOm/+ siblings are offset by suckling from a
Grb10KOm/+ mother
Wild type pups in a mixed litter raised by a Grb10KOm/+ mother (purple) had a very similar
growth profile to wild type pups in a pure wild type litter raised by a wild type mother
(red). This suggested that the benefit to a wild type pup of having transgenic siblings, which
demand more nutrients, is offset by suckling from a transgenic mother, who is a relatively
poor supplier of nutrients.
6.2.4 Milk quality is not the molecular basis for the observed differences in maternal
provisioning
To address the mechanistic basis for reduced nutrient supply from Grb10KOm/+ females,
and increased response to high demand in wild type females, milk was isolated from some
of the mothers raising cross‐fostered litters (Figure 6.7a and b).
First, the proportion of fat in the milk was assessed. For all datasets examined, the mean
fat content was between 23 and 26 %, with no significant differences observed between
any of the genotypes (assessed by one‐way ANOVA; Figure 6.7c).
Following the removal of fat, milk protein content was analysed by sodium dodecyl
sulphate (SDS) polyacrylamide gel electrophoresis (PAGE; Figure 6.7d). Key milk proteins,
including albumin, whey acidic protein (WAP) and  α‐ and  β‐caseins, were detected in all
samples, as well as other protein species observed in previous analyses but not identified
(Kumar et al, 1994; Hurley, 2009, Milk composition and synthesis resource library,
http://classes.ansci.illinois.edu/ansc438/Milkcompsynth/milkcompsynthresources.html).
Equal volumes of milk protein were loaded for each sample, to permit a direct comparison
of protein content. Although there was some variation in relative total protein levels
between individuals, this did not correlate with genotype.
Together, this data suggested that milk quality was probably not the basis for reduced
provisioning of Grb10KOm/+ females, or for increased provisioning of wild type females
when suckling mixed litters, although subtle differences in milk quality cannot be excluded
as part of the mechanism.
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6.2.5 Grb10KOm/+ lactating females display elevated pituitary Prolactin expression
Although differences in milk quality did not appear to be the basis for the reduced
provisioning of Grb10KOm/+ mothers, we examined whether expression of Prolactin in the
pituitary glands might be perturbed. Poor nutrient suppliers might be expected to display
reduced levels of Prolactin expression.
At the end of the experimental period (i.e. on postnatal day 15), mothers were dissected
and total RNA extracted from pituitary glands for examination by quantitative real‐time
PCR (qPCR). The levels of Prolactin and Growth hormone transcripts were assessed. Figure
6.8 shows expression levels of these two genes normalised to the levels of Actin, a house‐
keeping gene.
Grb10KOm/+ females exhibited elevated pituitary Prolactin expression relative to wild type
control females, when both groups were suckling pure wild type litters (Figure 6.8a). This
was statistically significant when assessed by the Kruskal‐Wallis test. This was contrary to
our original hypothesis, and demonstrated that reduced pituitary Prolactin expression was
not the basis for poor provisioning among Grb10KOm/+ mothers.
Additionally, Prolactin expression in wild type mothers was unaffected by the genotype of
fostered pups, with no significant differences observed between wild type mothers raising
wild type pups and those raising mixed litters. The expression of Growth hormone did not
differ significantly between any of the groups examined (Figure 6.8b).
6.2.6 Grb10KOm/+mammary glands exhibit a trend towards more rapid involution
In the mammary epithelium, genes activated in response to prolactin, through Stat5, are
predicted to play positive roles in the function of the mammary gland, either by promoting
gland differentiation or branching, or by promoting milk protein synthesis or release
(Clarkson et al, 2006). In this manner, Stat5 and its downstream ‘survival factors’ protect
against Stat3‐mediated apoptosis; over‐expression of Stat5a in vivo delays involution
(Iavnilovitch et al, 2002). As Grb10 appeared to promote mammary gland function, and
might thus be classified as a ‘survival factor’, we addressed whether Grb10KOm/+ glands
exhibited more rapid involution.
To address this possibility, glands were isolated from age‐matched and litter size‐matched
females 48 hours after a forced‐wean. This time point corresponded with the transition
from the reversible phase I to irreversible phase II of involution. Glands were sectioned and
fragmented nuclei, indicative of apoptosing cells, identified by terminal deoxynucleotidyl
transferase dUTP nick‐end labelling (TUNEL). Figure 6.9b shows an illustrative wild type
gland section subjected to TUNEL and subsequently counter‐stained with methyl green.
Epithelial cells were easily identifiable by their relatively small size when compared with
stromal cells. A sub‐population of epithelial cells were TUNEL‐positive. Randomly‐selected
sections from five wild type and five Grb10KOm/+ glands were assessed for TUNEL‐positive
nuclei in a quantitative manner. Representative images for this quantification are shown in
166
Prolactin
Re
la
tiv
e
ex
pr
es
si
on
Growth hormone
Re
la
tiv
e
ex
pr
es
si
on
*
167
Wild type Grb10KOm/+
TUNEL‐positive cells
48 hours after forced wean
st
du
ep
b
a
Wild typec
Grb10KOm/+d
168
Chapter Six 
Figure 6.9c and d. The assessment was performed ‘blind’ without knowledge of the
corresponding genotypes. No significant difference was observed between wild type and
Grb10KOm/+ glands, when TUNEL‐positive cells were considered as a proportion of the total
number of cells counted (Figure 6.9a). However, Grb10KOm/+ glands did exhibit a trend
towards a larger proportion of TUNEL‐positive nuclei, consistent with the hypothesis of
Grb10 as a Stat5‐dependent mammary gland survival factor.
169
Chapter Six 
6.3 Discussion
Work described in Chapter Five revealed a probable Stat5 binding site at the Grb10 locus.
This supported the results of another study identifying Grb10 as a likely target of this
transcription factor, downstream of prolactin receptor activation (Clarkson et al, 2006). The
presence of the Stat5 binding site appeared to be necessary for the in vivo expression of a
LacZ transgene knocked‐in to the Grb10 locus, in mammary epithelial cells (Figure 5.13).
The current study also revealed that the expression of Grb10 in this tissue is pregnancy‐
dependent, providing support for the hypothesis that Grb10 expression is activated in
response to prolactin through Stat5. Typically, genes activated via this pathway are
proposed to promote mammary gland function, and are therefore termed ‘survival factors’.
Aside from this general hypothesis, nothing was previously known of the role of Grb10 in
the mammary gland. We thus characterised the effect of Grb10 ablation on gland structure
and function, with a view to finding evidence of perturbation of prolactin action. Whilst no
obvious changes to mammary gland development or growth were observed, the present
study revealed that Grb10KOm/+ females were less capable of supplying nutrients to
suckling offspring, consistent with a role for Grb10 as a promoter of prolactin action in the
mammary gland. However, the study also revealed an unexpected result: that Grb10
mediates a system of supply and demand between lactating mother and suckling pup.
Comparable mammary glands from wild type, Grb10KOm/+ and Grb10KO+/p females were
isolated at early‐  and mid‐gestation, and during lactation. These were fixed and stained
with carmine alum. The epithelial cell proliferation and invasion of the mammary fat pad
observed for wild type glands were consistent with previous descriptions (Hennighausen,
Biology of the Mammary Gland, http://mammary.nih.gov/index.html). Glands isolated from
Grb10KOm/+ and Grb10KO+/p females did not obviously differ in their morphology to wild
type controls. No difference was expected in Grb10KO+/p glands as Grb10 transcription is
exclusively from the maternally‐inherited chromosome in this tissue (Figure 5.13), and thus
Grb10KO+/p glands still retain functional Grb10 protein. If Grb10 is a prolactin/Stat5‐
dependent survival factor, ablation of Grb10 in this tissue might be expected to perturb
branching morphogenesis, but this was not observed. Although the Stat5 proteins have
many transcriptional targets (Basham et al, 2008), and thus the absence of Grb10 alone is
unlikely to result in such a dramatic phenotype as the compound Stat5a/b ablation, a more
subtle effect may have been predicted.
The absence of a gross morphological defect was supported by quantitative measurements.
Grb10 ablation did not significantly alter the number of branch points within a fixed area,
implying that epithelial cell proliferation was not affected. Similarly, the distance from the
lymph node to the leading edge did not change, although such a measurement may be
expected to remain quite constant between individuals, unless their body size proportions
are dramatically altered. Whilst Grb10KOm/+ animals are larger than their littermates in late
gestation and early neonatal stages, this overgrowth normalises to that of wild type
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controls within a few days (provided the pups are nurtured by their biological mothers;
discussed later).
Further quantitative assessments might have included a measurement of the overall size of
the mammary fat pad, and percentage occupation by epithelial cells and ducts. Such an
analysis was not performed because a phenotype of Grb10KOm/+ animals in adulthood is a
reduced fat mass (Smith et al, 2007). Thus, it would be difficult to differentiate between an
effect specific to the mammary gland and a more global phenotype.
Subtle differences in gland architecture, such as the total ductal volume, for example, are
difficult to determine from the analysis of wholemount glands in two‐dimensions. A three‐
dimensional assessment may provide more accurate data, and may be sufficient to detect a
subtle phenotype. To this end, a pilot study was initiated to examine isolated and carmine
alum‐stained mammary glands using Optical Projection Tomography (OPT). This technique
permits the stacking of multiple 2D scans of a tissue sample to generate a 3D
reconstruction. Considerable success with this technique has already been documented for
in situ hybridisation on developing chicken embryos (Fisher et al, 2008). Wild type glands at
G12.5 were utilised in the present analysis. Despite scanning at the highest resolution
currently available with the present equipment, the output was not an accurate
representation of gland morphology. One key issue was the discrimination between ‘real’
structures and background staining; the threshold of acceptance could be altered over a
wide‐ranging scale, but it was impossible to eliminate all background without
compromising real gland structures. This might be improved by de‐staining the glands
before preparing for OPT analysis, or by staining for a shorter time. At present, the current
OPT output is inappropriate for quantitative assessment, but this might be possible with
methodological improvements.
It is pertinent to note that the quantitative analyses performed in the present study used
glands isolated at G12.5. This corresponds with a low‐level of Grb10 expression in the
mammary epithelium, and thus might be too early to detect any subtle phenotypic change.
However, branch measurements become challenging in glands more developed than
G12.5, as the network of ducts and alveoli make it difficult to identify and track individual
branches. Thus, being able to compare glands removed at later gestational, and even in
lactational, stages by OPT would be a considerable advantage. As already highlighted, there
is scope for this technique to be optimised for such an application.
Although no gross morphological defects could be attributed to Grb10 ablation in the
mammary gland, we wished to assay the function of the gland, using postnatal pup growth
as an endpoint measure. In this manner, any subtle changes in gene transcription or duct
ultrastructure which might ultimately affect milk secretion or synthesis would hopefully be
revealed. Previous studies have examined pup growth as a direct correlate of mammary
gland function (Wlodek et al, 2003; Manhès et al, 2006). In the current study, wild type and
Grb10KOm/+ females were mated with wild type males to produce pure wild type and mixed
litters, respectively. All females were seven weeks of age at mating, and were previously
virgins. It was necessary to control for age and pregnancy number because both of these
factors influence mammary gland function; although glands undergo involution after the
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weaning of pups, they typically retain more branches than that observed in virgin animals.
To track pups over the first 15 days of growth, a method to identify individuals was
necessary. This was particularly important in mixed litters, such that after culling, pups
could be genotyped and correlated with their respective weights. Grb10KOm/+ animals are
overgrown at birth (Charalambous et al, 2003), and thus their growth had to be recorded
separately to their wild type sibs. Various methods were employed to enable the
identification of individual pups, including the marking of skin with permanent waterproof
ink. This was rapidly washed off by the mother and did not permit long‐term identification.
To circumvent this issue, tattooing was used, in which a small volume of India ink was
injected under the skin and thus could not be removed by washing. As the mice were of a
mixed C57BL/6:CBA origin, they developed agouti or black pigmentation within a few days,
which obscured tattoo marks, regardless of ink colour. However, the pads of the paws
remain pink throughout postnatal life, offering the most suitable location for tattoo marks
to be easily seen. Further, this created the opportunity to develop a scheme in which
differential paw tattoo combinations could be correlated with a number system. This
provided an easy and consistent means for identifying individual pups, and caused limited
distress to the animals involved. Indeed, the tattoo marks on control animals not utilised in
the present study were still clearly visible six months or more after application.
Although tattoo marks enabled the discrimination between wild type and transgenic
littermates, thus permitting wild type pups born to a Grb10KOm/+ mother to be compared
with wild type pups born to a wild type mother, the comparison could potentially be
confounded by the presence of transgenic pups in litters suckling from a transgenic mother.
This was a particular concern because Grb10KOm/+ pups are overgrown at birth, offering a
potential advantage in competing with wild type littermates for access to a nipple. To
uncouple the influence of maternal genotype and sibling genotype on wild type pup
growth, a cross‐fostering study was designed. This included a control for the process of
cross‐fostering, in which pure wild type litters suckled by their biological wild type mothers
were compared with pure wild type litters raised by foster wild type mothers. On the day of
birth, both groups were indistinguishable, confirming that neither exhibited a growth
advantage. 24 hours after fostering, at which point any negative effects of cross‐fostering,
such as desertion, would be expected to manifest, there remained no difference in weight
between the datasets. This persisted until the end of the experimental period, confirming
that the process of cross‐fostering in itself did not influence pup growth. All pups in all
datasets were tattooed, to ensure that tattooing could also be eliminated as a parameter
influencing weight gain.
Before analysing the growth data from the cross‐fostering study, we first examined the
growth of wild type and Grb10KOm/+ pups raised by their biological mothers, separated by
gender. Three time points were examined which spanned the experimental period. At all
time points, pups of both genders displayed a considerable range of weight values, and
there were no significant differences between the mean values for male and female pups in
matched litters. This correlates with previous observations that body weight sexual
dimorphism does not manifest until after weaning, when sex‐specific differences in the
pulsatile release of growth hormone develop (Lichanska and Waters, 2008). The lack of any
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statistically significant difference in weight between the genders enabled the pooling of
data for subsequent analyses, and thus larger population sizes with more robust statistical
comparisons.
Analysis of postnatal pup growth in the cross‐fostering experiment revealed several points
of interest. Firstly, wild type pups in a mixed litter were indistinguishable from wild type
pups in a pure litter on the day of birth. This suggests that the growth of wild type pups is
not influenced in utero by Grb10 ablation in the mother or by sharing the uterus with
Grb10KOm/+ siblings. Importantly, this implies that neither group has a growth advantage at
birth which could be used to explain subsequent differences. In our previous studies, we
found that, at e17.5, wild type pups in a mixed wild type and Grb10KOm/+ litter were ~10 %
smaller than wild type pups in a mixed wild type and Grb10KO+/p litter (Charalambous et al
submitted). This difference was not attributed to competition from larger Grb10KOm/+ sibs
but correlated with an increased litter size for Grb10KOm/+ females. As Grb10KO+/p pups do
not exhibit a growth phenotype, such a size difference might also have been expected in
the present study between wild type pups of a mixed wild type and Grb10KOm/+ litter and
wild type pups of a pure litter. Whilst the original observation of a size difference was made
at e17.5, this is late in gestation and might be expected to persist at birth. An unpaired
Students’ T‐test between the two datasets in the current study was performed (not shown)
in addition to the one‐way ANOVA described, which also failed to detect such a difference.
This might be a consequence of using equipment not sensitive enough to detect such a
subtle change. If the mean weight of wild type pups born to wild type mothers is ~1.4 g, a
10 % reduction would represent a loss of ~0.14 g. This would be too subtle to detect on the
balance used in this study, which displayed weights to only one decimal place. Thus, it is
reasonable to assume that this effect may still be apparent at postnatal day 1, and wild
type pups in mixed litters therefore exhibit a very small growth disadvantage. However, the
influence of litter size was immediately removed at birth by normalising all litters to
between 5 and 7 animals.
Secondly, suckling Grb10KOm/+ pups demanded more nutrients than wild type pups.
Evidence for this includes the observation that wild type pups in mixed litters grew more
rapidly than wild type pups in pure litters. The implication is that Grb10KOm/+ pups, which
are larger at birth, demand more nutrients, promoting milk supply and thus benefitting
wild type siblings. Initially, our prediction was that wild type pups may be disadvantaged by
being raised alongside transgenic sibs, as they may be outcompeted in access to a nipple,
for example. However, the opposite effect was observed. Indeed, wild type pups were
expected to be marginally smaller in mixed litters, due to the effect of an increased litter
size in utero, as previously discussed. Any such disadvantage was clearly rapidly
compensated for by having more demanding Grb10KOm/+ siblings; a difference in growth
became apparent around postnatal days 5‐7, and continued to increase to the end of the
experimental period.
The third key observation relates to the original goal to identify a phenotype which might
be attributed to a perturbation of prolactin action. Grb10KOm/+ females exhibited a reduced
supply of nutrients to suckling offspring relative to wild type female controls. This was
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observed regardless of the pup genotype being compared. This implies that the normal in
vivo role of Grb10 is to promote mammary gland function in response to prolactin, and fits
the prediction that Stat5‐dependent genes in the mammary gland are ‘survival factors’.
Whilst a separation of the influences of maternal and offspring genotypes revealed
phenotypes relating to both lactation and suckling, a combination of the two demonstrated
a compound effect. Grb10KOm/+mothers were less able to respond than wild type mothers
to an increased demand from Grb10KOm/+ pups. As such, Grb10KOm/+ pups raised by
Grb10KOm/+mothers normalised to wild type littermate weight within a few days, whereas
those raised by wild type mothers continued to grow significantly larger than their wild
type littermates, with the biggest difference observed at the end of the experimental
period. Grb10KOm/+ pups suckling from a Grb10KOm/+ mother were also indistinguishable
from wild type pups in a pure litter raised by a wild type mother at days 8 and 15,
demonstrating a compensation effect. These observations suggest that Grb10 mediates a
supply and demand system between lactating mother and suckling pup.
This alone is an intriguing observation, but is perhaps even more so in the knowledge that
Grb10 is an imprinted gene. Can these data say much about why Grb10 imprinting, and
perhaps imprinting more generally, may have evolved? The most widely‐accepted
explanation for imprinting is the parental conflict hypothesis, discussed in Chapter One.
This predicts that maternally‐expressed genes will act to suppress growth, whilst
paternally‐expressed genes have the opposite effect. However, this logic is applicable only
up to the point of weaning and cannot explain the existence of imprinting in adult tissues,
such as the mammary gland, as discussed in Chapter Five. Indeed, the imprinting profile
and function of Grb10 during embryonic growth fit the hypothesis; Grb10KOm/+ foetuses are
overgrown and have more efficient placentae (Charalambous et al, 2003; Charalambous et
al, submitted). It is therefore possible that imprinting of Grb10 evolved for this purpose,
but an alternative model is required to explain why this should extend to the regulation of
nutrient supply from the mammary gland. An attractive alternative is the maternal‐
offspring coadaptation hypothesis proposed by Wolf and Hager (2006). This model
demonstrates that genes with pleiotropy, affecting different maternal and offspring traits,
are more likely to be selected for imprinting. Moreover, such selection will favour
expression from the maternally‐inherited chromosome, as this will increase the adaptive
integration between the genomes of mother and offspring. The observed role of Grb10 in
mediating supply and demand is consistent with the model on three levels. Firstly, it is
maternally‐expressed Grb10 which is mediating the supply/demand system. Secondly,
Grb10 is pleiotropic, promoting nutrient output from the mother’s mammary glands and
suppressing nutrient demand in suckling pups. Finally, the integration of these roles
controls offspring fitness. Ablation of maternally‐expressed Grb10 in a suckling pup
increases demand, but the corresponding ablation of Grb10 in the lactating mother reduces
supply, with the result that Grb10KOm/+ pups normalise to wild type weight within a few
days. A lactating mother with a fully functional Grb10 allele does not apply such a brake to
nutrient output, allowing growth to proceed with a ‘check’ at a higher threshold. Thus,
Grb10 helps achieve optimal fitness. A larger pup is not necessarily fitter, when one
considers the measure of fitness to be the effectiveness of gene propagation. If this was
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the case, the wild type weight would simply be larger. Additionally, as discussed in Chapter
Four, when considering the likelihood of morbidity, the optimal birth weight is just above
the mean for a population (Sansing and Chinnici, 1976).
Coadaptation of an imprinted gene with pleiotropic effects in mother and offspring has
previously been described for Peg3, but this example exhibits some different properties to
those seen for Grb10. Peg3 is a paternally‐expressed gene, whose expression is
predominantly in the hypothalamus and placenta (Kuroiwa et al, 1996; Hiby et al, 2001).
Because of the direction of the imprint, the effects of Peg3 mutation in the pup can be
separated from the effects of Peg3 mutation in the mother, without the need for cross‐
fostering. Peg3+/p embryos and placentae were growth retarded, which correlated with a
reduced pup size on the day of birth (Curley et al, 2004). Wild type females carrying mutant
embryos failed to match the weight gain of females carrying wild type embryos at the late
stages of pregnancy, which prepares the mother for lactation. Mutant pups failed to gain
weight in line with wild type pups through the suckling period, despite suckling from a wild
type mother. In the mother, Peg3 ablation from the paternally‐expressed chromosome
resulted in a failure to gain weight in the late stages of pregnancy, even though the
embryos were all wild type. At birth, wild type pups born to a Peg3+/p mother were growth
retarded and were restricted in postnatal growth by an impairment of milk letdown. It is
intriguing that the outcomes of Peg3 mutation in mother and pup were essentially
complimentary: impaired milk letdown versus impaired suckling; reduced maternal food
intake versus a small placenta; the time the mother takes to achieve weaning weight of
wild type pups versus impaired postnatal growth. The significance of such coadaptation is
that offspring who have extracted ‘good’ maternal nurturing are well‐provisioned and will,
themselves, be genetically predisposed towards ‘good’ mothering (Curley et al, 2004;
Keverne and Curley, 2008). This complimentarity effect is not the case for Grb10. It is not
possible to differentiate between the effects of maternal and offspring genotype in utero,
but the cross‐fostering study demonstrates that, postnatally, Grb10 ablation on the
maternally‐inherited chromosome increases pup demand whilst limiting maternal supply.
The effects of mutation in mother and pup are therefore opposite, producing a
compensation effect. In a wild population, it is perhaps more relevant to think of Grb10
allelic variation, rather than ‘wild type’ or ‘Grb10KO’. An allelic variant which suppresses
nutrient supply is passed to offspring who, as a consequence of that same allelic variant,
demand more nutrients in compensation. Expression of this allele from the maternal
chromosome ensures that all future generations will continue to compensate a reduced
supply with an increased demand. Thus, although Peg3 and Grb10mutations in mother and
pup produce complimentary and opposite effects, respectively, the outcome in both cases
is increased mother‐offspring coadaptation.
Grb10, like Peg3, is expressed in the hypothalamus (Smith et al, 2007; Garfield et al,
submitted), and thus it is conceivable that the reduction in nutrient transfer observed in
Grb10KOm/+ mothers is a consequence of perturbed hypothalamic function. However,
Grb10 expression at this site is exclusively from the paternally‐derived chromosome, both
during development and adulthood (Figure 3.4). Thus, hypothalamic dysfunction is unlikely
to be the basis for the observed phenotype.
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The mechanism through which Grb10 mediates nutrient supply via the mammary gland is
unclear, but does not seem to be through the regulation of branching morphogenesis. An
assessment of milk quality also suggested that this was not the physiological basis for a
difference, although the influence of subtle variation, not detected in our approach, cannot
be excluded. Many genes encoding milk proteins, including  β‐casein and WAP, are direct
transcriptional targets of Stat5 (Happ and Groner, 1993; Wakao et al, 1994; Li and Rosen,
1995). Although not tested in mammary glands, Stat5 protein levels were unaffected by
Grb10 ablation in the placenta (Figure 5.12), suggesting Grb10 does not feed back to
suppress the prolactin‐Stat5‐Grb10 pathway. Changes in milk protein levels might not,
therefore, have been expected. The result implied that milk letdown might be perturbed,
such that the total volume of milk available to suckling offspring was reduced. This was
assessed for Peg3+/p mutant mothers, by separating mother and pups for a fixed period,
then recording weight change in both six hours after being reunited (Curley et al, 2004). A
similar experiment should be performed for Grb10KOm/+ mothers to confirm this inference.
We initially hypothesised that lactating Grb10KOm/+ mothers would exhibit reduced levels
of pituitary Prolactin expression relative to wild type controls, because of their poor
provisioning. However, the opposite result was observed. This apparently paradoxical
finding may actually help to pinpoint the physiological basis for the reduced nutrient supply
of Grb10KOm/+ mothers. Pups suckling from transgenic mothers, regardless of their own
genotype, are unable to extract the nutrients they demand from the mammary gland. This
might promote suckling for longer durations and/or more frequently. The physical act of
suckling, through a neurological connection, promotes Prolactin expression in the pituitary
gland of a lactating female (Callahan et al, 1996). The extent of PRL secretion is directly
correlated with the intensity of the stimulus, as determined by the assessment of mothers
suckling various litter sizes (Mena and Grosvenor, 1968). Thus, the likely increased suckling
in pups raised by a Grb10KOm/+ mother might cause elevated Prolactin expression in the
mother’s pituitary gland, presumably correlating with increased prolactin levels in the
blood serum. The observation suggests that this neuroendocrine feedback loop is
functioning adequately in Grb10KOm/+ mothers, but the mammary glands are resistant to
the increased levels of prolactin. This effect is not observed in wild type females raising
more demanding Grb10KOm/+ pups, at least at postnatal day 15. The increased demand
presumably causes elevated Prolactin expression at first, but the wild type mammary gland
responds by promoting milk synthesis and release. Pup demand is more closely matched,
and thus pituitary Prolactin levels normalise again. It would be interesting to examine
Prolactin expression in the pituitary glands of Grb10KOm/+ mothers raising mixed litters;
levels may be elevated beyond that seen in Grb10KOm/+ mothers raising wild type pups,
because the demand is increased still further. The prediction that pups suckle for longer or
more frequently from a Grb10KOm/+ mother could be tested by behavioural studies.
Additionally, prolactin serum levels should be assayed to confirm that this correlates with
gene expression.
Expression of Growth hormone did not alter between any of the experimental groups. GH is
essential for correct pubertal development of the mammary glands, but a role in
pregnancy‐dependent gland development has not been defined. As such, GH acts as a
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suitable control, confirming that the changes in Prolactin expression are probably not a
consequence of a general hypothalamic or pituitary dysfunction.
Whilst this data suggests a physiological basis for the observed nutrient supply phenotype
(i.e. mammary gland resistance to prolactin), the molecular control of this remains unclear.
One mechanism for prolactin resistance might be reduced prolactin receptor (PRLR)
expression. However, this appears unlikely as Grb10KOm/+ mammary glands do not exhibit
perturbed branching morphogenesis, a process under the influence of pituitary prolactin.
Indeed, mice deficient for the prolactin receptor gene are infertile, whilst Prlr+/‐ mice still
show an almost complete failure to lactate (Ormandy et al, 1997). Additionally, the levels
of milk proteins, the expression of which are prolactin‐  and Stat5‐dependent, are
unaffected by Grb10 ablation.
Recently, serotonin (5‐HT) has been described as a paracrine/autocrine regulator of
mammary gland homeostasis during lactation (Matsuda et al, 2004). 5‐HT is secreted into
milk, and thus the accumulation of milk in the mammary ducts also results in 5‐HT
accumulation (Stull et al, 2007). This molecule suppresses milk protein gene expression in
epithelial cells (Matsuda et al, 2004). As Grb10KOm/+ mammary glands are less effective at
transferring nutrients to suckling offspring, yet do not exhibit a gross morphological
perturbation, one hypothesis might be that 5‐HT levels are altered. Indeed, this may even
be the mechanism of resistance to prolactin. If Grb10 ablation causes 5‐HT levels to be
increased, this would suppress milk production, but the relative levels of milk protein
expression might not necessarily change, explaining the consistent levels of whey acidic
protein,  β‐casein and others extracted from wild type and Grb10KOm/+ milk. Additionally,
elevated 5‐HT levels would engender more rapid apoptosis, consistent with the
observation that Grb10KOm/+ glands exhibit a trend towards this.
If 5‐HT levels are not the molecular basis for prolactin resistance, Grb10KOm/+ glands might
still be expected to display elevated 5‐HT levels in response to milk stasis. Thus, examining
5‐HT activity would not permit differentiation between the two effects, without further
knowledge of the molecular interactions Grb10 is involved in in the mammary gland.
Nonetheless, 5‐HT levels should be investigated in wild type and Grb10KOm/+ mammary
glands, most easily achieved by assaying for Tph1 transcript levels as a proxy.
Finally, as previously mentioned, Grb10KOm/+ mammary glands exhibited a trend towards
more rapid involution, although this did not reach statistical significance in the datasets
examined. A more comprehensive analysis of involution should be performed, especially in
light of the expectation of elevated 5‐HT levels in transgenic glands; 5‐HT promotes
epithelial tight junction disruption, a key event in tissue remodelling (Stull et al, 2007; Pai
and Horseman, 2008). In the current study, mammary glands were harvested 48 hours
after a forced‐wean, around the time of the transition from phase I to phase II, and assayed
by TUNEL. This should be extended, initially by histological examination of glands at late
gestation and at a range of involution stages. Glands isolated from mice deficient for the
Insulin‐like growth factor binding protein 5 (Igfbp5) gene, for example, showed delayed
involution, but a histological difference not observed until 6 days after a forced‐wean,
which correlated with an increase in TUNEL‐positive nuclei (Ning et al, 2007).
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The observation that Grb10 is expressed in a pregnancy‐dependent manner in the adult
mammary gland, and retains its imprinted status, caused us to investigate the function of
the gene in this tissue. The study revealed that Grb10 promotes nutrient transfer from
lactating female to offspring, but also that, in a demonstration of coadaptive traits, Grb10
suppresses nutrient demand in suckling pups. In this manner, Grb10 is important for the
homeostatic control of offspring growth. An analysis of pituitary Prolactin expression in
Grb10KOm/+mothers suggested that the neuroendocrine feedback loop, in response to the
suckling stimulus, is functionally intact, but that the mammary gland is resistant to elevated
pituitary Prolactin expression. The mechanism for the suppression of nutrient supply from
Grb10KOm/+ mammary glands remains elusive. The roles of Grb10 as a supply promoter and
demand suppressor are different to those in the placenta and embryo, in which Grb10
suppresses supply, as well as demand. These apparently paradoxical observations are
discussed with relevance to reproductive strategies in Chapter Seven.
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Since the demonstration of the requirement for both parental genomes to permit
successful embryonic development over 25 years ago (McGrath and Solter, 1983), and the
discovery of the first imprinted gene 8 years later (DeChiara et al, 1991), the field of
genomic imprinting has progressed and diversified rapidly. At the core of this research lie
two key questions: 1) why has genomic imprinting evolved; and 2) how is genomic
imprinting regulated? In the process of addressing the second of these questions, the new
discipline of epigenetics has been spawned. We have subsequently realised that epigenetic
modifications are not only important in the regulation of imprinted genes, but are in fact a
crucial component of regulating expression throughout the genome. Additionally,
epigenetic modifications appear to be fundamental in the regulation of stem cell
pluripotency. The significance of these findings is illustrated by the recent drive to ‘map’ the
epigenome, including genome‐wide analyses of DNA methylation sites and histone
modifications. This has revealed some intriguing global patterns. For example, whilst CpG
islands have typically been associated with the control of gene expression and have been
identified at many promoter regions, 55 % of CpG islands in the human genome are
‘orphans’, with no such association (Bird, 2009). Moreover, these orphans are
overwhelmingly hypermethylated. That methyl‐cytosine can spontaneously deaminate to
thymine implies positive selection for the maintenance of these CpG islands, and thus a
functional significance. The nature of this role is yet to be defined.
It is becoming increasingly apparent that many cancers arise through aberrant epigenetic
regulation, both of imprinted and biallelically‐expressed genes. As methylation is typically,
although not universally, associated with transcriptional repression, one model is that the
de novo methylation of CpG islands might silence tumour suppressor genes, and thus
contribute to cancer progression (Bestor, 2009). This may provide possibilities for future
therapeutic targets, and might aid our identification and staging of cancerous tissues. A
study examining the methylation status of CpG islands at four tumour suppressor genes
confirmed that 89 % of bladder cancer tumours analysed exhibited at least 20 %
methylation at one or more of these loci, relative to almost a complete absence of
methylation in control tissues (Salem et al, 2000). The stage of the tumour correlated with
the number of loci simultaneously methylated, with several highly aggressive cancers
demonstrating hypermethylation of all four markers.
Concurrent with this expansion of the epigenetics field has been the drive to understand
why imprinted genes have evolved. Key to addressing this question is the elucidation of
imprinted gene function. With this knowledge, we can hope to explain why positive
selection for functional haploidy should exist. To‐date, the most widely‐accepted model is
the parental conflict hypothesis (Haig and Westoby, 1989; Moore and Haig, 1991), but as
discussed in previous chapters, this has some important limitations. There exists a tendency
to generalise when discussing imprinted gene function and evolution, but perhaps we
cannot account for all imprinted loci with a single explanation. Imprinting at one or two loci
may have evolved for the reasons presented in the parental conflict hypothesis, for
example, but the mechanism for regulating parent‐of‐origin specific gene expression might
have subsequently been adopted for other roles.
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The imprinted gene Grb10 has some intriguing properties, and provides an excellent model
with which to investigate imprinted gene function, and indeed, regulation. The most
provocative of these features is the reciprocal imprint apparent between the central
nervous system (CNS) and peripheral tissues, a system conserved in both mouse and
human (Blagitko et al, 2000; Arnaud et al, 2003; Monk et al, 2009). Sanz et al (2008) have
described how this reciprocal imprint is achieved at the epigenetic level, but the reasons for
this pattern of monoallelic expression are still unclear. Our laboratory aims to address this
important question by examining the in vivo functions of Grb10, by transmitting
dysfunctional Grb10 alleles separately through each parental line.
The first transgenic allele in which Grb10 was ablated, Grb10Δ2‐4, identified maternally‐
expressed Grb10 as a potent foetal growth inhibitor and attenuator of insulin signalling in
adulthood (Charalambous et al, 2003; Smith et al, 2007). However, the LacZ gene‐trap
introduced at the locus to generate the Grb10Δ2‐4 allele failed to report expression in the
CNS of transgenic mice. To address this shortcoming, a second transgenic mouse line,
Grb10KO, was created. The LacZ gene‐trap in this allele successfully reported CNS
expression, but only when transmitted through the paternal lineage. The function of Grb10
in this organ was associated with the tempering of social dominance, a role independent of
maternally‐expressed Grb10 in peripheral tissues (Garfield, 2007; Garfield et al, submitted).
The present study was initiated by characterising the Grb10KO allele at the genetic level,
and confirming its efficacy in the ablation of full‐length Grb10. This process identified a
phenotypic inconsistency between transgenic mice harbouring the Grb10KO and Grb10Δ2‐4
alleles; the former was homozygous lethal during embryonic development, whilst Grb10Δ2‐
4m/p animals were viable. The genetic mapping of Grb10KO provided a possible explanation
for this effect, although further investigation is required to confirm this.
With a detailed knowledge of the structure of the two transgenic alleles, we were able to
hypothesise on why Grb10Δ2‐4+/p animals failed to report expression in the CNS. This led to
the identification of a short conserved sequence at the Grb10 locus, which exhibited
properties of an enhancer element. In an in vitro luciferase assay, we demonstrated that
this sequence could promote reporter gene expression in the presence of constitutively
active Stat5b, consistent with the identification of sequences within the putative enhancer
with high similarity to the Stat5 consensus recognition site. The expression profile of Stat5b
was very similar to that of Grb10 in the adult mouse brain. That the putative enhancer
element is absent from the Grb10Δ2‐4 allele suggested that the failure to detect LacZ
transcription in the CNS of Grb10Δ2‐4+/p animals was likely to be a consequence of Stat5b
being unable to bind at the locus and promote gene transcription.
Intriguingly, a previous study, working with mammary epithelial cell culture, alluded to an
interaction between Stat5 and Grb10 at the transcriptional level (Clarkson et al, 2006). We
demonstrated that whilst strong reporter expression was detected in the mammary glands
of Grb10KOm/+ females, no detectable expression was observed in Grb10Δ2‐4m/+ glands,
reminiscent of the difference in the CNS, and supportive of a Stat5‐Grb10 interaction in this
tissue. Importantly, reporter expression, under the control of the endogenous Grb10
promoter, was pregnancy‐dependent and confined to epithelial cells. This suggested that
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Grb10 activation was under the control of prolactin. Whilst the downstream effects of
growth hormone can also be transduced through Stat5, the stroma, rather than the
epithelium, is the target cell type of this hormone in the mammary gland.
The observation that the imprinted status of Grb10 expression in the mammary epithelium
was retained is particularly intriguing. This is the first description of a tissue in which Grb10
is activated in adulthood, and is thus inconsistent with conflict theory. With this in mind, we
examined the function of the gene in this tissue, using postnatal pup growth as an endpoint
measure. To differentiate between the influences of mother and pup genotype, a cross‐
fostering study was performed, with relevant controls. This extended our understanding of
the role of maternally‐expressed Grb10 in the regulation of growth. We clearly
demonstrated that Grb10 ablation enhances postnatal pup nutrient demand and restricts
maternal supply, implying that one function of Grb10 is to mediate a supply/demand
system. As such, Grb10 is a demand suppressor and supply promoter during the suckling
period. This contrasts with the role of maternally‐expressed Grb10 in the placenta; work in
the present study, as well as studies published previously (Charalambous et al, 2003;
Charalambous et al, submitted), identify Grb10 as a supply and demand suppressor in
utero. At first glance, these interpretations might seem paradoxical. However, they hint at a
wider role for Grb10 in the control of reproductive strategy.
Reproductive success can be defined as the number of pregnancies a female can sustain
together with successful weaning of those offspring (Keverne and Curley, 2008). A gene, or
an allelic variant of a gene, will always be positively‐selected if it promotes self‐
propagation. Thus, the investment of too many resources in a single litter will be to the
detriment of the future reproductive success, and therefore gene propagation, of the
mother, an assumption upon which conflict theory is based. Whilst it is important to
provision offspring adequately to promote gene propagation, there exists a trade‐off
between resource allocation and litter number. This explains why natural selection does not
favour an ever‐increasing animal size or maternal investment. Human studies have
demonstrated that children with an intermediate birth weight have the highest fitness
levels (Sansing and Chinnici, 1976).
Although experimental manipulations show clearly that maternally‐expressed Grb10
restricts foetal growth, it is perhaps more valuable to consider Grb10 as part of the
mechanism maintaining optimal fitness. Grb10, expressed from the maternally‐inherited
chromosome in the placenta and foetus, prevents embryos becoming ‘too large’ and ‘too
demanding’, promoting their mother’s lifetime reproductive success. There is also a risk of
death or injury with giving birth to large offspring (Zhang et al, 2008), suggesting that
natural selection would also favour a reduced embryo size for this reason. The function of
Grb10 as a supply and demand suppressor in utero can thus easily be rationalised.
After birth, the role of Grb10 is to continue to maintain optimal fitness. It prevents pups
from demanding ‘too much’ maternal provisioning, whilst enabling the mother to match
supply with demand. This was exquisitely demonstrated by the impaired growth of wild
type pups in a pure wild type litter when raised by a Grb10KOm/+ mother, relative to a wild
type mother. As discussed in Chapter Six, Grb10 demonstrates pleiotropic effects in mother
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and offspring, promoting their coadaptation. Whilst the ablation of maternal Grb10 in both
mother and offspring resulted in pup overgrowth on the day of birth, the mother was able
to respond by restricting postnatal nutrient supply and normalising pups to wild type
weight.
Foetal programming is intimately coupled to optimal fitness. Such programming describes
how the conditions to which embryos are exposed in utero can influence metabolism in
adulthood. This has implications for the understanding of predispositions to human
diseases, such as type 2 diabetes and cardiovascular disease (reviewed in Le Clair et al,
2009; Jones and Ozanne, 2009). There is also clear evidence that the influence of the
postnatal environment is important in future fitness. Lactating female rats receiving diluted
ethanol to drink instead of water secrete ethanol in their milk. This has been shown to have
dramatic effects on hypothalamic development of suckling offspring, and subsequent
hypothalamic function (Klintsova et al, 2007), as well as overall growth (Murillo‐Fuentes et
al, 2001). Perinatal undernutrition in humans compromises cognitive development and
growth, and increases the risk of chronic adulthood diseases (Prost, 2009). Such effects will
ultimately compromise the ability of offspring to breed, and by definition, will decrease
their fitness. It would be interesting to examine the body compositions and metabolic
states of the pups reared in the cross‐fostering study. For example, the Grb10KOm/+ pups
raised by wild type mothers were considerably overgrown at the end of the experimental
period; does this overgrowth correlate with an increased fat mass or lean mass? The ratio
of fat:lean tissue may influence susceptibility to insulin intolerance, such that a ‘fatty’
mouse might acquire a diabetic‐like state in adulthood. This could be assessed by dual X‐ray
absorptiometry. Other developmental processes might be perturbed, such as the time at
which the pups enter puberty. This would have a considerable effect on the number of
litters it may be possible to raise in a lifetime, especially for females, affecting fitness. Wild
type pups raised by Peg3+/p mothers enter puberty significantly later than controls (Curley
et al, 2004).
In the case of Grb10, its contribution to the maintenance of optimal fitness is achieved by
influencing coadaptive traits in mother and offspring. As discussed in Chapter Six, genes
with pleiotropic effects, influencing such coadaptive traits, are favoured by selection to
become imprinted (Wolf and Hager, 2006). Perhaps imprinting initially arose at the Grb10
locus for reasons consistent with the conflict theory, regulating embryonic growth. The
mechanism might have been adopted for Grb10 expression in the mammary gland; the
consequential increased coadapativeness of mother and offspring would have promoted
rapid fixation of the imprinting status in the population. Indeed, the evolution of Grb10 as a
prolactin/Stat5‐dependent gene is particularly intriguing, given that the Stat5 binding site is
conserved in chicken, an organism which does not demonstrate imprinting nor does it
possess mammary glands. Nonetheless, chickens do secrete PRL, which, through Stat5‐
mediated signalling, is involved in egg production and regulation of the immune system
(Skwarlo‐Sońta, 1992; Cui et al, 2006). PRL involvement in the immune system is conserved
in mammals. Whilst it is not clear if Grb10 is also a downstream target of PRL in
lymphocytes, it might explain the evolution of a Stat5 binding site at the Grb10 locus in
chicken, which was retained in mammals and permitted diversification of Grb10 function.
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Perhaps the growth functions of Grb10 are specific to mammals, and thus correlate with
the evolution of imprinting; preliminary data on the functions of the zebrafish Grb10
orthologs support this hypothesis (Lee, Ward and Kelsh, unpublished data). To help dissect
the evolutionary origins of PRL/Stat5‐dependent Grb10 expression, it would be interesting
to examine Grb10 expression and regulation in mouse lymphocytes. Thus, whilst Stat5‐
mediated Grb10 expression has been implicated in brain, mammary gland and placenta in
the current study, we cannot rule out other tissues in which this system operates.
It is interesting that PRL/Stat5 signalling might represent one of the pathways responsible
for Grb10 expression in the placenta. Unpublished data from our laboratory suggests that
much of the foetal growth effects of Grb10 may be mediated through the Dlk1 signalling
pathway (Madon, Cowley, Garfield and Ward, unpublished data), but this appears not to be
the case for the placenta. PRL/Stat5 signalling could account for some of the placental
growth effects, perhaps acting in concert with Dlk1 signalling. The potential for the Grb7
superfamily proteins to mediate cross‐talk between signalling pathways has been noted
previously (Riedel, 2004). In support of this, deletion of the Stat5 binding site in vivo, using
the Grb10Δ2‐4 mouse strain, did not abolish Grb10 expression in the placenta entirely,
suggesting the presence of the Stat5 binding site is necessary to achieve correct transcript
levels but is not absolutely required for Grb10 transcription. This is reminiscent of previous
observations in the brains of Grb10Δ2‐4+/p animals (Garfield, 2007).
The Grb10‐mediated mechanisms maintaining optimal fitness, both in utero and
postnatally, require further investigation. Previous studies of the placenta had
demonstrated that Grb10 limits labyrinthine volume (Charalambous et al, submitted). The
present study suggested that this might be a specific restriction of foetal vascularisation,
thereby controlling the surface area available for nutrient exchange. Whilst this fits
comfortably with the roles of Grb10 as an attenuator of cell proliferation, the molecular
pathways through which this is achieved are not clear. Similarly, the mechanism through
which Grb10 regulates nutrient supply in a lactating female is unclear. Perturbed pituitary
gland function may be the basis for the reduced provisioning of Grb10KOm/+ females, but
the elevated levels of PRL synthesis in response to pup suckling argues against this,
although it would be interesting to examine the levels of PRL synthesis in virgin wild type
and Grb10KOm/+ females as a control. Instead, the data suggests that the provisioning
deficiency may be a consequence of mammary gland insensitivity to PRL. No gross
morphological perturbations were observed in Grb10KOm/+ glands, although it is not
possible to exclude the influence of subtle effects. Milk quality does not appear to be the
physiological basis for the phenotype, inferring that milk letdown may be impaired.
Dissecting the molecular mechanism for this effect could begin with an analysis of
circulating oxytocin levels in the serum of lactating females, and an assessment of 5‐HT
accumulation in the glands, as discussed in Chapter Six.
Although there is currently no experimental evidence to support this, it is conceivable that
Grb10 ablation in the placenta affects mammary gland function. As discussed previously,
hormone release from the placenta is fundamental for the preparation of the mother for
lactation, stimulating mammary gland branching morphogenesis and promoting maternal
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care behaviours (Thordarson et al, 1986; Bridges et al, 1996). Stimulation of these
physiological processes might be impaired by the Grb10KOm/+ placenta, possibly as a
mechanism to compensate for increased foetal size, thus normalising postnatal pup weight
to that of wild type animals, improving fitness. This argument would be equally applicable
to natural allelic variants of the Grb10 gene. Experimental assessment of this possibility
would be challenging, especially in the knowledge that Grb10KOm/+ mammary gland
morphology is not obviously perturbed. Serum levels of placental lactogens in gravid
females could be examined as a starting point.
Although the imprinted status of Grb10 was revealed over ten years ago (Miyoshi et al,
1998), the intricacies of its functions and regulation ensure it continues to be a dynamic and
exciting gene on which to work. Although not expected at the outset, this study has
revealed an important facet to the function of Grb10 as a growth regulator, which may
have implications for understanding why Grb10, and perhaps other genes, are imprinted. At
present, nothing is known of the imprinted status of other genes in the adult mammary
gland, and this may represent an exciting area of future investigation.
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